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Sexual development in mammals involves a complex cascade of genetic events. These 
begin with a cell fate decision, whether to make Sertoli or follicle cells, that gives rise to 
the development of a male or female gonad, which is controlled by the testis-determining 
gene Sry. Following the expression of Sry, genes involved in the male pathway act to 
reinforce and maintain testis-specific cell fate decisions, as well as to repress the female 
pathway.  Sox9 becomes rapidly upregulated  after the  onset  of Sry  expression,  and  is 
expressed in Sertoli cells throughout life. From mutation studies, SOX9 is known to be 
essential for male development in humans and to initiate Sertoli cell differentiation in 
mice.  However,  the  function  of SOX9  after sex  determination  and  the  reason  for  its 
maintenance in Sertoli cells remains unknown.
In order to understand the function of Sox9 in the fetal and adult mouse testis, new tools 
have been generated to control gene activity in a conditional manner. This thesis mainly 
describes strategies to control either deletion of misexpression of Sox9. To make the tools 
useful at different stages, the tamoxifen-inducible Cre/loxP system was employed. This 
involves the establishment of two elements: a “Cre-driver” and a ‘\Sbx9-responder”. Cre- 
driver transgenes  were  made  under the  control  of several  gonadal-specific  regulatory 
elements, as well as a strong, ubiquitous promoter. Responder mice allow Cre activated 
conditional misexpression or deletion of Sox9. Analyses on gonad morphologies and gene 
expression levels were compared between animals that have altered Sox9 expression and 
those  that have  not.  The  results  reveal  that  Sox9  is  necessary  and  sufficient  for the 
expression of Sfl in the Sertoli cells, and suggest that Sox9 is antagonistic to the ovarian- 
specific gene Foxl2.
The newly established Cre-drivers  can also be  applied  in functional  studies  involving 
other genes implicated in sexual development.TABLE OF CONTENTS
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11.1  Sexual reproduction
There are two types of reproduction, asexual or sexual.  Asexual reproduction involves the 
generation  of offspring  from  an  individual  organism  and without  involving  different  sex 
organs. As a consequence, the offspring are phenotypically and genetically very similar or 
identical to the parent.  This can happen by binary fission as in bacteria, by budding as in 
yeast,  or by  parthenogenesis,  as  in  some  lower plants  (see review  Charlesworth,  2006a), 
some invertebrates (e.g. snail, Johnson, 2006) and some vertebrates including certain species 
of reptiles,  amphibians  (see  review  Charlesworth,  2006b)  and  fish  (Itono  et  al.,  2006), 
salamanders (Bi and Bogart, 2006) and even, on rare occasions, turkeys (Cassar et al., 1998).
However,  during  evolution  most  metazoan  plants  and  animals,  including  apparently  all 
mammals, have adopted sexual reproduction, which involves two different types of gametes. 
Male  gametes,  pollen  or  sperm,  are  small  and  motile  and tend  to  be  produced  in  large 
numbers, whereas female gametes, ovules or oocytes, are large and sessile, and relatively few 
are made. In multicellular organisms with separate sexes, the soma will differ according to 
which type of gamete they carry.
The gametes are derived from germ cells and the existence of two different types of gamete 
implies requirement of two different germ cell niches to nurture their distinct needs. These 
are the gonads, which begin to develop during the period of organogenesis in a mammalian 
embryo and are the first elements of the reproductive system to show a difference between 
males and females. The events that underlie sexual differentiation of the gonad are critical for 
the generation of functional gametes.  Therefore, it is important to understand how the two
2different types of gonad are formed and how this relates to their function. During gonadal 
differentiation, a cascade of events happens at the molecular level to direct the formation of 
either testes in the male or ovaries in the female. Subsequently, sexually dimorphic internal 
and  external  genitalia  develop  to  give  a  functional  male  or  female  reproductive  system. 
Sexual  development  also  involves the  development of other sexual  characteristics,  which 
largely depend on secretion of sex-specific hormones, but these are all events downstream of 
the formation of the gonads.
The development into a male or female depends on a specific genetic signal, which becomes 
important mid-way through gestation  in the mouse or at  about 6  weeks  in humans.  This 
process  is  called  sex  determination.  Almost  immediately  after  sex  determination,  sexual 
differentiation begins in the gonad, allowing translation of the genetic sex into formation of 
different sex organs.
1.2  The biology of sexual development in mammals
To understand what happens at molecular and cellular levels, we must first understand the 
biology  of urogenital  development.  In  the  following  sections,  the  steps  that  lead  to  the 
formation of a complete sex organ will be described.
In the mammalian embryo, the  gonad arises from the presumptive urogenital tract, which 
comprises both the excretory and the genital systems and is situated at the lower posterior 
part  of the  embryo  (Figure  1.1 A).  The  excretory  system  develops  from  three  primordial 
kidneys  (in  Latin:  nephros),  pronephros,  mesonephros,  and  metanephros,  which  develop
3respectively in a consecutive manner.  In the mouse, the nephric primordium first appears 
between  11-13  somites  stage.  From  the  pronephros,  caudal  extension  of  condensed 
intermediate  mesoderm  separates  from  the  dorsal  mesoderm  and  gives  rise  to  the 
nephrogenic ridge, which in turn gives rise to the mesonephric nephrons and tubules. On the 
other hand,  several canals project from the coelomic epithelium to the nephrogenic ridge. 
The Wolffian duct forms from the intermediate mesoderm at around embryonic day (E) 9.0 
in mice, in craniocaudal succession.  It initially forms as an extension of the pronephric duct 
in the region of the future forelimb buds, and grows caudally (Torrey, 1945; also see review 
Hannema and Hughes, 2006).  Between El 1.5 and 12.5, the Mullerian ducts form in parallel 
to the Wolffian ducts. They are paired longitudinal tubes that arise by caudal extension of an 
initial invagination of coelomic epithelium at the rostral end of the mesonephros, which are 
then surrounded as they grow by mesenchymal cells originating  from  overlying coelomic 
epithelium (Guioli et al, 2006). Later on, the Wolffian duct will give rise to the epididymis, 
vas deferens and seminal vesicles in the male; whereas in the female the Mullerian ducts give 
rise to the uterus, oviducts and the upper portion of the vagina (Figure 1. IB).
1.3  Sex-determination and differentiation in mammals
Sex determination is the process by which a bipotential gonad takes up a genetic pre-decision 
to develop into either a testis or an ovary.  The earliest morphological event in the process 
leading to sex determination in the mouse happens around E9.75, when the genital ridges 
first arise as a thickening along the inner surface of the mesonephros (Figure 1.2).  Research 
findings support the theory that the gonadal primordium originates from cells from both the 
coelomic epithelium and the mesonephros (Byskov,  1986; Martineau et al.,  1997; and see
4also Sekido and Lovell-Badge, 2006).  As there is no difference between XX and XY gonads 
at this stage, the genital ridge is often described as “indifferent” or “bipotential”, which refers 
to its ability to develop either into a testis or an ovary.  Shortly after the genital ridges are 
formed, sex determination occurs.
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5Our knowledge of mammalian sex determination is based on two main areas of study.  The 
first  one  is  the  characterization  of  the  biological  events  that  determine  the  sexual 
development  of the  individual,  including  patterns  of gene  expression.  The  second  one  is 
based on  the study  of genetic mutations  in humans  and mice that lead to  abnormal  sexual 
phenotypes (Reviewed by Swain and Lovell-Badge,  1999; Nikolova and Vilain, 2006).  In 
the following sections of this chapter, I will discuss the major known events that occur during 
sexual development in mammals and their cellular and genetic contexts.
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Figure 1.2  Molecular events that happen during mammalian sex determination.
61.4 Mammalian sexual differentiation: the cellular context
1.4.1  Gonadal cell lineages: Somatic cells
Somatic cells in the gonads include 5 main cell types (Figure  1.3A). The supporting cells, 
which are called Sertoli cells in the male and follicle, or granulosa cells in the female, form 
the environment for the germ cells to reside within the adult organ. The supporting cells are 
important for gonadal maintenance and germ cell survival in both sexes, and all available 
evidence  suggests  they have  a  common precursor (Albrecht and Eicher,  2001;  Ito et al., 
2006).  Other somatic cell types include the steroidogenic cells, which are called Leydig cells 
in the male and theca cells in the female, which produce sex-specific steroid hormones, and 
the endothelial cells of the vasculature. Finally, there are the peritubular myoid cells (PMCs), 
which  are  testis-specific  and  together  with  Sertoli  cells  form  the  epithelial  testis  cords 
(Figure 1.3B).
Of all the somatic cell types in the developing testis, it is the Sertoli cell lineage that is the 
most critical for testis differentiation in mammals. Studies of chimaeras made by aggregating 
early XY and XX embryos indicate that if the early Sertoli cell number in a gonad reaches a 
threshold (about 25% of all supporting cells), they are able to recruit all other cell types in the 
gonad, whether XX or XY, towards the testicular pathway (Palmer and Burgoyne,  1991). 
Anti-Mullerian hormone (AMH) is a TGFp-related factor secreted by Sertoli cells,  and is 
important for Mullerian duct regression.  It is male-specific in the embryo, but is also made 
by follicle cells in the postnatal ovary (Munsterberg and Lovell-Badge, 1991; Arrango et al., 
1999, Salmon et al., 2005).
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It has been reported that Sertoli cells have different origins in different vertebrate species. In 
the mouse, Sertoli cells originate from cells that have migrated from the coelomic epithelium 
(Karl  and  Capel,  1998)  whereas  those  in  the  chick  are  derived  from  the  nephrogenic 
mesenchyme  (Sekido  and  Lovell-Badge,  2006).  Three  events  take  place  to  give  rise  to 
Sertoli cells: (1) proliferation, (2) migration and (3), differentiation. In the mouse, precursorsof  Sertoli  cells  form  between  El0.5  to  El2.5,  in  response  to  the  expression  of  a 
transcriptional signal from the Y chromosome (Koopman et al., 1991).  Before arranging into 
testis cords, these cells are termed pre-Sertoli cells.  During differentiation, pre-Sertoli cells 
probably signal back to the coelomic epithelium to recruit more cells into the developing 
testis, which then give rise to more pre-Sertoli cells (Martineau, 1997; Brennan et al.,  1998; 
Sekido et al., 2004). The establishment of the (pre-)Sertoli cell population then influences the 
development of all other cell lineages in the gonad.  A number of reports have suggested that 
cell migration from the mesonephros and coelomic epithelium into the XY genital ridge is 
essential for cord formation (Buehr et al.,  1993; Merchant-Larios et al.,  1993; Martineau et 
al.,  1997).  PMCs  and  endothelial  cells  migrate  into  the  gonad  from  the  mesonephros, 
probably also in response to signals from Sertoli cells. PMCs, possibly the only cell lineage 
unique to the testis, participate with Sertoli cells to form the epithelial testis cords (Martineau 
et al.,  1997; Tilmann and Capel,  1999). The endothelial cells contribute to the characteristic 
vasculature of the testis, which is thought to be important to support rapid growth of the testis 
in comparison to the ovary, and to allow efficient transport of hormones, which masculinise 
the remainder of the embryo.
The  origin  of steroidogenic  cells  in  the  mouse  is  not  known.  They  are  likely  to  have 
populated the genital ridge by El 1.5 and differentiate into Leydig cells later on (Figure 1.3; 
Morohashi  1997).  It  has  been  shown  recently  that  Leydig  cells  can  survive  in  gonads 
depleted of Sertoli cells (Gao et al.y  2006), indicating that these cell lineages are maintained 
by  different  factors.  Leydig  cells  secrete  two  male-specific  hormones,  testosterone  and 
insulin-like  factor 3  (INSL3).  These  are  important to the  formation  of secondary  sexual 
characteristics in the male.
9The differentiation  of the  ovary appears  relatively quiescent.  There  is  no  obvious tissue 
remodelling, no complex tubule and vascular structures, and the localization of the different 
somatic cell types within the early XX gonad is not obvious. However, changes are occurring 
at a molecular level during these early stages, even though the mechanisms directing ovarian 
development are still poorly understood (see below). The first morphological change during 
ovarian differentiation in the mouse appears at around El3.5, when the germ cells progress 
into meiosis (Byskov, 1981). Subsequently, the follicle cells aggregate around the germ cells 
(oocytes) to form follicles (Torrey, 1945).  The follicle cells, or granulosa cells, belong to the 
same lineage as the Sertoli cells in the testis.  These cells produce receptors for the follicle- 
stimulating hormone (FSH), a hormone produced by the anterior pituitary.  FSH stimulates 
the granulosa cells to produce estrogen, with the help of theca cells, the steroidogenic cells in 
the ovary, which forms the outer layer of the follicle.  Proliferation of, and hormone synthesis 
by,  theca  cells  is  stimulated  by  luteinising  hormone,  a  gonadotrophin  produced  by  the 
anterior pituitary (Vander et al., 1990).
1.4.2  Gonadal cell lineages: Primordial germ cells (PGCs^
Germ cell competence in mice is induced at E6.5 in epiblast cells by signals emanating from 
the  extraembryonic  ectoderm  (Lawson  et  al.,  1999).  PGCs  are  first  specified  at 
approximately E7.2.  They appear as clusters just posterior to the definitive primitive streak 
in the extraembryonic mesoderm.  Later on, these cells move back into the embryo proper, to 
the  mesoderm  of the  primitive  streak  and then  to  the  endoderm  (Ginsburg,  1990).  They 
migrate along the hind gut and dorsal mesentery and then into each mesonephros, entering 
the  genital  ridges  as  they  form.  By the time  of sex  determination,  the  PGCs  are  already
10within the genital ridges.  By E12.5, the PGCs are packed inside the cords in the developing 
testis, and gather in small clusters that are uniformly distributed across the ovary (Fox et al., 
1981).
Germ cell migration is not a sex-specific process. Differentiation of germ cells along either 
the male or female pathway does not depend on the sex chromosome constitution of the germ 
cell, but instead depends on the somatic environment of the gonad, which forms the germ cell 
niche  (McLaren  and Monk,  1981; Palmer and Burgoyne,  1991).  In the mouse,  germ  cell 
identity  is  established  around  El2.5,  as  somatic  differentiation  of the  gonad  becomes 
morphologically dimorphic (McLaren, 2003, also see review Swain, 2006). Germ cells in the 
XX gonad undergo an anterior-to-posterior wave of differentiation that lasts approximately 
from El2.5 to El6.5  (Menke et al., 2003), giving rise to oogonia, which arrest in the last 
phase  of  the  meiotic  prophase,  the  diplotene  stage.  They  then  become  surrounded  by 
granulosa cells and a basal lamina, to form the follicle around each germ cell, now referred to 
as an oocyte. Postnatally, a subset of oocytes will be grown and upon ovulation, the oocyte 
(now termed  secondary  oocyte) resumes meiosis,  completing the  second meiotic  division 
after fertilization (Peters, 1978, Figure 1.4).
At around El3.5, male germ cells arrest in mitosis, rather than entering meiosis (McLaren 
and Southee,  1997).  These prospermatogonia resume mitosis a few days after birth, then 
shortly before puberty,  a subset, now named spermatogonia, begin the  first meiotic wave, 
becoming spermatocytes (Figure 1.4). In the mouse, this happens around postnatal day 10-14. 
Subsequently,  spermatocytes  undergo  meiotic  divisions,  giving  rise  to  spermatids,  which 
differentiate into spermatozoa, carrying either the X or Y chromosome (Moens,  1987), and
11one set of autosomes.  The entry of a spermatozoan into a secondary oocyte restores the 
diploid state of the zygote and subsequent fetus.  As the spermatozoan carries either an X or 
Y  chromosome,  the  sex  of the  newly  conceived  embryo  is  pre-decided  by  which  sex 
chromosome the spermatozoan carries.
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Figure 1.4  Gamatogenesis: (A) Spermatogenesis; (B) Oogenesis
121.5  Genes involved in mammalian gonadal development
Sexual development in mammals is tightly controlled by gene function.  As discussed earlier, 
there  are  three  major  steps  involved:  the  formation  of  the  gonadal  primordia,  sex 
determination, and sexual differentiation.  The initiation of each step and the progression into 
the next one is coordinated by genes that are expressed at the relevant stage.  In this section, 
genes will be discussed according to the stage(s) when their function becomes important.
1.5.1  The formation of the gonadal primordia
The formation and maintenance of the gonadal primordial is an important process that sex 
determination in mammals depends upon.  Several genes have been shown essential for the 
development and survival of the genital ridge.
Steroidogenic factor 1
Sfl is an example of a gene that plays roles at multiple stages and in many cell types during 
gonadal  development.  In mice, Sfl  expression  is  detected around E9.0  in the  cells  of the 
coelomic  epithelium.  By E12.5,  following sex  determination, Sfl  is  downregulated  in the 
ovary, whereas in the testis SF1-expressing cells differentiate into Sertoli and Leydig cells. 
At later stages, Sfl plays important roles in regulating steroidogenesis in both sexes.
Sfl encodes an orphan nuclear receptor with a highly conserved, typical zinc finger DNA- 
binding domain (Lynch et al., 1993).  Other than the developing gonad, it is also expressed in
13cells in the adrenal gland, hypothalamus and pituitary.
Sfl null mutant mice lack both adrenal glands and gonads, and die by postnatal day 8 due to 
adrenal  insufficiency  (Luo et al.,  1994).  The  gonads  start to  form but  fail  to  give  either 
ovaries or testes, undergoing instead massive apoptosis by El2.5.  As XY gonads do not 
produce testosterone  or Anti-Miillerian Hormone, Wolffian ducts  do not  differentiate and 
there  is  no  Mullerian  regression.  As  a result,  both XX  and XY  Sfl'A mice  have  female 
internal and external genitalia.
Wilm’s turmor suppressor zene 1 (WtJ)
Wtl encodes zinc finger protein that regulates gene transcription, and has at least 24 isoforms 
(Menke et al.,  1998; Lee et al., 1999).  The most commonly studied isoforms, + and -KTS, 
are splice variants resulting either in an insertion or an omission of the KTS amino acid motif 
between  zinc  fingers  three  and  four.  These  isoforms  are  highly  conserved  amongst 
vertebrates (Kent et al.  1995, Miles et al., 1998).  Mutations of the KTS domain lead to two 
developmental syndromes in humans (Gubler et al.,  1999).  Denys-Drash-Syndrome (DDS) 
patients display urogenital abnormalties, whereas Frasier patients display male-to-female sex 
reversal.
In mice, transcription of Wtl in the genital ridge begins at E9.5 within the coelomic epithelial 
cell layer.  Following sex determination,  Wtl is expressed in Sertoli cells in the testis, and 
(pre-)granulosa cells in the ovary (Armstrong et al., 1993).
14Wtl'1 ' mutants were found not to express Sfl and fail to develop kidneys, gonads and adrenal 
glands.  These mice die after birth due to kidney failure (Kreidberg et al., 1993; Moore et al., 
1999).
To  investigate the  function of Wtl  during  gonadogenesis,  mouse models  were  developed 
based  on  observations  in  human  patients  (Hammes  et  al.,  2001).  “KTS”  mice  were 
developed as  a model  for DDS patients. These mice are ablated for the -KTS  isoform of 
WT1, and the gonadal primordia undergo apoptosis by El 1.5.  It has been demonstrated that 
the  -KTS  isoforms  associate  and  synergize  with  SF1  to  promote  male-specific  gene 
expression (Nachtigal et al.,  1998).  Analyses of WT1-binding sites within an Sfl gonadal 
specific  promoter  demonstrated  that  the  -KTS  isoform  can  bind  and  activate  the  Sfl 
promoter (Wilhelm and Englert, 2002).  This indicates that Wtl may regulate development of 
the bipotential gonad via activating Sfl, and therefore gonadal defects observed in KTS mice 
and Sfl null mice were similar.
LIM class homeobox zene 9
LIMclass homeobox gene 9 (Lhx9) also functions in close relation to Sfl.  Lhx9 is detected in 
the epithelial cells of the mouse bipotential gonad by E9.5.  After sex determination, Lhx9 
transcripts were localized in the interstitium in the differentiating testis (Birk et al., 2000).
Somatic cell proliferation in the genital ridge is greatly reduced in mice lacking Lhx9 (Birk et 
al.,  2000),  with Sfl  transcription reduced to minimal  (Wilhelm  and Englert,  2002).  This 
results in the failure to form the bipotential gonad and to express testosterone and Amh in XY
15embryos.  Therefore, XX and XY Lhx9'A mice have  internal  and extenal  female genitalia,  a 
phenotype similar to that of Sfl (Birk et al., 2000).
1.5.2  Sex-determination: cell fate decisions
With respect to cell fate choices, sex determination can be divided into three different phases: 
(1) the  operation of the  genetic  switch that triggers the  initiation of cell  fate decisions;  (2) 
initiation  of sex-specific  cellular  activity,  and  (3)  reinforcement  of cell  fate  decision.  A 
current model of genetic pathways during this process is schematically presented  in Figure 
1.5.
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Figure 1.5  Schematic diagram presenting the current model of genetic pathways during
early gonadogenesis.  Note: the location of genes in this diagram refers to when they 
become upregulated and exerting function but not correspond to the time they first 
become expressed in the urogenital ridge.
16Amongst all gonadal cell lineages, the supporting cells are the first to adopt a sex-specific 
identity.  Upon  sex determination,  supporting cell progenitors  will  differentiate  into  either 
Sertoli cells  in the testis,  or granulosa cells in the ovary.  The  fate of other lineages will 
follow that of supporting cell precursors.  Steroidogenic cells differentiate after specificity of 
the supporting cells have been established, and secrete sex-specific hormones. In the absence 
of a masculinised environment, germ cells in the XX gonad adopt the female identity and 
start to enter meiosis at around El3.5, whereas germ cells in the XY gonad arrest in mitosis.
Stage I:  Sry -  the Sertoli cell fate switch
In the search of the testis-determining factor (TDF), efforts have been made on looking for 
the minimal region of the human Y chromosome that led to development of XX males.  By 
looking within this region for sequences that were conserved on the Y chromosome of other 
mammals, with the mouse being special importance, few genes were put forward as the TDY 
candidates but eliminated.  A more focused search using two sex reversing mouse models, 
XXSxrb males and XYtdyml females, led to the discovery of Sry (Sex-determining region on 
the Y chromosome, Gubbay et al.,  1990; Sinclair et al.,  1990).  In humans, the discovery of 
de novo point mutations in SRY in XY sex-reversed females made it highly likely that SRY 
was TDY (Berta et al.,  1990).  In mice, evidence equating Sry with Tdy came from mutation 
studies, notably XY females carrying an  llkb deletion of Sry (Gubbay et al.,  1992).  More 
critically, transgenic experiments, in which XX mice bearing an Sry transgene developed into 
normal, albeit infertile males (Koopman et al.,  1991).  This result showed that Sry was the 
only gene on the Y chromosome required for testis determination, and that Sry alone was 
sufficient to drive the formation of testes on an XX background.
17SRY is the founder member of the SOX (Sty-like HMG box) gene family, members of which 
possess  an  HMG  box  DNA-binding  domain,  implicating  them  as  transcription  factors 
(Gubbay et al.,  1990).  SRY exhibits poor or even no conservation outside the HMG box 
among different mammalian species (Whitfield et al., 1993; Marshall Graves, 2002).  Sry has 
a narrow expression ‘window’, it is detected shortly after the bipotential gonad is formed, 
specifically in  supporting cell precursors  in the XY genital ridge.  Sry is  expressed in a 
dynamic wave that emanates from the central and/or anterior regions of the genital ridges. 
This wave  extends subsequently to both poles and ends  in the caudal pole,  and does not 
affect coelomic surface epithelial cells, suggesting that their proliferation is not dependent on 
Sry  (Bullejos  and  Koopman,  2001).  A  peak  of Sry  expression  occurs  at  El 1.5,  which 
coincides with increased proliferation within the coelomic epithelium and the migration of 
cells  from  the  coelomic  epithelium.  Twenty-four  hours  after  Sry  peak  of expression, 
transcripts are no longer detectable indicating that Sry must initiate Sertoli cell differentiation 
during this critical period (Hacker et al.,  1995).  It has been shown that all cells that once 
expressed Sry would commit to Sertoli cell fate (Sekido et al., 2004).
A few genes have been suggested in the involvement of upregulating Sry.  A mouse model 
has been developed based on Frasier syndrome.  Frasier mice are ablated for the Wtl +KTS 
splice variant, and displayed male-to-female sex-reversal resembling the phenotype seen in 
humans.  Further examination revealed a reduction in Sry transcription, indicating that the 
WT1  +KTS splice variant is required to upregulate Sry.  However, it was not mentioned in 
the report whether the cell number has been affected in this mutant.  Wtl is known to cause 
apotosis in somatic cells in the genital ridges (Loeb, 2006), and therefore the reduction in Sry 
transcription observed might be due to the loss of cells expressing Sry instead of an effect of
18Wtl directly regulating Sry expression. SF1 has been reported to bind and trans-activate the 
Sry promoter in vitro (Shimamura et al., 1997).
By El2.5, Sry transcripts are no longer detectable in the mouse testis. This suggests that Sry 
acts as a molecular ‘switch’ to specify Sertoli cell fate, but is not required for mediating testis 
differentiation.  It is  therefore reasonable to think that genes downstream  of Sry will play 
maintenance roles to reinforce and stabilize the initial cell fate decision.
Stage II: Sertoli cell proliferation and maintenance
Sox9 -  Critical for Sertoli cell proliferation and testis cord formation
Amongst the factors identified to be upregulated by Sry, the transcriptional factor Sox9 (Sry- 
like HMG box gene 9) is the most extensively investigated.  Sox9, together with Sox8 and 
Sox 10, belongs to the SoxE group of the Sox gene family.  The Sox9 gene is highly conserved 
and displays testis-specific up-regulation in all vertebrates examined to date (Morais da Silva 
et al., 1996; Kent et al., 1996; Kobayashi et al., 2005).  Sox9 is expressed at low levels in the 
mouse bipotential gonad.  It is rapidly upregulated in the supporting cells of the XY gential 
ridge by the time Sry expression reaches its peak (Morais da Silva et al.,  1996; Kent et al., 
1996, Sekido et al., 2004).  Unlike Sry, Sox9 expression persists in the sex cords of the testis 
throughout life.  In the XX, Sox9 is down-regulated following sex determination (Morais da 
Silva et al.,  1996) (Kent et al.,  1996).  Without Sox9, or with its level lower than a certain 
threshold, Sertoli cells either do not begin to differentiate or fail to maintain differentiation 
(Morais da Silva et al., 1996; Chaboissier et al., 2004).
19In  humans,  heterozygous  mutations  of  SOX9  cause  campomelic  dysplasia  (CD),  a 
pleiomorphic syndrome characterized by abnormal bone development.  In 75% of cases, XY 
individuals  develop  as  females  (Foster et al.,  1994).  Duplication  of Sox9 has  also  been 
shown to cause testis development in an XX patient (Huang et al.,  1999).  In contrast, testis 
development  in  mice  harbouring  heterozygous  Sox9  deletion  progress  normally  despite 
perinatal  lethality (Bi et al., 2001),  indicating that testis determination in humans is more 
sensitive to the dosage of the gene.  Sox9 null mutation obtained through conditional gene 
targeting lead to absence of sex cord development and expression of female markers in XY 
gonads  (Chaboissier et al.,  2004,  Barrionuevo  et al.,  2006).  On the  other hand,  ectopic 
expression of Sox9 in the XX genital ridge leads to male development despite the absence of 
Sry (Vidal et al., 2001; Qin et al., 2004).  These findings show that Sox9 can substitute Sry 
function in testis determination.
Stage III: reinforcing the cell fate decision
Several  studies  lead  to  a  model  for  the  regulation  of Sox9  expression  during  gonadal 
development (Figure 1.5).
Fibroblast growth factor 9 (Fgf9), an extracellular signalling molecule, was proven essential 
to maintain Sox9 expression and therefore Sertoli cell differentiation (Reviewed by Kim and 
Capel, 2006).
Fgf9 transcripts were first detected at El 1.5 in the Sertoli cell precursors of the XY gonad 
(Colvin  et  al.,  2001),  and  may  act  as  an  autocrine  factor  to  maintain  Sox9  expression.
20However, it may also act as a paracrine factor in neighbouring cells. FGF receptor 2 (FGFR2) 
is  the  principle  receptor  for  FGF9.  In  the  developing  gonad,  FGFR2  displayed  sexual 
dimorphic  sub-cellular  localization.  While  it  was  detected  in  the  cytoplasm  of ovarian 
somatic cells, FGFR2 becomes nuclearly localized in the XY gonad by E12.5, coinciding 
with the nuclear translocation of both FGF9 and SOX9 (Schmahl et al., 2004).
Fg/9 is one of the signalling molecules identified so far that can cause complete sex reversal 
in null mutant mice.  Organ culture of Fgf9'A XY mutant gonads demonstrates testis cord 
formation failure in proliferation of Sertoli cell precursors (Colvin et al., 2001; Schmal et al., 
2004; Kim et al., 2006).  Studies on genetic interactions between Fg/9, Sox9 and Sry revealed 
the importance of Fg/9 during early stages of Sertoli cell specification.  Although Sry activity 
and the initial upregulation of Sox9 in Sertoli cells of XY Fgf9'A mice are not affected, Sox9 
expression could not be maintained.  As a result,  Sertoli cells undergo cell fate transition 
causing sex reversal (Kim and Capel, 2006).
WT1 may be required for continued expression of Sox9.  Wtl null mice and -KTS mice both 
show an  early failure of gonadal  development, whereas Frasier mice  display sex reversal 
(Kreidberg  et  al.,  1993;  Hammes  et  al.,  2001).  Studies  on  Wtl  function  after  sex 
determination therefore have to rely on mutant mice generated through conditional deletion. 
Amh-Cre  mice  were  employed  to  conditionally  remove  exons  8  and  9  of  Wtl.  Mice 
harbouring only one functional  Wtl  allele have lost the majority of Sertoli cells by El5.5, 
and also Sertoli cell markers SOX8, SOX9 and AMH (Gao et al., 2006).  This suggests that 
continual Sox9 expression in the developing testis relies directly or indirectly on Wtl, and is
21independent of WTl’s putative function in upregulating Sox9, as shown in the -KTS mouse 
model (Hammes et al., 2001).
Sox8 belongs to the same group of SOX protein-encoding genes as Sox9 and functions in 
close relation with Sox9 during testis determination.  In vitro data showed that SOX8 can 
bind and activate promoters of SOX9 downstream targets including Amh (Schepers et al., 
2003, see below). Moreover, an attempt to use an Sfl-Cre driver to conditionally delete Sox9 
in vivo failed to give complete XY sex reversal, whereas introducing one null allele of Sox8 
into the same background, to give, in theory, supporting cells that would be Sox9'A; Sox8+ /\ 
lead to development of ovaries (Chaboissier et al., 2004). This could mean that SOX8 and 
SOX9 have an additive role to give  Sertoli cell  differentiation in the mouse. However,  it 
seems that the Sfl-Cre driver that was used probably acts too  late and/or incompletely to 
delete Sox9 from the early gonad, and there was evidence that Sox8 expression depends on 
SOX9,  suggesting  instead that Sox8 serves  as  a backup  mechanism  for Sox9 function, to 
reinforce testis determination and differentiation (Chaboissier et al., 2004).
Mini-summary on testis determination
Sry  is  required  to  switch  supporting  cell  fate  from  that  of follicle  cells  to  Sertoli  cells, 
characteristic  of the testis, and is  sufficient to  initiate the male pathway.  Although Sry is 
normally required to do this, in certain circumstances it is, however, not essential for testis 
determination, because Sox9 has been shown able to substitute for Sry function during testis 
determination. More importantly, Sox9 is required for building up the Sertoli cell population, 
which is a crucial event during early stages of testis development. On the other hand, Fgf9
22functions to maintain  SOX9  levels  and cell proliferation.  Without  a threshold number of 
Sertoli cells, testis cords will not form and the testicular pathway will not be maintained.
Other  than  Sry  cell-autonomously  switching  cell  fate,  the  paracrine-signalling  molecule 
prostaglandin D2 (PGD2) has been postulated to induce Sertoli cell differentiation.  PGD2 
has been shown able to partially masculinise XX gonads in culture, probably by inducing 
supporting cells in the ovary to differentiate into Sertoli cells (Adams and McLaren, 2002). 
Recent studies suggested a possible role of PGD2 to induce SOX9 nuclear translocation in 
the XY gonad (Malki et al., 2005), a sex-specific process that is important in the male sex 
determination cascade (Argento et al., 2003; Smith and Koopman, 2004).  PGD2 was further 
proposed to be sufficient in upregulating Sox9 expression in cells that did not express Sry 
(Wilhelm et al., 2005), suggesting a likely backup candidate to ensure efficient Sertoli cell 
differentiation, which becomes activated when cells destined to the Sertoli cell lineage failed 
to differentiate.
An ovarian determinant -  does one exist or is it “when Sry is absent”?
As  Sry  acts  as  the  genetic  switch towards  testis  development,  its  absence  will  allow the 
network  of transcription  factors  and  extracellular  signalling  in  the  bipotential  gonad  to 
proceed to female development.  The first significant cellular event in female differentiation 
happens at El3.5, when germ cells enter meiosis.  However, before this happens, genetic 
activities  in somatic  cells have  already adopted the  female pattern and cell  fate  decisions 
appear to have been taken. Several attempts have been made to identify genes that actively 
promote ovarian development, or at least act as anti-testis genes. These would counteract the
23idea  that  ovarian  development  is  a  passive  pathway.  This  section  focuses  on  several 
candidates that have proposed to be ovarian determinants.
Deal (Dosage-sensitive sex-reversal-adrenal hypoplasia congenital-critical region of the X 
chromosome gene 1)
DAX1  is  an  unusual  member  of  the  nuclear  hormone  receptor  superfamily,  with  an 
expression pattern that overlaps that of SF1  in various tissues, including the gonad, adrenal, 
hypothalamus and pituitary (Ikeda et al.,  1996). Indeed it is thought to physically interact 
with SF1 and to recruit co-repressors to the complex, thereby modulating SF1 transcriptional 
activity (Ikeda at al.,  1994). Daxl is expressed in the bipotential gonad at the same time as 
Sry, and becomes specific to ovarian somatic cells shortly after El2.5  (Swain et al.,  1996, 
Bouma et al., 2004).  DAX1 expression persists in ovarian somatic cells throughout life.
Daxl is an X-linked gene that is involved in mammalian sex determination.  In XY humans, 
loss of DAX1  does not affect male development, however, duplication of a genomic region 
encompassing  DAX1  can  cause  male-to-female  sex  reversal  (Bardoni  et  al.,  1994), 
suggesting that DAX1  is the gene responsible for dosage sensitive sex reversal (DSS).  The 
function of Daxl during sex determination in mice is controversial: while its overexpression 
is able to antagonize Sry function and can cause XY female sex reversal (Swain et al., 1998), 
Deal was also reported to be important for upregulating Sox9 in Sertoli cells, and therefore 
for cord formation (Bouma et al. 2004), although only on specific genetic backgrounds. The 
function  of  Deal  during  testis/ovary  differentiation  will  require  further  studies  using 
conditional transgenesis.
24Daxl transcription could be enhanced by the addition of P-catenin in vitro, indicating that a 
WNT signalling molecule might be involved in the upregulation of Daxl in vivo. However, 
p-catenin-mediated upregulation of Daxl occurred only in the presence of SF1  in a dosage- 
dependent manner (Mizusaki  et al.,  2003),  indicating DAX1  functions  through  a cellular 
balance with SF1.  The early expression of Daxl has also been shown to depend directly on 
SF1 (Hoyle et al, 2002).
Wnt4
WNT4 is an extracellular signalling molecule and is conserved in all vertebrates (Hollyday et 
al., 1995).  It is expressed in the mesonephros and bipotential gonad, but is downregulated in 
the XY gonad after Sry is upregulated and therefore becomes ovary specific (Vainio et al., 
1999).  A  single point mutation within the  WNT4 locus  has been  found in  a human XX 
patient  showing  signs  of masculinisation,  while  XX  Wnt4'/~   mice  develop  gonads  with  a 
mixed  phenotype  and  with  signs  of androgen  action  on  internal  and  external  genitalia 
(Biason-Lauber et al., 2004; Vainio et al., 1999). Mullerian ducts were not formed, but this is 
due to an additional role of Wnt4 common to both sexes. The gonads display some male- 
specific characteristics,  including coelomic vessels, and have Leydig-like cells that secrete 
testosterone. Although a very recent report suggests that there is transient up-regulation of 
Sox9 (Kim et al, 2006), testis cords do not form and there is no obvious differentiation of 
Sertoli cells, at least early on. The germ cells also do not follow the male pathway; instead 
oocytes are lost during mid-fetal stages (Vainio et al.,  1999). This precedes the detection of 
Sertoli cell markers at perinatal stages, which was therefore attributed to a type of secondary 
sex reversal seen in a number of circumstances when germ cells are lost from ovaries after
25they have begun to differentiate (e.g. Behringer et al., 1990; Morais da Silva et al., 1996). (If 
germ cells are never present or are lost early from an XX gonad, this type of sex reversal is 
not seen and the gonad simply forms a “streak” of connective tissue.)
The lack of Sertoli cell differentation early on in Wnt4'/' XX mutants appeared to rule Wnt4 
as the ovarian determinant. However, the data from Kim et al (2006), together with new work 
that revealed a new candidate ovary determining gene, R-Spondinl, which is also involved in 
the WNT signalling pathway (Parma et al, 2006), suggests instead a redundant mechanism 
where Wnt4 is only one of several genes used to ensure ovary development in XX animals.
WNT4 acts to prevent the migration of endothelial cells from the mesonephros into the gonad, 
forming  vascular  structures  (Jeays-Ward  et  al.,  2002).  The  loss  of  WNT4  also  led  to 
elimination of other female specific gene expression including that of follistatin (Fst) and 
Bmp2,  suggesting  these  genes  act  as  downstream  effectors  of  WNT4.  Other  than  its 
importance  in  female  development,  WNT4  also  appears  to  be  required  for  male 
differentiation.  XY  gonads  from  Wnt4'A  mice  displayed  reduction  in  Sertoli  cell 
differentiation,  evidenced  by  the  decreased  levels  of markers  including  SOX9  by  El 1.5 
(Jeays-Ward et al., 2004). However, this may reflect a role for WNT4 in achieving a correct 
balance between proliferation and differentiation of supporting cells.
Recently,  Wnt4  was  shown  to  be  an  antagonist  of Fgf9:  Fgf9'/'  XY  gonads  displayed 
upregulation  of Wnt4  and  its  downstream  markers  including Fst (DiNapoli  et al.,  2006). 
Ectopic expression of FGF9 in organ cultures not only induced SOX9 expression in the XX 
gonad, but also blocked Wnt4 expression, demonstrating the ability of FGF9 to act non-cell-
26autonomously to block signals specific to ovarian development and perhaps to recruit all the 
supporting cells in the gonad to follow the male pathway. WNT4 reciprocates by suppressing 
the male pathway: in addition to the transient effects on Sox9 expression as mentioned above, 
Fg/9 was upregulated in gonads of W n tfXX embryos, while ectopic  Wnt4 could repress 
both Sox9 and Fg/9 (Kim et al., 2006).  These findings show that Sox9 upregulation in the 
gonad  does  not  have  to  depend  on  Sry,  as  in  this  case  it  happened  as  a  result  of 
downregulation  of  Wnt4.  It was  proposed that  the  antagonism  between  Wnt4  and Fg/9 
balances  the bipotential  gonad between two  alternative  fates.  In  the male  this  balance  is 
disturbed by the action of SRY, which rapidly leads to upregulation of Sox9, while in the 
female it naturally, but perhaps more slowly, tips towards the ovarian pathway (Reviewed by 
Kim and Capel, 2006).
Forkhead domain/wineed-helix transcription factor L2 (Foxl2)
A candidate for a gene acting downstream of WNT4  is Foxl2, which encodes a forkhead 
domain/winged-helix  transcription  factor.  Mutations  in  FOXL2  cause  Blepharophimosis- 
ptosis-epicanthus  inversus  syndrome  (BPES),  which  is  associated with premature  ovarian 
failure (Crisponi et al., 2001; De Baere et al., 2001). The gene was also found to map to the 
critical region responsible for an XX male sex reversal syndrome in goats associated with the 
polled mutation (Pailhoux et al., 2004).
Foxl2 is specifically expressed in the ovary in mouse, chick, turtle and fish embryos at the 
time of sex determination (Loffler et al., 2003; Wang et al., 2004).  Foxl2 transcripts start to 
appear in the mouse XX gonad at around El2, which coincides with the downregulation of
27Wnt4 and Fst (Yao, 2005). After this stage, Foxl2 expression levels are maintained at a high 
level in follicle cells (Ottolenghi et al., 2005).  In the adult ovary, Foxl2 expression was seen 
highest in the granulosa cells in early follicles, whereas expression levels decline during later 
stages of folliculogenesis (Schmidt et al, 2004).
Foxl2  does  not  appear  to  affect  initial  ovary  formation,  but  it  is  essential  for  ovarian 
maintenance.  Foxl2'A  mutants  display high perinatal  mortality rates,  as  the  gene  is  also 
required for pituitary function, but the survivors are pre-dominantly, phenotypically males 
(Ottolenghi et al.,  2005),  implicating perinatal sex reversal,  a late sex-reversal phenotype 
similar to that observed in Wnt4 null mutants (Vainio et al.,  1999).  XX mice heterozygous 
for Foxl2 have an early block in folliculogenesis, with a failure to form primordial follicles, 
and are infertile (Uda et al., 2004).  However, unlike Wnt4 null ovaries, Foxl2 null ovaries do 
not display massive loss of oocyte (Ottolenghi et al., 2005; Vainio et al., 1999).
While overdosage of the DSS region encompassing DAX1 and WNT4 can both lead to XY- 
sex  reversal  in  humans,  they  are  both  shown  to  be  required  for  proper  Sertoli  cell 
differentiation, at least in certain genetic backgrounds in mice (Meeks et al, 2003; Jeays- 
Ward et al, 2004). The female-specific gene Foxl2 is not upregulated in the XX until El2.0, 
which is significantly after the establishment of differentiation of the Sertoli cell lineage in 
the male, which would appear to rule out Foxl2 as a primary ovarian determinant. Moreover, 
Foxl2 mutant mice do not show primary XX male sex reversal, which would suggest that at 
best it was only part of a redundant mechanism. In order to further address the function of 
Foxl2  during  sex  determination,  transgenic  mice  misexpressing Foxl2  are  needed  for the 
investigation of possible sex reversal phenotypes.
28The list of genes implicated in sex determination seems to be ever expanding. However, for 
most  of these  genes  there  is  still  relatively  little  understanding  of underlying  molecular 
mechanisms and more  effort has to be made to uncover their place  in the pathways  and 
networks involved in cell fate decisions and morphogenesis of the ovary and testis. Genes 
that are not discussed here include in particular Dessert Hedgehog, a gene that is expressed in 
Sertoli cells shortly after Sry but plays roles in Leydig and germ cell survival; Dmrtl, which 
is expressed in Sertoli and germ cells in the testis, but whose function is not yet understood; 
Fst and Bmp2, expression of which is exclusive to somatic cells in the developing ovary and 
are important for germ cell survival, Vanin 1, which may be involved in extracellular matrix 
remodelling specifically in the testis (Grimmond et al., 2000), and many others (see review 
by Wilhelm and Koopman, 2006).
1.5.3  Sexual differentiation -  executing the decision
The previous sub-section detailed landmark genetic activities taking place during different 
phases  of sex  determination.  After  the  initial  establishment  of supporting  cell  identity, 
sexually dimorphic gonad development proceeds to a further level, with other cell lineages 
being  induced  or  permitted  to  follow  the  male  or  female  pathway,  while  factors  made 
specifically in the testis instruct the rest of the embryo to follow a male pathway.  In the 
absence of such factors or their receptors, or in the absence of any gonads, the embryo will 
become female (Luo et al.,  1994; Adams and McLaren, 2002).  As soon as they begin to 
differentiate, the Sertoli cells organise into cords and secrete AMH. This induces Mullerian 
duct regression,  an early masculinisation  event (Behringer et al.,  1994).  Testosterone  and 
INSL3,  start to  be  expressed  shortly  after  Leydig  cells  differentiate  at  about  E12.5  (for
29reviews see Haider,  2004; Viger et al., 2005).  In the female, the earliest obvious cellular 
event happens at around E13.5, when germ cells undergo meiosis (McLaren,  1984; Adams 
and McLaren, 2002).
Amh -  eliminating the female reproductive tract
Amh is responsible for Mullerian duct regression in the male, and is therefore an essential 
component of the male sexual developmental pathway in mammals (Josso et al.,  1993).  In 
the mouse, the expression of Amh initiates at around El 1.5, shortly after Sox9 is activated, 
and  is  expressed  in  increasing  levels  by the  Sertoli  cells  through  El9.5.  Testicular Amh 
expression transiently declines at perinatal stages  (Josso et al.,  1993),  and is  dramatically 
downregulated  at  puberty  (Miinsterberg  and  Lovell-Badge,  1991;  Hacker  et  al.,  1995), 
coinciding with the onset of meiosis (Hirobe et al.,  1992; Rey et al.,  1996; Al-attar et al., 
1997).  Other  than  Mullerian  regression,  Amh  also  appears  to  have  a  secondary  role  to 
eliminate  any  germ  cells  that  have  entered  meiosis  early  in  the  testis  (Josso,  1990). 
Expression of AMH is not male-specific towards the end of gestation: it is also expressed in 
the XX gonads during late stages of embryogenesis and in postnatal granulosa cells (Vigier et 
al, 1984; Rey et al., 1996).
Apart from SOX9 and SOX8 as mentioned before, SF1 has been shown able to bind putative 
sites  on the  rat Amh  promoter  in  gel  shift  assays  (Hatano  et al.,  1994)  and mutating  its 
binding site upstream of Amh in vivo significantly reduces expression (Arango et al., 1999).
30Embryonic germ cell meiosis -  a cellular landmark of ovarian development
Morphological landmarks of ovarian development are not obvious until late gestation, when 
follicles start to surround the oocyte.  Before this, changes in the germ  cell  lineage have 
already begun.  Germ cells in the XX gonad enter meiosis at around El3.5; this process was 
recently shown to be related to Retinoic  acid (RA) signalling,  which  acts to regulate the 
timing  of meiosis,  and therefore  determines  germ  cell  sex.  Stra8,  a gene that positively 
responds to RA, displays XX-specific expression by E12.5, just a day prior to the onset of 
meiosis (Menke et al., 2003). In the male, CYP26B1, the enzyme that catabolizes RA to an 
inactive form, was found to be specifically expressed in somatic cells in the XY gonad at 
El3.5,  coinciding  with  the  onset  of germ  cell  meiosis  in  the  XX  (Menke  et  al.,  2002; 
Koubova et al.,  2006; Bowles et al., 2006).  This suggests that RA  signalling is  a likely 
inducer of germ  cell  meiosis,  which  in  the  XX  is  promoted  by  Stra8  and  in  the  XY  is 
inhibited by Cyp26bl (Reviewed by Swain, 2006).
Sexual hormone production
Sex hormone synthesis is a process downstream of sex determination. In the embryonic testis, 
male-specific  hormones  including  AMH  and  testosterone  start  to  be  produced  during 
gestation. In the ovary, follicle-stimulating hormone is produced by granulosa cells, whereas 
estrogen is synthesized by theca cells during folliculogenesis.
Six distinct forms of cytochrome p450 enzymes are involved in the synthetic pathway of 
steroid hormones from cholesterol. At least three of these P450 enzymes have been identified
31in the steroidogenic cells in the gonads: side chain cleavage enzyme (P450scc), aromatase 
(CYP19), and reductase (P450cl7 or CYP17).  P450scc is required for testosterone synthesis 
in  the  male.  In  females  P450scc  is  expressed  in  theca  cells  and  the  corpus  luteum. 
Biosynthesis  of  estrogens  from  androgens  is  catalyzed  by  P450  aromatase,  which  is 
important  in  follicular  growth,  especially towards  ovulation.  It  has been postulated that 
estrodiol blocks expression of male-specific genes including Sox9 and Fgf9 in granulosa cells 
(Richards,  2001).  P450  reductase  (P450cl7,  CYP17)  is  expressed  at  high  levels  in  the 
embryonic testis  during late  gestation  and in theca cells  of pre-ovulatory  follicles,  and is 
responsible for catalyzing the synthesis of androgens (Reviewed by Richards, 2001).
Sfl  is  linked  to  these  steroidogenic  P450s  by  their  coexpression  pattern  in  various 
steroidogenic tissues (Honda et al., 1993).  The expression of Sfl seems to correlate with the 
timing  of  hormone  synthesis  in  gonads  of  both  sexes.  After  sex  determination,  Sfl 
expression levels increase and are maintained in Leydig cells in the testis, but are decreased 
in the ovary.  This refers to a phase of testosterone and INSL3 production by the Leydig cells. 
Puberty sees a dramatic change in the Sfl expression pattern: it becomes expressed at high 
levels in the theca and granulosa cells in the postnatal ovary around the first ovulation cycles 
(Hatano  et  al.,  1994).  This  coincides  to  the  expression  of P450scc  and  aromatase  in 
granulosa cells  and reductase  in theca cells  (Reviewed by Richards, 2001),  both of them 
synthesizing hormones including estrodial and progesterone.
Putative  SF1-binding  sites  were  found  in  the  cw-regulatory  elements  of  P450scc  and 
aromatase (Rice et al.,  1991; Morohashi et al.,  1992). In vitro assays demonstrated that SF1 
is  able  to  activate  the  transcription  of  genes  encoding  both  enzymes  even  in  non-
32steroidogenic cells (Morohashi et al.,  1993).  Using Amh-receptor-Cre, XY Sfl  null mice 
were achieved, and were depleted for SF1  specifically in Leydig cells and granulosa cells. 
Embryonic Leydig  cells  from these mice do not express P450scc,  and therefore  failed to 
produce  testosterone  and  INSL3.  Although  embryonic  SfFA  ovaries  look normal,  fewer 
follicles are formed and corpora lutea are absent in female adults, indicating that ovulation is 
impaired in these mice (Jeyasuria et al., 2004).  However, further studies will be required to 
address the function of Sfl in ovarian development.
Other than Sfl, several other genes were found important in regulating P450s.  P450scc is 
also regulated by at least Fgf9 in the XY gonad. It has been shown that Fgf9~A mice failed to 
upregulate  Cypllal,  the  gene  encoding  P450scc,  resulting  in  failure  in  Leydig  cell 
development (Colvin et al., 2001). During late folliculogenesis, aromatase is upregulated by 
Wnt4 and Foxl2, and is expressed in granulosa cells (Pannetier et al., 2006).
1.6  Technologies developed for conditional mutagenesis in the mouse
The  ability  to  produce  mice  that  carry  altered  genomic  loci  or  foreign  transgenes  has 
facilitated the  study  of many  biological processes.  Undoubtedly,  studying  gene  function 
during embryogenesis is one of these.  However, the complexity of development demands 
further control of gene alteration in vivo to facilitate gene function analyses.  In many cases, 
introducing genetic changes to the germ line also have severe developmental consequences, 
complicating or even precluding the desired experimental analysis. For example, the loss-of- 
function of a gene might cause early embryonic lethality, rendering the study of its function
33in other later-developed tissues impossible. Conditional mutagenesis is therefore required to 
overcome these undesired limitations.
The  establishment  of several  conditional  technologies  in  mice  has  enabled  considerable 
sophistication to be applied to gene function research.  Many of these apply the concept of a 
‘genetic switch’, which ideally results in zero basal gene alteration when switched ‘off and 
high levels of activity when ‘on’.  These criteria have largely been met by binary transgenic 
systems, in which gene expression is controlled by two components: an ‘effector’ transgene, 
which  acts  on  a target,  or  ‘responder’  transgene.  The  most  commonly  applied  effector 
involves a recombinase that rearranges the responder gene, by either activating or silencing it 
(for reviews see Lewandoski, 2001; Ryding et al., 2001; Bockamp et al., 2002).
Cre (for “causes recombination”) recombinase, originally from bacteriophage PI  (Sternberg 
and  Hamilton,  1981),  and Flp recombinase  from Saccharomyces  cerevisiae  (Kilby  et al., 
1993)  are  both  powerful  tools  to  make  site-specific  changes  in  the  genome.  Both  have 
become popular in conditional mutagenesis in the mouse, especially during embryogenesis 
(Figure  1.6).  Cre and Flp operate in similar manners: both mediate effects on their DNA 
target sequences depending on the orientation, location and frequencies of the recognition 
molecules.  Recombinase-mediated changes range from excision, inversion, duplication, and 
chromosomal  translocation.  For the  interest  of my project,  I  will  focus  on the  Cre/loxP 
system.
341.6.1  Cre/loxP system
The  Cre/loxP  system  has  attracted  a  lot  of attention  in  recent  years  (see Nagy A’s  Cre 
transgenic database).  Cre recombinase has now evolved to become more suitable for in vivo 
usage in the mouse by changing a few codons in cis.  This improved version, called iCre (for 
improved-codon Cre; Shimshek et al., 2002), was proved to function better than the original 
Cre  recombinase  (Casanova  et al.,  2002).  Both  of them  recognize  a  34  basepair DNA 
sequence (loxP, for locus of cross-over PI) in the same orientation, and are believed to gain 
access to  chromatin either through diffusion  or following the transient breakdown of the 
nuclear membrane during mitosis (Orban et al.,  1992).  Upon homologous recombination, 
any DNA sequence bound between these loxP sequences would be deleted (Abremski et al., 
1983; Review by Kwan, 2002).  In the classic set up, the Cre-recombinase would be driven 
by a regulatory element, which defines where and when homologous recombination takes 
place, i.e., the effector, or ‘Cre-driver’.  On the other hand, the ‘responder’ allele would be 
‘floxed’ by two loxP sequences (flanked by loxP).  This can either be a genomic sequence or 
a transgene driven by an exogenous regulatory element.  In the latter case, it is usual to have 
a gene of interest, or otherwise a ‘reporter gene’, to follow the floxed transgene.  This genetic 
set-up  allows  loss-  or gain-of-function  studies  based  on  the  time  and  space  specific  Cre 
recombination profile, by conditional alteration of gene expression patterns in vivo.
1.6.2  Tamoxifen-inducible Cre
The  generation  of a  tamoxifen-inducible  Cre  system  is  achieved  via  fusing  Cre  with  a 
mutated  ligand-binding  domain  (LBD)  from  estrogen  receptor.  This  domain  no  longer
35recognizes endogenous estrogen 17p-estrodiol but an exogenous drug called tamoxifen, and 
therefore specially termed ERT (Danielian et al.,  1993; Brocard et al.,  1997).  The function 
of the ERT domain is to hold the Cre inactive in the cytoplasm by forming a complex with 
heat-shock  protein  90.  In  the  presence  of  the  catabolized  form  of  tamoxifen  (4- 
hydroxygentamoxifen,  or  OHT)  and  its  binding  to  ERT,  the  Cre-ERT  fusion  protein 
translocates into the nucleus, where it can trigger homologous recombination between target 
loxP sequences.  By doing this, although Cre expression is controlled by a tissue-specific 
promoter, its activities are prohibited until tamoxifen is introduced into the system.
Different versions of the ERT domain have been developed.  The improved version ERT2 
has been made more sensitive to OHT, which does not require hepatic catabolism (Indra et 
al., 1999).
1.6.3  Other conditional or inducible systems
Apart  from  Cre/loxP  and  the  inducible  forms  of it,  other  conditional  systems  for  gene 
expression  are  available,  and  are  also  accompanied  with  inducible  versions.  The  most 
commonly used one is the tetracycline responsive system, in which the effector is a fusion 
between sequences that encode the VP 16 transactivation domain and the Escherichia coli 
tetracycline  repressor  (TetR).  TetR  specifically  binds  to  both  tetracycline  and the  19bp 
operator  sequences  (tetO)  of the  tet  operon  in  the  target  sequence,  which  results  in  its 
transcription (Gossen and Bujard, 1992).  The TetR system is later on modified to enhance its 
efficiency and reduce basal transcription levels (Gossen et al., 1995).  Also available now is a
36doxycycline  (Dox)-inducible  system  (Baron  and Bujard,  2000;  Hasan  et al.,  2001),  which 
applies similar concepts to the tamoxifen-inducible Cre system.  This inducible TetR system 
is also applied in several cases to temporally control Cre activity (Saam and Gordon,  1999; 
Utomo et al., 1999; Holzenberger et al., 2000).
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Figure  1.6  C ontrolling gene expression  by 
DNA recom bination.
(a) The 34-bp loxP and FRT sites each consist 
o f two  13-bp inverse repeats (black) that flank 
an 8-bp core sequence (red). This core sequence 
confers directionality to these sites (red arrows).
(b) Dimers o f Cre or Flp (pink) catalyse in cis 
the conservative recom bination between two 
directly repeated loxP or FRT sites (red 
arrowheads), resulting in the formation o f a 
synaptic structure, the excision o f region B 
and the juxtaposition o f regions A and C. If 
region B  is an essential region o f a gene, then 
the recombination event results in gene 
inactivation. Recombination can also activate 
gene expression.  For example, transcription 
from a prom oter in region A could fail to reach 
protein-coding sequences in region C if 
polyadenylation sites exist in region  B; excising 
region B would therefore activate transcription 
o f region C.
(c) Use o f three loxP sites and a 'partial' 
recombination event (between  loxP sites 
labelled  1   and 2) to rem ove a neomycin 
resistance (neo) selection cassette and  leave an 
essential region floxed. The other two products 
o f recombination between loxP sites 2 and 3, 
and between  1   and 3 are also shown.
(pA, polyadenylation site; TSP, tissue-specific 
promoter.)
371.7  Project outline
Existing data suggests that both Sry and Sox9 need to be expressed in a highly coordinated 
temporal and cell-specific manner in order to initiate testis formation in the mouse.  The aim 
of my project is to manipulate the timing and cell-specificity of Sry and Sox9 expression, and 
to test the effect of this manipulation on sex determination.  For this purpose I am using the 
tamoxifen-inducible Cre/loxP system, which allows gene expression in a highly controlled 
manner.
In my  experiments,  gonad  specific regulatory  elements  will  be  employed to  control  iCre 
expression, thereby controlling the conditional expression profiles of Sry or Sox9 (Figure 1.7). 
Following the next chapter, which outlines all materials and general techniques in use in my 
project,  I  describe  how  Cre-driver  and  responder  elements  were  chosen  and  how  these 
transgenes were made and tested (Chapters 3-5).  I then describe the tools chosen for studies 
on  the  possible  function  of Sox9  (Chapter  6).  Briefly,  an  inducible  iCre  driven  by  a 
ubiquitous promoter is used to study the effects of loss- or gain-of-function of Sox9 in the 
developing mouse gonad.  Experiments are performed in different systems,  including cell 
cultures,  in  vivo  or  explant  cultures.  We  proved  that  our  newly  established  tamoxifen- 
inducible  Cre  system,  called  CAGGSET,  has  no  basal  activity,  but  can  produce 
recombination activity in different cell types in the gonad,  as well as many other tissues. 
Using CAGGSET, Sox9 was partially knockdown in the XY gonad, giving rise to changes in 
gene expression patterns.  On the other hand, misexpression of Sox9 by either CAGGSET or 
fi-actin-Cre (Lewandoski et al., 1997a) led to the formation of cord-like structures in gonads
38of both sexes.  Using the new tools developed, we can explore the function of Sox9, as well 
as many other genes involved in gonadal development in the mouse.
Gonad-specific promoter prom oter
STOP Sry/Sox9   — Inducible iCre
TAM
Gonadal cell nucleus
STOP Sry/Sox9
iducible iCre
Chrom osom e K indi ciblo iCre
H I   H H W H
Gonadal cell cytoplasm
Figure 1.7  Schematic  diagram  presenting the  project.  An example here is the conditional 
misexpression of Sry or Sox9 in the developing mouse gonad, which is mediated by a tamoxifen- 
inducible  Cre.  Upon  tamoxifen  administration,  the  iCre  protein,  which  is  flanked  by  two  ERT 
domains,  translocates  into  the  cell  nucleus,  allowing  DNA  recombination  to  remove  the  floxed 
(yellow triangles) stop codon, thereby allowing gene expression.  (TAM: tamoxifen).
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402.1  Reagents
Preparation of all reagents followed a published guide (Roskams and Rodgers, 2002).
2.2  Molecular cloning
Reagents for DNA  manipulation:  Restriction  enzymes  and  their  buffers  were  purchased 
either from Roche Diagnostic Inc, Germany, or New England Biolabs, UK.  Klenow enzyme 
(Promega,  UK)  was  used  for  generating blunt-ended DNA.  Ligase  and  shrimp  alkaline 
phosphatase were purchased from Invitrogen, UK.  The DNA polymerase used to generate 
fragments  for  sub-cloning purposes  was  Pfx  (Invitrogen,  UK).  The  BIO101  GeneClean 
system  was  used  for  agarose  gel  purification.  Plasmid  preparation  was  done  with  the 
Quantum Prep Plasmid Miniprep Kit (BIORAD, USA).  Large quantity DNA preps were 
done with the QIAGEN-tips 500 (Qiagen, Germany).  DNA concentration was measured by 
optical density using a DNA spectrophotometer.  Reagents for bacterial growth:  Escherichia 
coli strains used included DH5a, XL 1-Blue, Top 10 and Stbl2.  Cells were grown in Luria 
Broth  (LB) that contains antibiotics,  either  lOOpg/mL (w/v) Ampicilin  or 30pg/mL (w/v) 
Kanamycin.  For plating, cells were spread onto LB agar that contained the same amount of 
antibiotics.
2.2.1  Sub-cloning
All  steps  in  molecular  sub-cloning  followed  standard  protocols  (Sambrook  and  Russell,
2001).  Up to  lpg DNA was used in 50pL of reaction buffer for endonuclease digestion, 
which was carried out at the designated temperature according to the enzyme for no more
41than 24 hours.  For partial digestion, 0.1 unit of enzymes were used and digestion was carried 
out for 15-30 minutes.  For 5’ DNA-flanks removal, digested DNA was treated with Klenow 
enzyme at 37°C for 1  hour.  Before proceeding to the next steps, digested DNA was checked 
by electrophoresis.  Digested fragments were purified and diluted for ligation.  Sticky end 
ligation  took place  at room temperature  from  5  hours  to  overnight,  whereas  blunt-ended 
ligation took place at 16°C overnight.  In both cases, the ligation mixture is 20 pL.
2.2.2  Transformation and bacterial culture
After  ligation,  the  DNA  was  transformed  either  chemically  or  by  electroporation. 
Chemically  transformation:  the  ligated mixture  was  mixed with  200pL  freshly  defrosted 
chemically competent bacteria on ice and incubated for  10 minutes.  Transformation took 
place at 42°C for 90 seconds, after that the transformed cells were placed on ice for 2 minutes, 
and then added with 800pL warm LB.  The mixture was then incubated at 37°C for 1  hour, 
and  spread  out  on  LB  agar plates  that  contain  the  relevant  antibiotic.  Electroporation: 
ligation DNA was ethanol precipitated and resuspended in with 50pL electrocompetent cells 
(Appendix A).  The DNA-cell mixture was then transferred into a 0.1mm electroporation 
cuvette  (Bio-Rad,  UK)  and  transformed at  1.8V.  Cells  were  immediately transferred to 
200pL warm LB and incubated at 37°C for 1  hour, before plating out.
2.2.3  Plasmid extraction and amplification
Mini-DNA-prep:  A  single colony was  inoculated into  3mL LB-antibiotic and agitated at 
37°C for 6 hours.  Small scale DNA preparation was carried out using a commercial available
42kit, following manufacturer’s protocol.  Large-scale DNA prep:  For plasmid maintenance 
and pronuclear injection, large amount of DNA was needed.  Maxi-DNA prep, was carried 
out using Qiagen Tip 500 (Qiagen, Germany), following the kit protocol.  DNA was kept at 
4°C.
2.2.4  Preparation for microiniection
For linearization and to get rid of the bacterial backbone of the plasmid, the transgene was 
digested with restriction  endonucleases.  20-50pg DNA was  digested overnight,  and then 
purified using the QIAQuik kit (Qiagen, Germany).  Microinjections were carried out by the 
Biological Service Team at the NIMR.
A list of all imported plasmid, and plasmids generated during my PhD in Lovell-Badge lab is 
listed in Appendix F.
2.3  Tissue culture
Media: The culture medium base used was standard DMEM (Sigma, UK), with 1% (v/v) L- 
glutamate, 1% 9v/v) Penecillin/Streptomycin, and 5-10% (v/v) fetal bovine serum (FBS). To 
ensure that the pH  is maintained outside the incubator, the dissection medium  for culture 
purposes was supplemented with 20mM HEPES buffer (Gibco, BRL, UK).  Washes: Cells 
were washed with PBS, calcium-magnesium free (CMF), Tissue culture grade (Gibco BRL, 
UK).  Trypsinizalion:  The  trypsinization  reagent  used  was  ready-to-use  Trypsin-EDTA 
(Gibco BRL, UK).  Transfection: Lipofectamine 2000 (Invitrogen, UK) was used to transfect
43C0S7 cells (ATCC No. CRL-1651).  FuGene6 (Roche, USA) was used to transfect granulosa 
cells.  All transfections were carried out in the serum-free OptiMEM medium (Gibco BRL, 
UK).  Freezing: The freezing medium consists of FBS and 5% dimethyl sulfoxide (Sigma, 
UK).  Plastics: Plasticwares, including culture dishes and plates, were purchased from either 
Costar Inc. or Nunc.  For harvesting and mounting purposes, cells were cultured on cover 
slips, either of 22 x 22 cm2 or 13mm diameter (VWR or BDH).
2.3.1  Immortalized cell lines
COS7 (ATCC# CRL-1657) cells were cultured in standard medium with  10% FBS.  Cells 
were split between 70-80% confluence, by rinsing with PBS-CMF, and then incubating in 
Trypsin-EDTA until cells become detached from the plasticware.  To quench trypsinization, 
three fold of culture medium was added.  Cells were then centrifuged at lOOOrpm at 4°C for 5 
minutes  and  the  pellet  was  resuspended  with  culture  medium  and  split  to  a  desired 
confluency.  For transfection purpose, cells were resuspended in OptiMEM and seeded onto 
a 22X22cm2  cover slip in 6-well culture plates between 80-90% confluency.  Lipofection was 
carried out 6 hours later using Lipofectamine 2000, following manufacturer’s protocol.  For 
each well, a total amount of 4pg DNA was used.  Cells were cultured for 36-48 hours after 
transfection.  In case of tamoxifen administration, 4-hydroxytamoxifen (OHT, Sigma H-7904, 
USA), or an equal amount of ethanol, were added to the culture medium at least 6 hours after 
transfection.  There was no medium change following tamoxifen administration.
442.3.2  Granulosa cell culture
To collect granulosa cells, female mice between 21 to 28 days of age were superovulated by 
PMSG, 5I.U.  Cells were centrifuged in culture medium containing HEPES at  lOOOrpm at 
4°C for 10 minutes, and the pellet was resuspended with normal culture medium containing 
5% FBS, and then seeded onto 13mm diameter cover slips in 24-well plates.  Either OHT or 
ethanol was added 6 hours after seeding.  Following tamoxifen administration,  cells were 
cultured for a further 24-36 hours before harvest.
2.3.3  Explant organ culture
Gonads were dissected in culture medium containing 5% FBS.  For conditional expression 
studies, each pair of gonad was grown separately on different agarose blocks, which were 
soaked in medium containing either OHT or ethanol.  Medium was discarded two days later, 
and changed to OHT free medium.  Gonads were cultured until harvest, with a change of 
medium every two days.
2.4  Animal colony maintenance
2.4.1  Legal declaration
All experiments were carried out in accordance with the UK (Scientific Procedures) Animal 
Act  1986,  under the project licence  70/5042  and its renewed version,  80/1949A.  During
45licence transition, part of the protocols were carried out using licences 80/1761 and 80/1653. 
I declare that all procedures untaken in my project follows the regulations stated in the above 
licences, and are legal procedures listed in my personal licence (80/8481).
2.4.2  Mouse line maintenance
The mouse colony is held in the Laidlaw Green (LLG) unit.  Day-to-day maintenance works, 
including husbandry, feeding, plug-checking, weaning and tailing, were mainly carried out 
by the LLG animal technicians.  Post-mortal investigation, embryo transfer, mouse line re­
derivation,  and pronuclear micro-injection,  were  general  services provided by  Procedural 
Services of the institute.  All reagents, chemicals, and drugs, unless otherwise specified, were 
provided by LLG or Procedural Services.
Mouse  lines  CAGGSET (Line  B),  Flox-Sox9,  Rosa26  Reporter  LacZ  (R26R  LacZ)  and 
Rosa26 Reporter EYFP (R26R EYFP) were maintained as homozygotes.  To generate a null 
allele for Sox9, subsequent breeding were set up between CAGGSET (Line B) and Flox-Sox9. 
Only heterozygotes could be maintained for Z/Sox9 lines so far.
2.4.3  Matings for vaginal plug check
For the interest of studies during embryonic stages, time matings were set up between 17:00 
and 00:00, and vaginal plug (VP) checks were carried out between 07:00 and 09:00.  The 
morning that a VP was detected is referred to embryonic day (E) 0.5.  For postnatal studies, 
the day when the pups were bom would be designated as postnatal day (P)0.
462.4.4  Genotvping
For mouse line maintenance, weaning and tailing were carried out between PI6 to P22 of 
newborns.  For embryos, the yolk sac was kept for genotyping.  With the exception to Z/Sox9 
Line  10F,  C  and  M,  which  were  genotyped  using  X-gal  staining  (See  section  2.7),  all 
genotyping were done using polymerase chain reaction (PCR) method.
Tissue samples for PCR genotyping were digested in lOOpL tail lysis buffer (Appendix B) at 
55°C overnight before 1:1 phenol-chloroform (v/v) extraction.  Extracted DNA samples were 
centrifuged  for 20  minutes  at  room  temperature  and  lpL  of the  supernatant  is  used  for 
template  in  the  PCR  reaction.  In  specified  cases,  supernatants  obtained  from  phenol 
extraction  were  further  precipitated  with  1:1  (v/v)  isopropyl  alcohol,  washed  with  75% 
ethanol, and resuspended in lOOpL water.
For  CAGGSET,  DaxCSET,  SflET and  S9iCre  mouse  lines,  PCR  were  done  against  the 
presence  of the  iCre  transgene.  Sox9:ECFP  and AngelBLUE-Sry were  genotyped using 
ECFP-specific primers.  R26R LacZ and ZlSox9 lines were genotyped using LacZ-specific 
primers, or X-gal staining.  De-floxed Z/Sox9 embryos were genotyped with EGFP, using its 
specific  primers.  To  genotype  the  sex  of the  animals,  Y-chromosome-specific  primers 
ZFY/YNLS were used.  To ensure homozygous status for all R26R mice, three primers were 
used for PCR (Soriano,  1999).  For Flox-Sox9, homozygous, heterozygous and knock-out 
alleles were genotyped using published primers (Akiyama et al., 2002).  PCR conditions are 
briefly summarized in Table 2.1.
47PCR Proaram Seauences Af2m Size (bD) NB
Cre CRE
ODB42: 5’ ggC ggA TCC gAA AAg AAA A 3'
54 -400
ODB43: 5’ CAg ggC gCg AgT TAg TAg C 3’
ECFP CYAN
cyanF’: 5’- gAC CCT gAA gTT CAT CTg CAC -3’
53 -400 ISOP;
Mag cyanR': 5’- gTg gCT gAT gTA gTT gTA CTC -3’
EGFP iZJEG
GT-EGFPF': 5’ ATg gTg AgC AAg ggC gAg gA 3’
57-58 -400
GT-EGFPR': 5' gTT cTT CTg CTT gTC ggC CA 3’
Flox S9 FLOXS91
FloxS9-TG: 5*ACA Cag CAT Agg CTA CCT g 3'
58
TG: -450 
WT: -400 
A: -400
ISOP,
sep
FloxS9-WT: 5' ggg gCT TgT CTC CTT CAg Ag 3’
FloxS9-KO: 5’ gTC AAg CgA CCC ATg 3’
FloxS9-3': 5' Tgg TAA TgA gTC ATA CAC AgT A 3*
iCre \Cre2
iCre2F': 5’ AGA TgC CAg gAC ATC Agg AAC CTg 3’
60-62 -350 no
DMSO iCre2R': 5’ ATC AgC CAC ACC AgA CAC AgA gAT C 
3’
LacZ iZ/EG
LacZ5': 5’ Cgg AAT TCC ggg CgT TAA CTC ggC gTT 
TCA T 3’ 57-58 -400
LacZ3': 5' AAC TgC Agg TTA ACg CCT CgA ATC A 3’
Rosa26 R26R2
R1: 5' AAA gTC gCT CTg AgT TgT TAT 3’ 50 TG: -340 
WT: -650 
A: -1000
R2: 5' gCg Aag AgT TTg TCC TCA ACC 3'
R3: 5' ggA gCg ggA gAA ATg gAT ATg 3'
sex ZFY/YNLS
ZFY:  5’ gAC Tag ACA TgT CTT AAC ATC TgT CC 3’
58-60 -300
YNLS: 5' CCT ATT gCA Tgg ACA gCA gCT TAT g 3’
Table 2-1  Primers and PCR programs used for mouse genotyping.  Unless specified 
in NB, all conditions followed standard PCR protocols.
1  Akiyama et al., 2002
2 http://www.fhcrc.org/science/labs/soriano/protocols/pcrgen.html
A(°C) Annealing temperature
ISOP: Isopropanol precipitation required.
Mag: Magnesium concentration reduced to 1.25mM
Sep: Reactions for differentiation primer combination has to be set up separately.
2.4.5  Drugs and chemicals: Preparation and administration
Tamoxifen:  Tamoxifen  was  purchased  from  Sigma,  Europe  (T-5648).  The  stock
concentration of tamoxifen was 20mg/mL (w/v), unless otherwise  stated.  To prepare the 
stock concentration, tamoxifen powder was dissolved in  1  part of absolute ethanol and then 
mixed  with  9  parts  of autoclaved  sunflower  oil  (TESCO  Ltd,  UK).  The  mixture  was 
dissolved in a 37°C water bath and then aliquoted into sterilized tubes (Falcon 2059), and 
kept in 4°C for one experimental period (5-10days) only.  OHT:  OHT for in vivo injection
48was purchased from  Sigma, Europe (H-6278).  The stock solution for OHT is  lOmg/mL 
(w/v).  To prepare the  stock concentration,  the  OHT powder was  dissolved in  1   part  of 
absolute ethanol and then mixed with 9 parts of autoclaved sunflower oil (TESCO Ltd, UK). 
The mixture was sonicated and then aliquoted directly into lmL syringes, and kept frozen in 
-20°C for no more than 3 months.  Anesthetics:  Hypnorm, which contains Fentanyl citrate 
0.315mg/mL (w/v) and Fluanisone lOmg/mL (w/v) (Vetapharma, UK) were used.
Administration  of tamoxifen  was  either  by  oral  gavage  (carried  out  only  under  project 
licences 70/5042, 80/1949 and 80/1653) for embryonic stages, or intraperitoneal injection to 
adults.  OHT  was  only  administrated  by  intraperitoneal  injection.  Hypnorm  was 
administered through intraperitoneal injection at a dosage of O.lmL/lOg mouse body weight. 
A summary of induction protocols was tabulated in Table 2-2.
Tamoxifen OHT
E7.5-E8.5 10mg+ 3mg
E9.0-E12.5 25mg+ 6mg
P1-P9 N.U.T. lmg
P21> 5 X 4mg N.U.T.
Table 2-2  Tamoxifen induction protocol for mice/embryos at different stages.
♦induction by oral gavage.
N.U.T.: not under test.
492.5  Animal harvest
2.5.1  Embryo harvest
Pregnant females were  sacrificed by schedule-1   killing methods  between  11:00 to  14:00. 
Embryos were dissected into PBS-CMF.  For genotyping purposes, either a small piece of 
tail or the yolk sac was kept.
2.5.2  Dissecting embryonic gonads
Gonads,  together  with  the  mesonephros,  were  dissected  in  PBS-CMF.  For  embryos 
exceeding stage El2.0, phenotypic sex of the gonads were recorded and compared with the 
genotypic sex, if required.
2.5.3  Harvesting adult gonads
Ovaries for granulosa cell culture: To induce supervulation, females were intraperitoneally 
injected with PMSG (5I.U.) between P21 and P28, and sacrificed by cervical dislocation 40- 
48 hours later.  Ovaries were dissected and dissociated in culture medium containing 20mM 
HEPES,  using  two  25G  needles  held  by  lmL  syringes.  General  dissection  of gonads: 
Gonads  were  generally  isolated  from  the  rest  of the  body  and  rinsed  with  PBS-CMF. 
Postnatal and adult testes collected were either processed for sectioning (Section 2.6) or cord 
dissociation.  For cord dissociation, testes were broken through with a 25G needle and cords 
were fixed in 4% (w/v) paraformaldehyde (PFA) at room temperature for 10 minutes.  Cords 
were  then  split  into  small portions  and transferred  onto  SuperFrost  Plus  slides,  and then
50squashed with a thumb through a cover slip.  The slides were then quick-frozen in liquid 
nitrogen.  After pulling off the cover slip, the slides were kept at -80°C until use.
2.6  Sample processing
2.6.1  Fixation bv immersion
Embryos, or tissues  from the embryo or adult, were immersed into different fixatives for 
different purposes.
Glutaraldehyde:  For X-gal staining, samples were fixed with a solution that contains 0.2% 
(v/v) glutaraldehyde and 2% formaldehyde (v/v) in phosphate-based buffer (Full recipe listed 
in  Appendix  C).  'Paraformaldehyde  (PFA):  For  cryosectioning  or  whole-mount
immunohistochemical staining, samples were fixed with 4% (w/v) paraformaldehyde in PBS. 
Bouin:  For histology wax sectioning, samples were fixed with Bouin, which contains picric 
acid, formaldehyde and glacial acidic acid (provided by Histology Service of the NIMR), and 
then rinsed and stored in 70% ethanol at 4°C.
2.6.2  Fixation bv cannulation of the heart
Adult mice (1 to 2 month old) were anesthetized using Hypnorm, and intracardially perfused 
with  chilled  4%  (w/v)  PFA  at room  temperature.  Samples  from  the  fixed  animals  were 
removed and washed in PBS-CMF.
512.6.3  Crvosectioning
Duration  of PFA  fixation  depends  on  the  size  and type  of the  tissue.  For wholemount 
embryos at or bigger than El 1.5, embryos were pinched at the back of the neck with a 25G 
needle to facilitate penetration of the fixative, and fixed for 30 minutes.  E13.5 embryos were 
fixed for 1   hour.  Embryonic gonads up to El4.5 days were fixed for 30 minutes, whereas 
El5.5 -  El8.5  gonads were fixed for 1   hour.  Postnatal testes, up to P14, were fixed for 1  
hour.  Adult testes from P14 onwards were fixed at 4°C overnight.  For cryoprotection, fixed 
samples  were  rinsed with  PBS-CMF  and then  equilibrated  in  30%  (w/v)  sucrose  at 4°C 
overnight, and then embedded in OCT compound (BDH).  Embedded tissue blocks were kept 
frozen at -20°C and sectioned within a week, using a Leica cryostat (model 3 05OS).  Sections 
were collected on Superfrost Plus slides and kept at -20°C until further processing.
2.6.4  Cutting free floating sections
Samples perfused with 4% PFA were rinsed in PBS-CMF and then embedded in agarose 
2.5%  (w/v).  70pm  free  floating  sections  were  made  using  a  vibratom  (VT1000S,  Leica, 
Germany), and collected into 24-well plates.
2.6.5  Histology
Sectioning: Samples were fixed in Bouin and rinsed with an increment percentage of ethanol, 
and were kept in absolute ethanol before handed over to the Histology Service Group of the 
NIMR.  For sectioning, samples were embedded in wax and cut at 6micron thickness with a
52microtom (Leica).  Haematoxylin-Eosin (H&E) staining'. H&E staining was performed by the 
histology Service group after paraffin sectioning.
2.7  Analyses and information technology
2.7.1  B-ealactosidase activity assay
Duration  of  glutaraldehyde  fixation  depends  on  the  size  of  type  of  the  tissue.  For 
wholemount embryos at or bigger than El 1.5, embryos were pinched at the back of the neck 
with  a  25G needle to  facilitate  fixative penetration.  All  fixations  take place  at 4°C  with 
agitation.  El 1.5  embryos  were  fixed  for 20  minutes.  E13.5  embryos  were  fixed  for 30 
minutes.  Embryonic gonads up to E14.5 days were fixed for 15 minutes, whereas E15.5 - 
El8.5 gonads were fixed for 30 minutes.  Samples were washed two times, 5 minutes each, 
with phosphate-based buffer Lo.  p-galactosidase activities were detected in X-gal solution at 
37°C, until signal develops, for no more than 48 hours.  The composition of all reagents used 
for X-gal staining is listed in Appendix C.
2.7.2  Immunocvtochemical staining
Upon harvest,  cells  were  fixed with 4%  (w/v) PFA  for 20 minutes  at room temperature, 
following a brief rinse with PBS-CMF (tissue culture grade).  Following fixation, cells were 
rinsed two times with PBS-CMF containing 0.1% (v/v) Triton (PBT), and then immersed in 
blocking solution, which is 2% (w/v) bovine serum albumin (BSA), for a minimum of 30 
minutes.  Primary antibodies were diluted in BSA and incubated either at room temperature
53for 2 hours or at 4°C overnight, unless otherwise specified.  To get rid of excessive antibodies 
and non-specific binding, cells were washed three times, 5 minutes each, with PBT.  Signals 
were visualized with fluorescent secondary antibodies, which were incubated in darkness at 
room temperature for 1  hour.  After three washes, 5 minutes each, cells were incubated with 
1:10,000 DAPI (gift from Francis Guillemot Lab, origin unknown) for 5 minutes at room 
temperature.  After  a  5-minute  wash,  the  coverslip  that  contained  the  cells  were  then 
transferred onto a glass slide and mounted with Aquapolymount (PolyScience, UK).  The 
details of the antibodies used are summarized in Table 2.3.
Primary antibodies used Secondary antibodies used
Protein Host Dilution From Hosts Dye Dilution
33HSD Rabbit 1/1000 Gift2 Goat a Rabbit 488 1/1000
AMH Goat 1/100 scbt Goat a Mouse 488 1/1000
c-myc Rabbit 1/500 scbt Donkey a Rabbit 488 1/1000
Cre Mouse 1/100 Covance Donkey a Goat 488 1/1000
DMC-1 Goat 1/200 scbt Goat a Chick6 488 1/1000
FOXL2 Rabbit 1/350 Gift4 Donkey a Chick6 FITC 1/500
GFP Sheep 1/1000 Covance Donkey a Sheep7 FITC 1/250
GFP Chick 1/500 Chemicon Donkey a Rabbit Cy3 1/500
Laminin Rabbit 1/1000 Gift5 Goat a Mouse 568 1/500
PECAM Rat 1/500 Pharmingen Donkey a Goat 568 1/500
SCP3 Rabbit 1/100 Upstate Goat a Rabbit 594 1/500
SCP3 Mouse 1/100 Upstate Goat a Mouse 594 1/500
SF1 Rabbit 1/400 Gift1 Goat a Rat 594 1/500
SOX9 Rabbit 1/1000 Gift3 Donkey a Rabbit Cy5 1/500
Stella Rabbit 1/100 Abeam
P-gal Mouse 1/500 Sigma
P-gai Goat 1/500 Gift8
YH2AX Rabbit 1/100 Upstate
YH2AX Mouse 1/100 Upstate
Table 2-3  Antibodies  used  in  this  study.  Unless  specified,  fluorescent 
secondary antibodies were purchased from Molecular Probes.
‘K Morohashi  5 H Erickson
2I Mason  6Chemicon
3 P Goodfellow  7 Jackson’s Lab
4 t  /->________*  8, J Cocquet  Ang Lab (N.B. commercially available)
542.7.3  Immunohistochemical staining
On cryosections:  Sections were brought to room temperature and washed in PBS-CMF to 
remove the OCT compound, and then blocked with BSA for at least 30 minutes.  All primary 
antibody  incubation  was  done  at  4°C  overnight.  Washing  and  secondary  antibodies 
incubation  procedures were the  same  as  for  immunocytochemical  staining.  For  enhance 
nuclear staining signal, sections were incubated with a DAPI solution (1:10,000 v/v DAPI in 
PBST) at room temperature for 5 minutes, before mounted by Vectorshield and covered by a 
coverslip.  On paraffin sections: Sections were de-waxed by immersing in histoclear solution 
for 5 minutes, and then re-hydrated with washes in decrement in percentage of ethanol, 75%, 
50%, 25%, 5 minutes each.  Re-hydrated sections were then rinsed in PBT, and blocked in 
BSA.  All following procedures were the same as that of on cryosections.
2.7.4  In situ hybridization
The  iCre  in  situ  hybridization  described  in  Chapter  4  is  performed  on  10  microns 
cryosections,  following  the  protocol  published  by  Wilkinson’s  lab.  Hydridization 
temperature of the iCre riboprobe was 70°C.  The riboprobe was synthesized as  follows: 
plasmid  pBlue.iCre  (Appendix  E)  was  cut  with  restriction  endonuclease  Bgl  II  and 
transcribed with the T7 polymerase.  The ~800bp RNA obtained was purified and used as the 
probe for iCre.
552.7.5  Microscopy and softwares
Light microscopy:  Pictures  of non-fluorescent wholemount embryos,  tissues,  or sections 
were taken by a light microscope, using the software IM50 (Leica, Germany) or OpenLab 
(Improvision,  UK).  Fluorescent  imaging:  Fluorescent  sections  were  handled with the 
following systems: DeltaVision; Leica systems including Concofal SP2 with LCS software, 
Confocal SP5 with LAS software, or with a Leica microscope with the software FW4000. 
Pictures  of fluorescent  wholemount  samples  were  taken  with  a  Leica  microscope,  using 
softwares  either  FW4000  (Leica,  Germany)  or  OpenLab  (Improvision,  UK).  Where 
necessary, images were processed using Adobe Photoshop CS2.  All figures presented in this 
thesis are produced by Adobe Illustrator CS2.  Softwares used for texts for this thesis include 
Microsoft Word 2003 and Excel 2003.  This thesis is printed out in Adobe Acrobat (.PDF) 
format.  Soft copies of all data, versions of this thesis, and the final corrected proof will be 
saved in a directory called “atye” in the Lovell-Badge lab archive.
56CHAPTER 3
ESTABLISHING TOOLS TO ALTER GENE EXPRESSION 
DURING GONADAL DEVELOPMENT IN MAMMALS
3.1  Introduction
3.2  Materials and Methods: Molecular cloning
3.2.1  Sox9:ECFP
3.2.2  Sox9:iCre
3.2.3  Daxl:ERT2iCreERT2
3.2.4  Sfl:ERT2iCreERT2
3.3  Establishment of  stable founder mice
3.4  Characterization of  founder mice
3.4.1  Sox9:ECFP
3.4.2  Sox9:iCre
3.4.3  Daxl:ERT2iCreERT2
3.4.4  Sfl:ERT2iCreERT2
3.5  Discussion
573.1  Introduction
For the purpose  of the project,  several tools  had to be  made.  As  described  in the general 
introduction  of this  thesis,  my  experiments  are  based  on  two  components,  a  “Cre-driver” 
mouse and a “responder” mouse.  Previous members of the lab have generated several mouse 
lines for these purposes, however, none of them turned out to be appropriate to drive reporter 
gene expression in the gonads.  For example, an Sry:Cre transgene made previously in the 
lab did not show evidence of functionality (Claire Canning, unpublished and data not shown), 
whereas Daxl:Cre was shown to be active in pre-implantation embryo (Amy Johnson, PhD 
thesis,  2002).  For  my  interest,  I  have  chosen  new  materials  to  create  the  transgenic 
constructs.  For the “Cre-drivers”, I have chosen regulatory elements of Sox9, Daxl and Sfl, 
which  are  all  gonad-specific  (at  least at mid-gestation  stages).  Apart from  gonad-specific 
sequences, a ubiquitous, strong promoter sequence was employed to drive the expression of 
Cre.  This latter system will be described in detail in the next chapter.
Figure 3.1  A 3.2kb Sox9 
enhancer exhibits activity in the 
embryonic testis.
(R. Sekido, unpublished)
A  X-gal staining of a El2.5 embryonic 
testis from a 3.2Sox9:LacZ embryo.
B  ECFP autofluorescence of the same 
stage from a Sox9:ECFP
58Ryohei Sekido, a current member of the lab has characterized aspects of the mouse Sox9 
upstream regulatory region,  defining an element that is gonad specific (unpublished).  He 
established transgenic lines using a 3.2kb enhancer to drive reporter LacZ, which displayed 
strong activity in the developing testis, where it showed expression equivalent to that of the 
endogenous Sox9 gene (Figure 3.1).  Based on his work, I made a transgene using this 3.2kb 
Sox9 enhancer region to drive the expression of ECFP (3.2S9ECFP), which also showed a 
similar, gonad-specific ECFP expression pattern in vivo (Figure 3.1).  This suggests that the 
3.2kb region would be a good element to drive Cre expression in Sertoli cells.
Daxl is expressed initially in the supporting cell lineage in the indifferent gonad of both XX 
and  XY  embryos.  It  is  then  downregulated  in  the  testis  at  about  El2.0,  but  remains 
expressed  in  the  ovarian  supporting  cell  lineage  throughout  development,  and  during 
folliculogenesis (Swain et al., 1996; Swain et al.y  1998).  An 1  lkb regulatory region just 5’ to 
the Daxl open reading frame has been characterized previously in the lab (Swain et al., 1998, 
Hoyle et al., 2002).  In Daxl:LacZ transgenic mice, this region was consistently able to drive 
LacZ  expression  in  a pattern  identical  to that  of endogenous Daxl.  Reasoning that this 
regulatory region will allow, for example, misexpression of male-specific genes in the XX 
supporting cell lineage, it was used to drive the expression of Sry. The Daxl :Sry transgene 
resulted in female-to-male sex reversal at the same frequency as LacZ expression was seen in 
the Daxl:LacZ mice (Swain et al.,  1998), proving this Daxl regulatory element to be both 
functional and efficient.  This 1  lkb fragment was therefore used to construct the Daxl Cre- 
driver.
59An Sfl regulatory element was also selected.  Sfl  is expressed in both the supporting and 
steroidogenic cell lineages at early stages, and while it is downregulated in the ovary, it is 
maintained  in  differentiated  Sertoli  cells  and  Leydig  cells.  In  theory  an  appropriate 
regulatory region will be useful in gene alteration studies both cell lineages.  For example, it 
could be used to ask if the expression of a Sertoli cell-specific gene in steroidogenic cells will 
lead to a change in cell fate.  A 674bp Sfl promoter region was shown to be sufficient to 
activate LacZ reporter gene expression in El 1.5 mouse gonads, spinal cord, and weakly in 
the hindbrain (Wilhelm and Englert, 2002).  In transgenic mice, this Sfl promoter driving Cre 
successfully deleted a conditional Sox9 allele in the gonads (Chacoissier et al., 2004) and was 
therefore chosen to generate the Sfl Cre-driver.
To enhance Cre recombination efficiency, the improved codon-Cre (iCre,  Shimshek et al.,
2002)  was used in all cases.  For Daxl, Sfl, and the ubiquitous Cre-drivers, an inducible 
version of iCre (ERT2iCreERT2, Casanova et al., 2002) was used.  This should allow control 
of  Cre  activation  through  the  administration  of  the  inducer  tamoxifen  at  the  desired 
embryonic stage.  In the nomenclature for the constructs, DaxCSET and SflET, the “ET” that 
follows the name of the regulatory element stands for Estrogen receptor-Tamoxifen inducible. 
The  “CS”  in  the  Daxl  driver  DaxCSET refers  to  the  shuttle  vector  pCS2+  used  for 
subcloning.
603.2 Materials and Methods: Molecular cloning
3.2.1  Sox9:ECFP
The  hsp68:LacZ  plasmid  was  used  as  the  backbone  for  constructing  3.2Sox9:ECFP 
(,Sox9:ECFP).  The  first step  involved swapping the LacZ encoding gene to the  one that 
encodes  ECFP  (Figure  3.2A).  To  facilitate  linearization  for  microinjection,  the  Notl 
restriction site between the ECFP sequence and the polyadenylation signal was destroyed by 
partial digestion and then blunt end ligation.  This resulted in the transgene, hsp68:ECFP, 
which was subcloned into a plasmid that contained the 3.2kb Sox9 enhancer sequence.  The 
resulting construct has the 3.2kb enhancer coupled to the hsp 68 minimal promoter driving 
ECFP (Figure 3.2B).
3.2.2  Sox9:iCre
The iCre fragment was excised and used to replace the ECFP fragment in Sox9:ECFP by 
blunt-end ligation.  This Sox9 Cre-driver transgene is named S9iCre (Figure 3.3).
3.2.3  Daxl :ER T2iCreER T2
To facilitate subcloning via compatible end ligation, pCS2+ (Appendix) has been used as a 
shuttle vector.  The sequence encoding the ERT2iCreERT2 fusion protein was inserted into 
pCS2+  to  generate pCSET,  and  from  this the Daxl:ERT2iCreERT2 transgene was made. 
This Daxl Cre-driver transgene was designated as DaxCSET (Figure 3.4).
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Figure 3.2  Construction of the 3.2kb SoxrP-enhancer driving ECFP transgene.
A  An ECFP-qncoding sequence from pECFP (Promega) was inserted into the hsp68:LacZ plasmid 
via  the  NcoUXbal  site.  Due  to  multiple  existence  of the  Xbal,  partial  digestion  was  done  for 
subcloning.  The Notl site between the ECFP and polyA signal in this resulting plasmid was removed 
blunt-ended self-ligation.
B  The 3.2kb Sox9 enhancer was then inserted via compatible-end ligation (Notl to NotHXhol to Sail). 
The Sox9:ECFP transgene was released for pronuclear microinjection by Notl digestion.
The hsp68:LacZ plasmid was used as the backbone for constructing 3.2Sox9:ECFP
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Figure 3.3  Construction of the 3.2kb Sax:9-enhancer driving iCre transgene.
The sequence encoding iCre from pBlueiCre (Shimshek et al, 2002) was excised by Hindlll/Xhol 
partial digestion and replaced the ECFP fragment in the Sox9:ECFP plasmid via blunt-ended ligation, 
resulting in the Sox9:iCre transgene.  For microinjection, this transgene was released by Sail/Notl 
double digestion.
pBS-ERT2iCreERT2-hGHpA
The BamHI site at the MCS between ERT2iCreERT2 
and the HGHpA was deleted by blunt-end self-ligation
ERT2iCreERT2 11 kb Daxl 5’ UTR
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Figure 3.4  Construction of the Daxl promoter driving inducible iCre transgene.
The Bam\{\ in the multiple cloning site in PBS.ERT2iCre was destroyed by blunt-ended self ligation. 
The  ERT2iCreERT2-human  growth  hormone polyA  (hGHpA)  fragment  was  subcloned  into  the 
shuttle vector pCS2+ via compatible-end ligation (Sail to Xhol/Notl to Notl).  The resulting plasmid, 
pCSET, was opened with BamHl/Clal for the insertion for the  llkb Daxl  promoter.  The resulting 
transgene was named DaxCSET.  For microinjection, this transgene was released by Bamtil/Notl 
double digestion.
633.2.4  Sfl :ER T2i CreER T2
The short Sfl regulatory region was amplified by PCR and subcloned directly into the 5’ of 
the  plasmid  containing  the  ERT2iCreERT2  fragment  (pBS-ERT2iCrehGHpA,  Figure  3.5). 
Restriction endonuclease linkers were added to the 5’ end of both primers to facilitate sticky- 
end ligation.
pBS-Sf1(700)  Sa"
5’  — 700bp Sf1  5’ UTR —  3’
Xhol
pBS-ERT2iCreERT2-hGHpA
ERT2iCreERT2
ERT2iCreERT2 700bp Sf1  5’ UTR
SflET
Figure 3.5  Construction of the Sfl promoter driving inducible iCre transgene.
The 674basepair Sfl promoter was amplified by PCR.  Sail linkers were attached to flanking 
ends to facilitate ligation into the plasmid PBS.ERT2iCre-hGHpA.  The resulting transgene 
was named SflET, and was released for microinjection via SaWNotl double digestion.
3.3  Establishment of stable founder mice
All  constructs  were  linearized  for  injection  into  pronuclear  stage  mouse  embryos. 
Sox9:ECFP and S9iCre were injected by Ryohei Sekido in the host lab.  For the former, 6 
founders were identified by PCR for ECFP, whereas 7 founders were generated for the latter.
64DaxCSET and SflET constructs were injected by the Procedural Service Section at the NIMR 
(directed by  Sophie  Wood).  Five DaxCSET founders  were  identified from microinjection 
using  transgene  Daxl:ERT2iCreERT2  and  three  SflET  founders  were  generated  from 
transgene  Sfl:ERT2iCreERT2.  S9iCre,  DaxCSET  and  SflET transgenic  founders  were 
identified by iCre PCR.  All transgenic mice were maintained on a mixed CBA/C57BL10 
background  by  mating  to  CBA10/F1  mice,  and  kept  as  heterozygotes  unless  otherwise 
specified.
3.4  Characterization of founder mice
3.4.1  Sox9:ECFP
Three  out of six Sox9:ECFP lines  showed strong ECFP  expression  in the  genital ridges. 
ECFP could be detected in the genital ridge as early as El 1.5, and was restricted to SOX9- 
expressing  cells  by  E12.5  (Figure  3.6).  Expression  was  also  seen  in  the  Wolffian  and 
Mullerian  ducts  of both  sexes  (Figure  3.7).  SOX9  has  been  detected  in  Wolffian  and 
Mtillerian ducts of several mammals, including marsupials (Pask et al., 2002) and mice (R. 
Behringer, personal communication; Guioli et al., 2006 and unpublished data from various 
lab  members).  These  results  show  that Sox9:ECFP  labels  SOX9  expressing  cells  in  the 
urogenital ridge.
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Figure 3.7  Sox9:ECFP mice display ECFP expression in the nephrogenic ducts.
A -  C Wholemount El3.5 ovary and mesonephros showing ECFP in the latter.
D -  F  10pm  cryosection of the above.  Antibodies used for co-labelling were chick anti-GFP (for 
ECFP) and Pax2 (for epithelial cells in Mullerian duct).
To  investigate  whether  the  3.2kb  Sox9  enhancer  is  still  active  in  the  adult  testis,  male 
Sox9:ECFP  mice  of different  ages  were  studied.  The  results  show  that  ECFP  was  still 
detectable  in  a  one-year-old  testis.  However,  unlike  at  embryonic  stages,  and  unlike 
endogenous SOX9, ECFP expression was detected in both Sertoli and Leydig cells in the 
adult. The activity of this enhancer seems therefore to lose its Sertoli cell specificity (Figure 
3.8). This requires further work, however, as only one line has been studied.  Moreover, itmay be  worth  exploring  the  onset of Leydig  cell  expression within  this  line to  see  if it 
coincides with replacement of fetal by adult Leydig cells.
3.4.2  Sox9:iCre (S9iCre)
To examine the recombination pattern of the S9iCre mice, founder lines were  crossed to 
ROSA26 Reporter (R26R) LacZ animals (Soriano, 1999).  Embryos were harvested at El 1.5 
or El3.5  for X-gal  staining. The intensity of X-gal  staining correlates with Cre-mediated 
recombination. Embryos negative for iCre by PCR did not display X-gal activity (data not 
shown). Unexpectedly, five out of the 7 lines showed extensive X-gal activity throughout the 
embryo. Examples of these are lines A and C, where the former shows mosaic expression 
and  the  latter  appears  ubiquitous  (Figure  3.9).  Line  V  displayed  mosaic  expression 
throughout much of the embryo, but particularly strong expression in the embryonic testis 
where it marks all Sertoli cells by El4.5  (Figure 3.10). Line E displayed variable staining 
patterns on different genetic backgrounds:  on a CBA/C57BL10  mixed background,  X-gal 
activity was localized largely to the adrenal gland, whereas after backcrossing to C57B1/6 (as 
in Figure 3.10), X-gal activity was detected in various tissues. In any case, no X-gal activity 
was detected in the embryonic testis for Line E.
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Figure 3.8  Sox9:ECFP is active in both Sertoli and  Leydig cells in the adult.
Antibody labelling involved anti-Sox9 for Sertoli cells and 3PHSI) for Leydig cells.  CFP was detected by autofluorescence.
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Figure 3.9  Four stable S9iCre mouse lines displayed Cre-mediated activities.
S9iCre-R26R LacZ embryos were dissected at El 1.5 (A -  D) and El3.5 (E -  H) for wholemount X- 
gal staining.  I -  L Gonads were dissected from El3.5 embryos showed in (E -  H).  Note that all of 
these gonads are testes, whereas in ovaries from the corresponding litters, none stained for X-gal.  In 
all cases, embryos or gonads that are negative for iCre and therefore the S9iCre transgene does not 
give any X-gal staining.
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Figure 3.10  S9iCre (Line V) displays high  iCre activity in Sertoli cells.
S9iCre (V) males were set up with R26R EYFP females, which were sacrificed are different stages for detection o f Cre activity in the embryos.  Gonads 
from the em bryos harvested were dissected out and cryosectioned for immunohistochemistry against SOX9 and GFP (for EYFP).  The figure shows iCre 
positive testes collected from staegs between  El 2.5 to El 5.5.  Note that the expression o f EYFP becomes Sertoli cell-specific by El 4.5, as marked by 
Sertoli cell m arker SOX9.  No expression o f EYFP could be observed in gonads that are negative for iCre. or in ovaries.Due to the extensive staining patterns observed, it was suspected that the 3.2kb enhancer is 
active  in  early  embryonic  stages.  Blastocysts  were  extracted  from  pregnant  R26R  EYFP 
females (Srinivas et al., 2001) mated to S9iCre mice.  EYFP was detected in the blastocysts 
from crosses with Lines A (50%) and C (65%), indicating the 3.2kb Sox9 enhancer is active 
during  preimplantation  development  in  these  lines.  Line  V  (20%)  displayed  sporadic 
expression in blastocysts (Figure 3.11). Line E was not examined. These results show that the 
3.2kb fragment from Sox9 has a strong tendency to be active at blastocyst stages, making it 
inappropriate for use with non-inducible forms of Cre.
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Figure 3.11  Three S9iCre 
lines dem onstrated activity 
at blastocyst stages.
Blastocysts were isolated 
from uteri o f R26R EYFP 
m ice mated to S9iCre mice. 
EYFP was observed by auto­
fluorescence and compared 
to the brightfield image 
captured by a light microscope.
3.4.3  Daxl:ERT2iCreERT2 (DaxCSET)
DaxCSET mice were  first tested for iCre expression  and activity  in  granulosa cell  culture. 
Founder animals were crossed to homozygous R26R EYFP mice.  To increase granulosa cell 
number,  adult  females  were  induced  for  superovulation  between  3-4  weeks  of  age.
72Granulosa cells of both iCre positive and negative females were plated out in culture, in the 
presence  of either  OHT  or  an  equal  concentration  of the  vehicle  (ethanol)  alone.  The 
presence of EYFP should reveal cells in which Cre-mediated recombination has occurred. 
Immunostaining using an antibody specific for Cre showed that only 3 of the 5 founder lines 
expressed the iCre protein in cultured granulosa cells.  These founders responded differently 
to  tamoxifen:  two  founder  lines,  F  and  M,  displayed  nuclear  localized  iCre  only  in  the 
presence  of  OHT,  and  at  the  same  time  expressed  EYFP  (Figure  3.12A  and  3.13A). 
However, Line P displayed nuclear localized iCre and expressed EYTP with or without OHT, 
indicating the nuclear translocation of iCre in this line is not regulated by the inducer (Figure 
3.14).
Following  this  observation,  lines  F  and  M  were  investigated  further to  find  out  if Cre- 
mediated  recombination  can  be  induced  in  utero.  DaxCSET  mice  were  crossed  to 
homozygous R26R mice and tamoxifen was administered to pregnant females by oral gavage 
at  El 1.5.  Gonads  were  dissected  from  the  embryos  at  El2.5  and  examined  for  (3- 
galactosidase activity by immunostaining.  Gonads positive for both iCre and reporter LacZ 
by PCR were compared to those positive only for the reporter.  Double positive gonads of 
both sexes from Line M embryos displayed reporter protein staining in cells located between 
the mesonephros and the gonad, a pattern similar to that in Daxl:LacZ mice (Figure 3.13B, 
Swain  et  al.,  1998).  Line  F  did  not  show  any  significant  difference  in  reporter protein 
expression  between  the  iCre  positive  and  negative  gonads  (Figure  3.12B).  In  parallel, 
several mice were given the vehicle (oil) only.  No P-galactosidase activity was detected in 
any gonad from either line, indicating the appearance of the reporter protein in Line M was a 
result of tamoxifen-induced Cre-recombination events.
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Figure 3.12  Cre-mediated recombination in DaxCSET Line F.
A  Dissociated granulosa cells isolated from DaxCSET (F)-R26R EYFP ovaries were plated in culture, 
in the presence of either 2pM OHT or same volumetric amount of ethanol.  Antibodies used for co­
labelling  were  anti-Cre  and  chick  anti-GFP  (for  reporter  EYFP).  B  in  utero  recombination  in 
DaxCSET (F)-R26R EYFP.  25mg tamoxifen was administered to the pregnant fmale by oral gavage 
at El 1.5, and gonads of the embryos were dissected at El 3.5, cryosectioned for immunohistochemical 
staining using sheep anti-EYFP.  M: mesonephroi; G: gonads.
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Figure 3.13  Cre-mediated 
recombination in DaxCSET 
Line M.
A  Dissociated granulosa cells 
isolated from DaxCSET(M)- 
RYFP ovaries were plated in 
culture, in the presence of either 
2pM OHT or same amount of 
ethanol for 48 hours.  Antibodies 
used for co-labelling were anti- 
Cre and chick anti-GFP.
B  in utero recombination in 
DaxCSET[U)-R26R LacZ.
25mg tamoxifen was 
administered to the pregnant 
female by oral gavage at El 1.5. 
gonads of the embry os w ere 
dissected at E l2.5. cryosectioned 
and stained using a mouse anti- 
[3-gal antibody to label cells that 
display recombination activity.
M: mesonephroi 
G; Gonads
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Figure 3.14  Cre-mediated recombination in DaxCSET Line P.
Dissociated granulosa cells isolated from DaxCSET (P)-RYFP ovaries were plated in culture, in the 
presence of either 2pM OHT or same volumetric amount of ethanol.  Antibodies used for co-labelling 
were anti-Cre and chick anti-GFP (for reporter EYFP).
3.4.4  Sfl:ERT2iCreERT2 (SflET)
One of the SflET founders (Line M) died at the age of ten weeks. This founder failed to mate 
with females and never produced any offspring. The remaining 2 lines were investigated for 
Cre-mediated recombination activities during embryonic stages. Lines C and P were crossed 
to  R26R  LacZ  mice  and  tamoxifen  given  via  oral  gavage.  Several  cells  displayed  |3- 
galactosidase  activity  in  Line  P  iCre;  LacZ double  positive  gonads  (Figure  3.15).  No  (3-
76galactosidase  activity  was  detected  in  iCre negative  gonads  or  in  gonads  of embryos that 
received  vehicle  alone,  indicating that any  (3-galactoside  activity  obtained  must have  been 
due to tamoxifen-induced Cre-recombination events. Unfortunately, Line P mice,  including 
the founder itself, stopped transmitting the SflET transgene later on during the study. Line C 
did not show  fLgalactosidase  activity  after  induction  in  utero  or ex vivo (data not shown). 
New  founders  have  been  generated  by  pronuclear  micro injection,  and  will  require 
characterization.
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Figure 3.15  in utero Cre-mediated recombination in SflET \Ant P.
773.5  Discussion
The establishment of the Sox9:ECFP mice provides a simple way to detect both fixed and 
live Sox9 expressing cells in the gonad. It can also be used to discover genetic factors that 
modulate the activity of this enhancer, which are likely to be required for regulation of Sox9 
expression in the gonads (see, for example, Kim et al 2006).
However,  the  widespread  expression  of S9iCre  in  R26R  LacZ  mid-gestation  embryos 
revealed wider  activity  of the  3.2kb Sox9 enhancer at earlier embryonic  stages.  Indeed, 
EYFP  was  detected  in  blastocysts,  indicating  enhancer  activity  in  the  pre-implantation 
embryo.  The  apparent  discrepancy  can  be  explained  by  the  differences  in  experimental 
approach in characterizing these transgenes. The reporter ECFP directly reports the activity 
of the  3.2kb  enhancer only  at the  stage  being  examined,  whereas,  enhancer activities  in 
S9iCre  mice  are  reflected by  the  expression  of a  reporter  activated  by  the  earliest  Cre- 
mediated  recombination,  which  in  this  case  happened  at  blastocyst  stages.  This  was 
unexpected as Sox9 expression has not been detected in preimplantation embryos, indeed it is 
first seen during gastrulation.
The S9iCre mice were created to study gene function in the Sertoli cell lineage.  S9iCre Line 
V displayed significant Cre-mediated activity  in the embryonic testis,  suggesting that the 
enhancer  does  drive  Cre  expression  efficiently  in  Sertoli  cells,  but  there  was  too  much 
activity outside the gonad to make even this line useful. Clearly it would have been better to 
have used the inducible version of iCre. This would also permit multistage tests.
78In contrast, DaxCSET and SflET mice both carry the inducible version of iCre,  allowing 
control of recombination at a specific time of interest.  DaxCSET Line M displayed Cre- 
mediated activity in the embryonic gonad that could be induced in utero.  Although in vivo 
induction during postnatal stages failed to give recombination in any DaxCSET line (data not 
shown), studies at stages after birth can make use of the granulosa cell culture system, for 
which Lines F and M showed efficient, inducer-specific Cre activity.
Sfl ET Line P showed recombination in the embryonic testis after in utero induction, proving 
this  transgene  functional.  Unfortunately,  not  many  founders  were  obtained  from 
microinjection, and Line P could not be maintained.  However, more transgenic lines are 
being made and characterized.
The activities obtained from gonad-specific inducible Cre-driver mice were not as strong as 
those obtained from reporter transgenes driven by the same promoter elements (Swain et al., 
1998; Wilhelm and Englert, 2002).  This could be due to induction efficiency, which needs 
further  optimization.  The  tests  done  and  described  in  this  chapter  followed  standard 
protocols  published  previously  (Feil  et  al.,  1997;  Joyner  Lab  Online  protocols, 
http://satum.ned.nyu.edu/research/dg/joynerlab/protocols.html),  but  could  be  modified 
according to our own requirements giving sufficient recombination.  Also, the experience 
gained  with  DaxCSET  and  SflET  suggests  that  it  would  be  very  beneficial  to  use 
ERT2iCreERT2 with the 3.2kb Sox9 regulatory region, to make S9ET.
Recently, a mouse line using Sry regulatory sequences to drive Cre expression was published 
(Ito et al., 2006).  Recombination activities of this Sry/Cre mouse were detected in fetal and
79adult Sertoli cells and in granulosa cells, although very few, which would make it of limited 
use  to  mediate  gene  expression  or  deletion  in  these  lineages.  Sry  is  also  expressed  in 
preimplantation stage embryos (Boyer and Erickson,  1994) and it is possible that the only 
line  obtained with  specific  expression  in  gonadal  supporting  cells  was  subject to  strong 
negative influences from sequences flanking the transgene integration site.
There  are  many  other  genes  expressed  in  the  developing  gonads  that  could  provide 
appropriate regulatory sequences for driving inducible or non-inducible Cre.  These would 
include  regulatory  sequences  specific  to  granulosa  cells,  e.g.  Foxl2,  or  those  that  are 
expressed in the bipotential gonad, and stay expressed in differentiating gonads.  The latter 
include Wtl, regulatory sequence of which was previously employed to drive expression of 
Sox9 in the XX leading to sex reversal (Vidal et al., 2001).  Sfl, for which a BAC clone has 
been recently reported to produce stronger activity compared to the 674bp gonad-specific 
promoter (Bingham et al., 2006).  Lhx9 is probably the earliest acting gene known that is 
essential for the formation of the gonadal primordia. However, its regulatory region has not 
been defined, and therefore, the generation of an inducible Cre-driver using Lhx9 will require 
subcloning into the BAC that contains Lhx9.
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814.1  Introduction
There have been several attempts to establish mice ubiquitously expressing an inducible Cre 
recombinase. The first used the CMV regulatory region to drive Cre-ERT (Feil et al.,  1996, 
Brocard et al.,  1997).  However, these CMV-Cre-ERT mice produced Cre activity in only a 
few  tissues  (F.  Guillemot;  D.  Metzger;  C.  Galichet,  personal  communication),  with  the 
highest activity (~40%) found in skin cell types. A similar line of transgenic mice, termed 
CMV-Cre-ER™, produced Cre activity in a wider variety of tissues (Hayashi and McMahon, 
2002).  It  is  not clear if these mice  actually harbour the  same  version of inducible  Cre. 
According to the original report and experience of several others (Casanova et al., 2002), this 
Cre-ER™ mouse displayed low levels of Cre activity even in the absence of the inducer. 
However, tamoxifen induction did not lead to any Cre-activity in the gonad (R. Behringer; 
personal  communication).  Because  these  Cre-driver  mice  were  unsatisfactory,  it  was 
important  to  attempt to  establish  lines  that have  more  widespread  expression  and  better 
control of recombinase activity.
It was decided to use the ERT2iCreERT2 (Casanova et al., 2002) for making the ubiquitous 
inducible Cre. The CMV regulatory region, as tried by others, is known to express well in 
various cell lines in vitro, but in transgenic mice it tends to give rather variable expression. 
We therefore chose instead to use the ubiquitous regulatory element in the expression vector 
pCAGGS, which comprises the CMV enhancer linked to the chicken p-actin promoter (Niwa 
et al., 1991), and was reported to drive high levels of gene expression. This was used to make 
the CAG:ERT2iCreERT2 transgene, called CAGGSET. It was found to produce high levels of 
Cre  activity  in  many  tissues,  including  different  gonadal  cell  types,  and  to  be  highly 
responsive to tamoxifen in all the systems under test.
82In this chapter, the establishment of CAGGSET, as well as the characterization in transgenic 
mice will be described in detail.
4.2  Molecular cloning of CAG:ERT2iCreERT2
The promoter/enhancer fragment of pCAGGS (Niwa et al.,  1991) was released and inserted 
into the pBS-ERT2iCrehGHpA plasmid (Casanova et al., 2002) via SaB/Xhol compatible-end 
ligation  (Figure 4.1).  This transgene is  designated as  CAGGSET.  The construct has been 
verified by sequencing the full-length of the transgene.
pCAGGS
CAG SA
c o   "
pBS-ERT2iCreERT2-hGHpA  7
ERT2iCreERT2
CAGGSET
CAG ERT2iCreERT2
Figure 4.1  The molecular construction of the transgene CAG:ERT2iCreERT2.
A ubiquitous 1729 basepair CMV enhancer/chicken beta-actin promoter complex was released from 
plasmid ipCAGGS by Sail and Xhol double digestion.  This fragment was inserted into the Safi site of 
the  plasmid  pBS-ERT2iCrehGHpA  via  compatible  sticky-end  ligation.  This  resulted  in  the 
ERT2iCreERT2  transgene  under-driven  by  the  ubiquitous  regulatory  complex.  The  recombinant 
transgene, CAG:ERT2iCreERT2, designated as CAGGSET, was removed from the vector backbone 
for pronuclear microinjection by Sail and Notl digestion.
834.3  In vitro assays for CAGGSET
CAGGSET function  was  first  assessed  in  vitro,  both  in  an  immortalized  cell  line  and in 
primary cell culture.
4.3.1  CAGGSET functions correctly in immortalized COS7 cells
To verify that the construct is able to express the Cre-recombinase correctly, and that Cre- 
mediated recombination could be induced by tamoxifen administration, plasmid CAGGSET 
(pCAGGSET) was transfected into COS7 cells, either on its own or with plasmid iZ/EG, a 
transgene that expresses EGFP as a reporter of Cre activity (Novak et al., 2000).  Cells were 
cultured in the presence of the inducer, 4-hydroxytamoxifen (OHT), or the vehicle (ethanol) 
alone.  An  anti-Cre  antibody  was  used  to  label  cells  that  express  the  ERT2iCreERT2 
transgene.  Without  the  inducer,  iCre  was  detected  in  the  cell  cytoplasm,  whereas  cells 
cultured in the presence of OHT displayed nuclear localized iCre.  Transfected cells were 
also co-labelled with an antibody against GFP, which was observed only in iCre positive 
cells that were cultured in the presence of OHT (Figure 4.2A).  The sub-cellular localization 
of the iCre protein and the expression of EGFP indicate that the nuclear translocation of iCre 
and its activity were highly dependent on the inducer.
4.3.2  CAGGSET undergoes Cre-recombination in primary culture cells
To test the possibility of recombination in primary cell culture, pCAGGSET and iZIEG were 
transfected into pre-ovulatory granulosa cells.  As in the test carried out in immortalized cells,
84iCre was only detected in the cell nucleus in the presence of OHT, and reporter EGFP was 
only detected in cells where iCre was nuclear localized. This result shows that CAGGSET is 
functional in ex vivo cell culture (Figure 4.2B).
4.4  Establishment of CAGGSET stable founder mouse lines
Having proven functional in  vitro, the  CAGGSET transgene was removed from its vector 
backbone  via  SaWNotl  double  digestion  (Figure  4.1)  for  pronuclear  microinjection  (for 
which I am grateful to Sophie Wood, NIMR Procedural Services Division). Five individual 
transgenic mouse founders (out of 35 animals bom in total) were positive for iCre by PCR. 
All founders were maintained for characterization.
To  ask whether the  transgenic  lines  can  respond  to  tamoxifen  and  trigger  Cre-mediated 
recombination  in  vivo,  CAGGSET mice  were  crossed  to  Rosa26 Reporter  (R26R)  LacZ 
animals (Soriano, 1999). Pregnant females were injected either with OHT or the vehicle (oil) 
alone at Embryonic day (E)  11.5 and embryos were harvested 48 hours later (E13.5) for X- 
gal staining. The presence and intensity of LacZ expression reflects the levels of CAGGSET- 
mediated  Cre  activity.  In  the  absence  of OHT,  no  LacZ  expression  was  detected  in  the 
embryos from any of the five lines (data not shown). However, three lines (Lines B, M and N) 
displayed  significant  LacZ  expression  (Figure  4.3A)  after  OHT  induction,  suggesting 
CAGGSET is active in recombination. We have focused on Line B, the line that showed the 
most intense X-gal staining, to conduct further experiments.  Despite displaying mosaicism, 
line  B  also  shows  highest levels  of transcript and the most intense X-gal  staining  in the 
gonads, and will benefit the studies in gonadal development (Figure 4.3B and C).
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Figure 4.2  CAGGSET- 
mediated recombination in 
vitro.
Plasmid CAGGSET was transiently 
transfected into either (A) COS7 
or (B) rat granulosa cells. In both 
cases, a mouse monoclonal 
antibody against Cre was used to 
detect the presence of iCre (red). 
EGFP protein (green) was detected 
using a sheep anti-GFP antibody. 
DAPI was used to stain cell nuclei.
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Figure 4.3  Three out of 5 
transgenic CAGGSET 
founders display Cre-mediated 
LacZ reporter activity.
CAGGSET founder mice were 
crossed to K26R LacZ animals, 
pregnant females were induced 
by  I mg of OHT at El l.5 and 
embryos were harvesed at E l3.5
(A) Out of the 5 founders. B. M 
and N showed significant X-gal 
staining, whereas only patches 
of X-gal staining were observed 
in Line A. No X-gal staining 
was observed in Line J.
(B) In situ hybridization o f iCre 
on Line B gonads.
(C) X-gal staining patterns of 
Line B gonads.
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874.5  Detailed characterization of CAGGSET mice
4.5.1  CAGGSET mice display mosaic iCre expression
Granulosa cells from CAGGSET-R26R-EYFP (Srinivas et al., 2001) females were dissociated 
and cultured in the presence of either OHT or the vehicle (ethanol) alone.  EYFP could be 
detected by autofluorescence as early as 24 hours after OHT administration (data not shown). 
Cells were co-labelled with antibodies against Cre and GFP (for EYFP).  iCre was localized 
in the cytoplasm of cells cultured without OHT, and in the nucleus in the presence of OHT 
(Figure 4.4).  Not all cells were positive for iCre, suggesting the expression of the transgene 
CAGGSET displayed mosaicism.  The reporter protein was detected only in the presence of 
OHT,  and  specifically  in  iCre  positive  cells.  No  reporter  protein  was  detected  in  cells 
negative for iCre or in the absence of OHT, indicating the expression of the reporter protein 
was  due  to  C4GG5£T-mediated  activities  (Figure  4.4).  This  experiment  showed  that 
CAGGSET is functional in an ex vivo culture environment.  However, not all the cells were 
iCre positive, indicating mosaic expression of the transgene, at least in ovarian cell types.
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Figure 4.5  For  figure legend see opposite page.
894.5.2  CAGGSET induces recombination in explant gonad culture
To  examine  if CAGGSET can  mediate  recombination  after  induction  in whole  organs  in 
culture, CAGGSET-R26R EYFP gonads were dissected from embryos at El2.5 and placed on 
agar  blocks  in  DMEM.  EYFP  autofluorescence  was  detected  48  hours  after  OHT  was 
administered  into  the  medium  (Figure  4.5A-C).  To  label  the  cells  that  have  undergone 
recombination, antibodies against GFP and lineage-specific markers were used together for 
immunohistochemical staining. EYFP expression was widespread in the gonad, and in many 
cases  co-localize with  SOX9  (Figure 4.5D-F)  or FOXL2  (Figure  4.5H-I),  indicating  Cre- 
mediated recombination events have occurred in the supporting cell lineage of both sexes. No 
recombination  event was  observed  in  the  absence  of OHT,  proving  CAGGSET-mtdiatQd 
recombination highly specific in this experimental system (Figure 4.5J-L).
4.5.3  CAGGSET activity at different embryonic and postnatal stages
To find out if CAGGSET can be used to induce recombination in embryos at different stages, 
pregnant females from CAGGSET-R26R EYFP matings were injected intraperitoneally with 
OHT at different time points between E7.5 and El 1.5. Sufficient recombination levels were 
detected  at  all  stages,  indicating  that  CAGGSET  may  be  of  general  use  throughout 
embryogenesis.
CAGGSET also functions during postnatal stages.  OHT was administered by intraperitoneal 
injection  to  CAGGSET-R26R  EYFP  pups  less  than  10  days  of  age,  while  3-week  old 
CAGGSET-R26R EYFP mice were injected with tamoxifen each day for a consecutive 5-day
90period. As a control, an equal volume of the vehicle (oil) was administered in parallel for all 
experiments.  Analyses show that significant levels of reporter EYFP  expression were only 
detected  from  animals  that  have  received  OHT  or  tamoxifen,  but  not  the  vehicle  alone 
(Figure 4.6).  This  showes that G4GG££T-mediated recombination  is highly specific to the 
inducer at all stages.
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Figure  4.6  CAGGSET- 
mediated  activity  after 
birth.
CAGGSET-R26R EYFP mice 
were  induced  postnatally, 
and the testes were collected, 
cryosectioned  and  examined 
for  immunohistochemistry 
using  sheep  anti-GFP  (for 
EYFP) and SOX9 antibodies. 
For testes harvested at P5 and 
PI 1,  in  vivo  induction  took 
place  two  days  earlier.  For 
the adult testes harvested at 6 
weeks  of  age,  tamoxifen 
induction began in vivo at the 
age of 4 weeks.  The inserts 
of each  panel  show  staining 
patterns  for  testes  that  are 
negative  for  the  CAGGSET 
transgene,  where  the 
expression of EYFP was not 
detected.
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Figure 4.7  Recombination activities of CAGGSET are dependent on the dosage of inducer.
CAGGSET males were crossed to R26R EYFP females.  Different amounts of OHT were given in utero at El 1.5 by intraperitoneal injection, whereas 
tamoxifen was administered by oral gavage. Gonads were dissected at E l3.5 and cryosexlioned for immunohistochemistry for EYFP using a sheep anti-GFP 
antibody (green).4.5.4  Recombination activities of CAGGSET are dependent on the dose of the inducer
Next it was asked how Cre activity responded to the dosage of the inducer. To examine Cre- 
mediated recombination levels in the gonads, pregnant females from the  CAGGSET-R26R 
EYFP cross were administered with different amounts of OHT by intraperitoneal injection, or 
tamoxifen  via  oral  gavage.  Similarly  for  the  adult,  CAGGSET-R26R  EYFP  mice  were 
induced  with  different  amounts  of tamoxifen  via  oral  gavage.  Levels  of reporter  EYFP 
expression were  examined by  immunohistochemical staining using an anti-GFP antibody. 
Figure  4.7  shows  that  at  all  stages  studied,  the  levels  of recombination  were  positively 
modulated by the amount of inducer given, with highest recombination activities achieved at 
the highest dosage under test (6mg of OHT for embryonic  stage,  20mg of tamoxifen for 
adults). However, not all cells were positive for reporter EYFP, suggesting a random event of 
recombination.  As expected, no reporter EYFP protein was detected in the absence of the 
inducer.
4.5.5  CAGGSET is active in different cell lineages in the gonads
Due  to  the  mosaicism  of  Cre-mediated  activity,  we  investigated  whether  CAGGSET- 
mediated  recombination  has  lineage  preferences.  To  examine  this  at  the  cellular  level, 
induced CAGGSET-R26R EYFP gonads were co-labelled with antibodies against GFP and 
cell-type specific markers.  As shown in Figures 4.8, all lineages in the gonads under test 
displayed  CAGGSET  activities,  although  at  different  levels.  These  results  showed  that 
recombination has taken place at least in all the major cell types we could test, although for 
some, not all the cells showed CAGGSET activity.
93CAGGSET:  Rosa26 Rep. EYFP
CMV enh Chicken B-actin promoter Chr6: Locus Roso26 EYFP stopx3
SOX9
EYFP
DAPI
IJ1HSD
EYFP
I  I   j   |K   eyfpB l
I   |   .  ey fp
scale bars: 150um
Figure 4.8  CAGGSET mediates  recombination  in  different cell  lineages  in the developing 
gonad.
CAGGSET males  were  crossed  to  R26R  EYFP  females.  OHT  was  given  in  utero  El 1.5  by 
intraperitoneal  injection  and  gonads  were  harvested  at  El3.5,  cryosectioned  and  examined  for 
immunohistochemistry.  Antibodies used  for co-labelling were  Sheep  anti-GFP for EYFP and  for 
lineage markers:  Sox9 for Sertoli cells (A -  D), 3J3HSD for Leydig cells (E -  H), and Stella for germ 
cells (I -  L).
944.5.6  Position  in  utero contributes to the efficiency of tamoxifen-induced recombination
after intraperitoneal injection
It was noticed that reporter activity varied  between embryos within  a  litter.  This was  in 
contrast to the explant or organ culture experiments mentioned above where the inducer was 
applied in vitro. Therefore it was decided to test whether the relative position of embryos in 
the uterus would affect recombination efficiency. To ensure all embryos in a litter harbour 
equal transgene copy number, homozygous CAGGSET males were crossed to homozygous 
R26R LacZ females. With all induction time points tested, highly variable intensities of X-gal 
staining were  detected  across the  same  litter,  indicating tamoxifen-administration  did  not 
distribute OHT equally to each embryo in utero (Figure 4.9). Although it may be difficult, 
further investigation would be required to address whether this is due to specific injection 
sites or to patterns of blood flow within the uterus, or both. However, this result needs to be 
borne in mind when interpreting results from embryos treated with inducer in utero.
4.5.7  CAGGSET activity was detected in a variety of tissues
Other than the gonads, recombination activities using CAGGSET were also observed in other 
tissues,  including  the  brain  and  heart,  at  different  stages.  As  these  tissues  were  not  the 
principle interests of this thesis, I will not discuss the results in detail. Example tissues that 
were positive for CAGGSET activities are presented in Figure 4.10.
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Figure 4.9  Intraperitoneal injection does not deliver the inducer evenly in utero.
The 7 embryos obtained from this litter harbour the same transgene dosage.  In utero induction took place at E9.5 by intraperitoneal injection o f 0.5mg OUT 
into each side o f the abdomen o f the pregnant female.  Embryos were harvested at El 1.5.F
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Heart (Ventricle) Brain (hippocampus)4.6  Discussion
CAGGSET offers  a  Cre-mediated recombination  system  for conditional  mutagenesis  in  a 
tightly controlled manner. Its activities were obtained in all the systems under test: in vitro 
culture, in utero induction, in vivo induction after birth, and explant culture. CAGGSET can 
also mediate recombination in developing chick embryos (collaboration with Martin Cheung 
and James Briscoe, data not shown) and will therefore be a useful tool in this system. As the 
focus of this thesis is mammalian gonadal development, the successful achievements in the 
chick model will not be discussed here. However, CAGGSET could well be of use to study 
gonadal development in ovo, and also in ex ovo gonad culture.
The CAGGSET plasmid was transiently expressed in culture systems and proved functional. 
This is particularly useful to test responder transgenes in an in vitro environment, providing a 
quick and reliable way to test newly created constructs (see Chapter 5).
GIGGSTT-mediated recombination can be induced at different stages during development 
and in postnatal mice.  It is the  first inducible-Cre driver shown to display recombination 
activity  at neonatal  stages.  CAGGSET allows  studies  of gene function in  a highly time- 
controlled manner:  it can delete an already expressing floxed gene in different tissues at a 
desired time; it can also mediate ectopic gene expression.
Induction via intraperitoneal injection in utero demonstrated highly variable X-gal staining 
within a litter, suggesting uneven distribution of OHT. The two embryos showing highest 
staining  intensity  could  have  been  situated  closest  to  injection  sites,  and  have  therefore
98received OHT more efficiently. An alternative method for in utero induction is oral gavage, 
which requires assimilation of the drug into the circulation system of the pregnant female. 
Comparison  between  these  two  types  of induction  methods  revealed  that  although  oral 
gavage distributes the inducer more evenly to all embryos, less recombination was observed 
within 24 hours after induction compared to intraperitoneal injection. However, similar levels 
of recombination  were  achieved  48  hours  after  induction,  indicating  that  both  methods 
resulted in recombination activity, but at different efficiencies. This has also been noted by 
others using Cre-ERT2 based systems (A Joyner, personal communication).
CAGGSET-mediated recombination displayed mosaicism, which perhaps reflects the biology 
of recombination and tamoxifen half-life. Mosaic transgene expression  is also a common 
problem  in transgenic mice generated by random  integration and usually reflects position 
effects.  There  are  two  subtypes  of position  effect,  stable,  or variegation.  Stable  position 
effects mean that the integration site influences the transcriptional activities of a transgene. 
Under this influence, the same transgene integrated at different loci will harbour different 
transcriptional efficiencies, and therefore display different expression levels. The 5 different 
CAGGSET mouse lines generated are good examples of this  effect:  the  injected embryos 
carried  the  same  transgene  but  displayed  different  activities  due  to  different  sites  of 
chromosomal integration (Kioussis and Festenstein, 1997).
Variegation  position  effects  occur  when  a  transgene  is  influenced  by  local  chromatin 
structure, which can vary between the same cell type (for example if integration occurred at a 
boundary between heterochromatin and euchromatin), between different cell types,  and/or 
between different stages. All of these can lead to gene silencing in an unexpected or random
99fashion. As the Cre antibody or probe did not work on sections or wholemount tissues, it was 
not possible to examine whether the mosaic pattern of CA GGSET-induced reporter activity 
was due to position effect variegation or to the dynamics of iCre-mediated recombination 
within specific cell lineages. However, it is possible to conclude that all of the cell lineages 
studied displayed significant levels of G4GGS!Zs7,-mediated iCRE activity, proving it useful 
for developmental studies.
Furthemore, the mosaicism can be advantageous for specific tests; notably CAGGSET allows 
comparison  between  mutant  and  wild  type  cells  within  the  same  environment,  and 
consequently the different downstream cellular events that occur due to the mis-expression of 
a transgene, or an altered genetic event.  For example, multiple attempts have been made to 
study gene function in the Sertoli cell lineage.  However, these generally give rise to sex 
reversal or severe testis cord disorganization, due to the complete extinction of Sertoli cells 
(e.g. Barrionuevo et al., 2006;  Gao et al., 2006).  In these circumstances it is difficult to 
know whether a particular effect is  due to  cell  autonomous action  of a gene  or not,  and 
whether disorganised tissue architecture leads to secondary effects on the cell lineage being 
studied.  It is therefore useful or necessary to use an effector, or a Cre-driver in our case, 
which does not alter gene expression in the whole lineage.  In this way it should be possible, 
for example, to investigate how specific genes act within Sertoli cells, build genetic pathways 
within  the  lineage,  and ask how  Sertoli  cells  influence  other cell  lineages.  Mosaic  Cre- 
mediated  recombination  can  also  be  useful  for  lineage  studies.  Observations  from  co­
labelling experiments have proved CAGGSET a good tool for all these purposes, within the 
gonad or in other tissues.
100Loss- or gain-of-function of a gene can lead to embryonic lethality, which might render in 
vivo gene function studies unfeasible. Sox9 provides a good example of this limitation: it has 
been shown that embryos homozygous for Sox9 deletion die around El 1.5, a stage before the 
sex of the embryo could be morphologically distinguished (Akiyama et al., 2002). In such a 
case, CAGGSET could serve to bypass embryonic lethality either by inducing Cre-mediated 
recombination later, or by reducing recombination efficiency by modulating inducer dosage. 
Another  option  is  explant  culture,  in  which  CAGGSET displayed  higher  recombination 
efficiencies.
CAGGSET activity is highly specific to the inducer, which is an absolute requirement for 
studies  involving  cell  lineage  tracing  or  gene  function  at  a  particular  time  point.  Any 
undesired activity will  abdicate the principle  of the  inducible  Cre  system  and impair the 
accuracy  of the  experiments.  In  this  respect,  CAGGSET is  certainly  advantageous  over 
previously  established  lines,  which  displayed  low  levels  of recombination  activity  in the 
absence of tamoxifen (e.g. CMV-CreERT2\ CMV-CreER™).
Recombination using  CAGGSET could be  activated not  only  in  all  gonadal  cell  lineages 
under test, but also in various tissues and cell lineages in the mouse. For example, CAGGSET 
demonstrated recombination activities in the adult brain (data not shown), which has not been 
reported  for  other  tamoxifen-inducible  Cre  mouse  lines.  Tissue-specific  recombination 
studies in various tissues and at various stages would benefit from the use of CAGGSET.
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1025.1  Introduction
The term “responder” is used here to refer to an allele that has been genetically engineered to 
respond to the activity of a site-specific recombinase in such as way as to trigger an alteration 
in gene activity, usually loss or gain of function. Although it has been published that loss or 
gain of function of Sry or Sox9 can lead to sex reversal phenotypes in both humans and mice 
(Chapter 1), it is not known if altering gene expression after sex determination can lead to 
cell-fate  reversal.  To  address  this  question,  conditional  alleles  for Sry  and Sox9 become 
necessary.  So far, conditional loss-of-SoxP-expression alleles have been generated in mice 
(Chaboissier et al., 2004; Barrionuevo et al., 2006). Sry is expressed briefly in the genital 
ridge, which would mean ther ea conditional loss of function allele  This leaves conditional 
misexpression alleles  for Sry and Sox9 to be  created.  This  chapter describes the design, 
establishment, and tests of conditional misexpression alleles for Sry and Sox9.
An ideal conditional misexpression allele, which can be introduced into mice as a transgene 
or through gene targeting (but see below), requires three elements: (1) the promoter, which 
controls where and when the gene of interest is expressed; (2) a “stop” cassette that is flanked 
by recombinase-recognizable sequences to block transcription of the conditional allele, i.e., 
the gene of interest. This can be the stop codon on its own, or include a reporter gene before 
the  stop  codon.  The  presence  of  this  reporter  reflects  promoter  activity,  whereas  its 
disappearance  indicates  a  successful  recombination  event;  (3)  the  responder  allele, 
expression of which is not allowed until the removal of the reporter allele.  A schematic 
representation is shown in Figure 5.1.
103—   Seleted promoter  >j  Reporter fleno-STP^|  1   Responder gene  | — ^
Figure 5.1  An ideal conditional expression transgene.
As mentioned in Chapter  1, the Cre/loxP conditional system was chosen for gene alteration 
studies. For the responder transgenes, cDNA sequences of Sry and Sox9 were used for sub­
cloning. The Sry gene was discovered in the host lab (Gubbay et al., 1990) and its expression 
in  XX  embryos  led  to  sex  reversal  XY  female  sex  reversal  (Koopman  et  al.,  1991).  To 
misexpress Sox9,  a previously reported cDNA was  employed (Wright  et al.,  1995), but in 
addition,  a  transgenic  construct  that  allows  conditional  expression  of the  mouse  genomic 
Sox9  DNA  (Z/Sox9,  Sarah  Wynn  et  al.,  unpublished)  was  also  adopted.  In  all  cases, 
transgenes  were  driven  by  a  ubiquitous  promoter.  The  floxed  “stop”  cassette  included  an 
ECFP  reporter  protein,  which  allows  live  detection  of cells  displaying  promoter  activity. 
Under the activity of the ubiquitous promoter, the reporter ECFP will be expressed in all cell 
types  and  at  all  times,  whereas  the  expression  of the  responder  gene  will  be  induced by 
cellular  Cre-activity,  which  is  in  turn  defined  by  the  regulatory  elements  that  drive  the 
expression of Cre (Chapters 3 and 4).
1045.2  Creating responder transgene alleles
5.2.1  CMV:ECFP/Sox9 (COND-FlaeSox9)
To create the floxed ECFP-reporter allele, the pGK-neo-pGK fragment in the vector pBigT 
(Srinivas  et al.,  2001) was replaced by ECFP via blunt-ended ligation.  Using this  as  a 
backbone, the cDNA of Sox9, which has a flag tag inserted into its 5’ end, was inserted after 
the floxed ECFP cassette to replace an existing EYFP, generating the shuttle vector TS9C2 
(Figure  5.2A).  The floxed ECFP/Sox9 fragment from  TS9C2 was then subcloned into the 
plasmid pGS2+, to generate a conditional Sox9 cDNA expression plasmid, COND-FlagSox9 
(Figure 5.2B). As a control for this plasmid, a ubiquitous FlagSox9 construct was also made 
by  removing  the  floxed ECFP  fragment  in  COND-FlagSox9,  generating  CMV:FlagSox9 
(Figure 5.2C).
5.2.2  Building a conditional 5rv-responder:
Due to the problems encountered during molecular cloning, parallel strategies were used to 
make  an  Sry-responder transgene.  In  both  attempts,  an  SryM yc  transgene  was  used.  This 
encodes a Myc tagged SRY protein, with 6 copies of the Myc tag inserted at the 3-prime end 
of the Sry open reading frame. This was proved functional, as it caused sex reversal in mice 
(Sekido et al., 2004).
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Figure 5.2  For figure legend see opposite page.
106(I)  CMV:ECFP/SrvMvc6 (C0ND-SrvMvc6)
In the first strategy to generate the ^-responder, the floxed ECFP-triple pA fragment from 
TS9C2 (Figure 5.2A) was inserted between the  CMV promoter and the SryM yc sequences in 
the pcDNA3 plasmid to generate COND-SryMyc6 (Figure 5.3).
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Figure 5.3  Molecular cloning of the COND-SryMyc6 construct.
To generate a conditional Sry allele, the floxed ZsCFP-triple pA sequence from earlier made plasmid 
TS9C2 was excised by NheVSpel double digestion and inserted into the Xbal site of plasmid pcDNA- 
SryMyc6  (Lovell-Badge  lab  plasmid  stock  0076).  This  transgene,  CMV:ECFP/SryMyc6,  is 
designated as COND-SryMyc6.
(II)  CAG:ECFP/SrvMvc6 (AneelBL UE-Srv)
Another strategy to make the Sry-responder transgene was to use the CAG promoter to drive 
conditional expression of Sry. To start with, the floxed ECFP-triple pA fragment was inserted 
into the plasmid pCAGGS (Niwa et al., 1991), generating a vector called AngelBLUE (Figure 
5.4A).  The SryM yc sequences were amplified by PCR, and inserted into the region after the 
floxed ECFP-triple pA sequence of AngelBLUE, giving AngelBLUE-Sry (Figure 5.4B).
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Figure 5.4  Molecular cloning of the AngelBLUE-Sry construct
(A) To make the shutter vector AngelBLUE, the floxed ECFP-Xriple pA sequence from earlier made 
plasmid TS9C2 was excised by Nhel/Spel double digestion and inserted into the Xbal site of plasmid 
pCAGGS (Niwa  et al., 1991) via compatible-end ligation.
(B) PCR cloning was employed to bring in the SryMyc6 cDNA: Primers for Sry was designed with 
Sail linkers attached to flanking ends.  The amplified fragment was then digested by Sail and inserted 
into the Xhol site of AngelBLUE via compatible-end ligation.  This transgene, CAG:ECFP/SryMyc6, 
is designated as AngelBLUE-Sry.
1085.3  In vitro functionality tests for responders
After sequence verification at all cloning junctions, constructs were tested in  vitro. As the 
aim was to observe gene misexpression effects at different stages using the same Cre-driver, 
a  tamoxifen-inducible  Cre/loxP  system  was  employed.  The  responder  constructs  were 
therefore co-transfected with plasmid CAGGSETinto immortalized COS7 cells.
5.3.1  CMV:ECFP/Sox9 (COND-FlazSox91
COND-FlagSox9 and CMV:FlagSox9 were tested in parallel. Both were co-transfected with 
CAGGSET and treated with either 4-hydroxytamoxifen (OHT) or the vehicle (ethanol) alone. 
In any experimental condition, neither of the Sox9 constructs expressed SOX9, even though 
iCre became nuclearly localized  in the presence of OHT in the culture medium (data not 
shown). This was found to reflect a problem in the Sox9 cDNA itself. Sequencing the full 
length of the construct revealed a missing basepair in the Flag sequence, which shifted the 
translation initiation codon and therefore no flag or SOX9 protein could be produced (data 
not shown).
5.3.2  Plasmid SW88 (Z/Sox9)
Z/Sox9:
CMV enh Chicken 6-actin promoter 
Figure 5.5  Schematic diagram of the Z/Sox9 transgene.
LacZ Sox9
IRES
ECFP
109The  alternative  conditional  Sox9  construct,  derived  using  the  plasmid  SW88  contains  the 
CAG ubiquitous promoter driving a floxed p-geo-stop/mouse genomic iSoxP-encoding region 
transgene,  termed  ZJSox9  (Figure  5.5,  Sarah  Wynn,  unpublished).  SW88  was  transiently 
transfected  into  COS7  cells  together  with  the  CAGGSET plasmid.  EGFP,  which  reports 
recombination activity, could be detected as early as  12 hours after administration of OHT. 
SOX9 was detected in cells that had nuclear localized iCre, indicating the expression of the 
transgene  is  due  to  CAGGSET-mQdiatQd  activity  (Figure  5.6).  SOX9  or  EGFP  was  not 
detected in non-transfected cells or in transfected cells in the absence of OHT, indicating that 
the expression of Sox9 and EGFP is specific to Cre activity (Figure 5.6).  Transfected cells 
cultured  without  OHT  showed  X-gal  activity,  indicating  the  floxed  ft-geo  gene  is  also 
functioning correctly (data not shown).
CAGGStT:
CMV enh Chicken 8 actin promoter
Z/Sox9:
CMV enh Chicken S-actm promoter
D A P llB SOX9
EGFP (auto)
scale bar: JOum
Figure 5.6  For figure legend see opposite page.
1105.3.3  CMV:ECFP/SrvMvc6 (COND-SrvMvc6)
Similar experiments were performed using COND-SryMyc6. ECFP was detected  12 hours 
after transfection in cells cultured in the presence of OHT. Antibody co-labelling revealed 
that in the absence of iCre or its nuclear localization, ECFP and low amounts of MYC were 
expressed. However, cells cultured in the presence of OHT displayed much higher levels of 
MYC  (Figure  5.7),  indicating  CAGGSET-mediated  recombination  gives  a  significant 
expression of Sry-myc and ‘leakage’ is a minor problem.
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Figure 5.7  In vitro functionality test of the construct COND-SryMyc6
Immunostaining was done on COS7 cells co-transfected with CAGGSET and COND-SryMyc6.  A 
and D: DAPI staining on cell nuclei; B:  in the absence of OHT, iCre was detected in the cytoplasm, 
ECFP autofluorescence was observed in the cell nucleus, however, small number of cells expressed 
myc (C); E: in the presence of OHT, iCre was detected in the cell nucleus, which co-localized with 
myc expression in several cells (F).
Ill5.3.4  CAG:ECFP/SrvMvc6 (AneelBLUE-Srv)
AngelBLUE-Sry was  also  co-transfected with  CAGGSET into  C0S7  cells.  Like  COND- 
SryMyc6, ECFP was detected by autofluorescence after OHT administration. In the absence 
of OHT,  iCre was detected in the cell cytoplasm and ECFP was co-localized with several 
iCre  positive  cells.  Trace  levels  of MYC  were  detected  in  these  cells,  indicating  minor 
leakage problems (Figure 5.8A-C). However, in the presence of OHT, most of the cells that 
were  positive  for  nuclear-localized  iCre  also  displayed  MYC  expression  (Figure  5.8F). 
Background Myc expression was seen in some cells which are iCre negative, indicating the 
possible  leakage  problem  was  due  to  the  responder construct but not  CAGGSET (Figure 
5.8D-F, white arrows).
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Figure 5.8  For  figure legend see opposite page.
1125.4 Establishing stable transgenic founder mice
Following the functionality tests of the responder alleles in vitro, transgenic mice were made 
using AngelBLUE-Sry, and SW88 for conditional misexpression of Sry and Sox9, respectively. 
Pronuclear microinjection was carried out by the Procedural Services Team of the NIMR 
(with thanks to Sophie Wood).
5.4.1  AneelBL UE-Srv
To remove the transgene from the vector backbone, plasmid AngelBLUE-Sry was digested by 
Sail and Hindlll. The resulting 5.5kb transgene fragment was then purified for pronuclear 
microinjection.
5.4.2  Z/Sox9
Plasmid SW88 encodes the transgenic Z/Sox9 allele. The schematic diagram of this construct 
is presented in Figure  5.5.  To remove the transgene  from the vector backbone, plasmid 
SW88 was digested by Sail and Notl.  The resulting  11.5kb transgene fragment was then 
purified for pronuclear microinjection.
5.5  The AnselBLUE-Srv transgenic mouse
Only  one  transgenic  founder  (out  of  47  genotyped  bom  pups)  was  obtained  from 
microinjection with AngelBLUE-Sry.  This line did not display detectable ECFP, either by
113autoflourescence or immunostaining on gonad sections, and was not characterized further. 
The most likely reason to explain this is a chromosomal insertion effect. In this particular 
animal, the transgene might have been inserted into a locus that is transcriptionaly silent.
5.6  Characterization of Z/Sox9 founder mouse lines
5.6.1  Z/Sox9 mice expressed the floxed B-zeo transgene
Six pups (out of 71) generated by pronuclear microinjection were positive for LacZ by PCR. 
Five  (Lines  B,  J,  M,  S,  and  V)  of these  founders  were  generated  on  the  CBA/B10  FI 
background,  and  one  (Line  C)  was  generated  on  the  C57BL6  background.  During 
characterization of these transgenic founders, we received ZJSox9- 10F mice from the Cheah 
lab  (unpublished).  This  line  carried only one  copy of the transgene,  and was  created by 
germline transmission  from  chimaeras  made by  injecting host blastocyts  with transfected 
embryonic  stem  cells.  It was maintained on a mixed  129Sv/J;  C57BL6 background.  All 
ZJSox9 lines were characterized for transgene expression.
Of the 7 lines generated by pronuclear injection, only 4 displayed X-gal activity in embryos 
positive for the Z/Sox9 transgene (Lines B, C, J, M, Figure 5.9A-J).  Alongside Line C, 10F, 
which is generated by injecting blastocysts, showed highest intensities of X-gal staining.  X- 
gal activities were also seen in both gonad subtypes of these lines, with the exception of Line 
M, which did not show any X-gal activity either in wholemount XX embryos or their ovaries 
(Figure  5.9K-T).  The  founder male  of Line M  had  only  one  transgenic pup  (out of 70 
genotyped).  This was a female, and her offspring did not display X-gal staining. We also
114observed that as the stage of harvest (between E9.5 and El3.5) proceeded, fewer transgenic 
embryos compared to wildtypes were obtained from breeding the founder, which suggested 
embryonic lethality. This could also explain why only one transgenic pup was obtained.
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Figure 5.9  For  figure legend see opposite page.
1155.6.2  ZJSox9 expression varies in different genetic backgrounds
It has been shown that several phenotypes related to gonadal development in mice were more 
readily seen on the C57BL6 genetic background (e.g. Fgf9, Schmal et al., 2004; DiNapoli et 
al., 2006). For comparison purposes, backcrossing was set up for individual Z/Sox9 lines in 
parallel to their characterization. Changes in the X-gal staining pattern were observed in at 
least Line  B.  On the  mixed  CBA/BL10  background,  embryos positive  for LacZ by  PCR 
showed a consistent staining pattern (Figure 5.9B and G). However,  in crosses between a 
male homozygous for Line B on this mixed-background and C57BL6 females, embryos from 
the same litter displayed highly variable X-gal staining in different tissues (Figure 5.10). As 
each embryo carried equal transgene copy numbers and no recombination event was involved, 
it  seems  likely  that  the  variable  genetic  background  was  the  most  likely  cause  for  the 
difference in X-gal staining pattern.
Z/Sox9:
CMV enh Chicken ft-actin promoter  j \ L a cZ D H Sox9 IK E S E C F P
Figure 5.10  X-gal staining intensities vary within a litter of Z/Sox9 (B) of mixed genetic 
background.
Crosses were set up between a Z/Sox9-(B) male with a C57B1/6 female.  Embryos were harvested at 
El 1.5 for X-gal staining.
1165.6.3  Z/Sox9 on a C57BL6 background are poor breeders
Another observation during back-crossing onto C57BL6 was the loss in number of transgenic 
pups. By the first backcrossing step onto C57BL6, transgene transmission rate of Line 10F 
dropped to 25%. No transgenic pup was obtained by the second generation. Also, several 
transgenic pups were much smaller in size and weaker compared to wildtype littermates. 
Several transgenic mice were also lost postnatally. Similar findings were obtained from Lines 
J during the backcrossing process. Line C was the only line generated by pronuclear injection 
on C57B1/6 and displayed strong X-gal staining. It has produced extremely low numbers of 
transgenic pups so far. Altogether, these results suggest that the ZJSox9 transgene might not 
be well maintained on C57B1/6. For maintenance of the transgenic lines, Lines 10F and C are 
now maintained on a mixed background with 129Sv/J.
5.7  Discussion
Due to the complexity of the design for the responder transgenes, it is essential to make sure 
every part of the transgene function correctly before using them to make mice.  During the 
tests in vitro, minor leakage problems were encountered.  This could be due to the use of 
immortalized cells in the culture system. As the number of cells displaying leaky expression 
patterns was less than 5% in all cases, it was concluded that this should not be of concern in 
making transgenic mice.
117Z/Sox9 mice were generated using two strategies:  We have generated several lines (Lines B, 
C,  J  and  M)  by  pronuclear  microinjection.  The  copy  number  of the  transgene  and  its 
expression levels were not known before the generation of the founder animals. On the other 
hand, the imported 10F line was generated by electroporation into embryonic stem (ES) cells, 
clones of which were screened for high (3-galactosidase activity and to ensure that there was 
only a single copy of the transgene. Undoubtedly, transgenic mice harbouring loxP sites with 
unknown  copy  number  could  raise  concern.  For  example,  if multiple  insertion  of the 
transgene happened at one  single  site,  Cre-mediated removal  of segments  will  become  a 
random event, which may not consistently express the conditional allele in all cases (Figure 
5.11 A). Rarer events include transgene insertion into multiple loci, which may happen within 
the same chromosome (Figure 5.1 IB), or different chromosomes, or events where one copy 
is not head-to-tail as usual, but has been inserted in an inverted orientation relative to other 
copies. All such cases may lead to chromosome translocations (Figure 5.11C). On the other 
hand, it has previously been reported that there was a good correlation between the levels of 
transgene  expression  observed  in  ES  cell  clones  and  the  resulting  expression  seen  in 
transgenic  mice  (Novak  et  al.,  2000).  However,  there  were  also  cases  when  transgene 
expression levels in mice did not correspond to those in the ES cell clone (James Critchley, 
PhD  thesis,  2005).  In  our  hands,  both  Line  C  (generated  by  microinjection)  and  10F 
(generated by ES  cell screening and blastocyst injection) displayed robust (3-galactosidase 
activity, indicating feasibility of both methods to achieve desirable results.
The third alternative to generate high expressor transgenic mouse lines is by gene-targeting. 
Different  loci  have  been  identified  to  produce  robust  transgene  expression  without 
influencing or being influenced by intrinsic factors.  Several of these, including Rosa26 on
118chromosome  6,  were  made  susceptible  for gene targeting  (Soriano,  1999;  Srinivas,  2001). 
Inserting  the  driver  transgene  into  the  Rosa26  locus  should  overcome  the  uncertainty  of 
position effects, and allow more appropriate conditional transgene expression patterns to be 
generated.
Sox9  GFP Sox9  GFP
Sox9  GFP
Figure 5.11  Possible  genomic  insertion  events  of  a  transgene  introduced  by  pronuclear 
microinjection.
(A) Multiple copy number of the transgene inserted into the same genome locus.  Upon Cre mediated 
recombination, loxP sites will be removed by random events.  In certain cases, this will not lead to 
Sox9 expression, but instead another LacZ cassette.
(B) Copies of transgene inserted into multiple loci on the same chromosome.  This is a rather rare 
event, but if this occurs it can lead to deletion of the genes situated between the transgene insertion 
loci.
(C) Chromosomal translocation between loci on different chromosomes.  This is another rare event, 
which can affect not only transgene expression patter, but also intrinsic gene expression.
The progeny of Z/Sox9 line M could not be maintained. The absence of transgene expression 
in the XX suggested gene silencing. The only transgenic female obtained from the founder 
bred normally, however her offspring of either sex did not display (3-galactosidase activity. 
Also,  strong  expressors  of the  transgene  might  have  died  during  embryogenesis,  as  the
119number of transgenic embryos obtained declined as the stage of harvest progressed. This also 
explained why only one transgenic pup was obtained out of 70 bom and genotyped.
Lines  10F and C displayed intense X-gal staining. Both comprised a high proportion of the 
C57BL6 genetic background.  This background seems  favourable  for improving transgene 
expression, as Line B displayed stronger expression patterns when mixed with C57BL6.  It 
has been shown that several phenotypes related to sex determination gene mutations are more 
robust in a C57BL6 background (e.g., Fgf9r/\ Schmal et al., 2004; DiNapoli et al, 2006), and 
we  therefore  wanted  to  expose  ZJSox9  to  this  genetic  background.  However,  during 
backcrossing, it was impossible to maintain Z/Sox9 lines on this background, perhaps with 
the exception of Line B. Strong expressing lines 10F and C suffered from loss of pups and 
general weakness under the influence of C57BL6.  Instead, both lines are now being kept on 
a mixed background with  129SWJ, which seemed successful with Line  10F so far.  It will 
require  further  characterization  during  outbreeding  to  monitor  the  influence  of different 
genetic  backgrounds.  Backcrossing  will  continue  on  Line  B,  with  all  offspring  being 
examined.
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1216.1  Introduction
During gonadal development in the mouse, Sox9 is weakly expressed in the genital ridge of 
both sexes until the onset of Sry expression, from when it is rapidly upregulated in the XY 
but  downregulated  in  the  XX  genital  ridge  (Morais  da  Silva  et  al.,  1996).  Testicular 
expression of Sox9 then persists throughout life, specifically in Sertoli cells. The upregulation 
of Sox9 was found to coincide with the onset of Sry expression in supporting cell precursors 
and the protein products of the two genes can be seen to co-localise within a subset of these 
cells prior to Sry switching off (Sekido et al., 2004). These data strengthened the belief that 
Sox9 is a direct downstream target of SRY.
Sox9 is essential for testis determination in both humans and mice. Heterozygous mutations 
in SOX9 in Campomelic Dysplasia patients are often associated with XY female sex reversal 
(Foster et al., 1994). In mice harbouring heterozygous loss of function mutations in Sox9, the 
testes  develop  normally  despite  perinatal  lethality  (Bi  et al.,  2001).  Mice  harbouring  a 
homozygous deletion of Sox9 die around embryonic day (E)  11.5  (Akiyama et al., 2002), 
rendering studies of gene function at later stages feasible only by organ culture or conditional 
mutagenesis.  Both  approaches  lead to XY  female  sex reversal  (Chaboissier et al.,  2004; 
Barrionuevo et al., 2006).  Conversely, ectopic expression of a Sox9 transgene in the XX 
gonad led to male development (Vidal et al., 2001) as does disregulated expression of Sox9 
due to a transgene insertion in Oddsex mice or duplication of the SOX9 locus in humans (Qin 
et al., 2004). Taken together, Sox9 is not only essential for initiating testis differentiation, but 
also able to do so in the absence of Sry. However, the precise function of SOX9 at different 
stages and the reason for its persistent expression in Sertoli cells remain unknown. Using 
CAGGSET’   as an inducible-Cre driver that can mediate gene expression or deletion in the
122developing gonad at any desired stage, the aim was to ask what happens if Sox9 expression is 
altered after sex determination has already taken place.
6.2  Materials and Methods
Experiments  were  performed using  established  mouse  lines  that have  been  described  in 
previous chapters. CAGGSET and Flox-Sox9 (Sox9F lox/+ , Akiyama et al., 2002) mice are kept 
on the  CBA/BL/10 mixed background.  Z/Sox9-\0¥  mice  (Cheah Lab,  unpublished)  were 
generated on  a  129Sv/J X  C57BL/6 mixed  genetic background,  and were maintained by 
backcrossing to C57BL/6. With the exception of Line C, other ZJSox9 lines were maintained 
on a mixed CBA/C57BL/10 background. Line C was generated and maintained in C57BL/6. 
Subsequent  backcrossing  events  will  be  discussed  where  relevant.  fi-actin-Cre  mice 
(Lewandoski  et al.,  1997a)  were  maintained  as  homozygotes  and  were  provided  by  the 
Specific Pathogen Free (SPF) unit of the NIMR, and have a mixed genetic background. To 
allow cells, tissues or animals carrying the homozygous null allele of Sox9 to be generated in 
a conditional/inducible manner, Flox-Sox9 and CAGGSET mice were bred together.  Male 
and female offspring were then  intercrossed until animals homozygous  for the flox allele 
(,Sox9F lox/F lax)  were  obtained.  For  analyzing  ZJSox9  mice  that  were  heterozygotes 
(.Z/Sox9LacZIW T or Z/Sox9G F P 'm ), homozygous CAGGSET (CAGGSEfC re,iC re) mice were used 
to increase the probability of obtaining double transgenic mutants.
The nomenclature for transgenes used in this chapter is summarised in Appendix D.
1236.3  Conditional Sox9 misexpression mediated bv B-actin-Cre
The  first  steps  of characterizing the Z/Sox9 mouse  lines  involved testing their ability to 
respond to Cre-mediated activity. To do this ZJSox9 lines were crossed to p-actin-Cre mice, 
which provide robust Cre activity throughout gestation. Analyses were based on observation 
of possible  sex  reversal  phenotypes.  However,  as  Sox9  displays  widespread  expression 
pattern in numerous tissues, phenotypic observation in some of these tissues would also be 
briefly described in this section.
6.3.1  Ubiquitous misexpression of Sox9 is embryonic lethal
To test whether Z/Sox9 mice can respond to Cre-mediated recombination, Lines C, J and 10F 
were  bred  to P-actin-Cre.  Embryos  were  dissected  at  E13.5  for  examination.  Embryos 
positive for both Cre and the Z/Sox9 transgene from Line J were not fluorescent (data not 
shown)  indicating  insufficient  transgene  expression.  16  embryos  from  four  litters  were 
obtained by crossing Line 10F with p-actin-Cre. None were positive for the Z/Sox9 transgene. 
No positives were identified amongst 13 pups from Line 10F. Similar results were obtained 
from Line  C.  The  small  litter sizes and failure to obtain double transgenic embryos/pups 
indicated possible embryonic lethality. To investigate this assumption, analyses were carried 
out at earlier embryonic stages.
Small numbers of Cre; Z/Sox9 double positive {Cre+\ ZJSox9G F P /W T) embryos from Lines 
10F and C were obtained between E10.5 and E12.5. These embryos were positive for EGFP 
as  observed  under  a  fluorescent  microscope  (Figure  6.1),  but  not  for  LacZ  by  PCR
124genotyping  (data  not  shown),  indicating  that  the  floxed  fi-geo  reporter  gene  has  been 
successfully removed and Sox9-iRES EGFP activated.  We also observed that the number of 
transgenic  embryos  obtained  decreased  as  the  stage  of harvest progressed,  supporting  the 
hypothesis that overexpression of Sox9 causes embryonic lethality.
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Figure 6.1  VVholemount embryos of p-acfinCre; Z/Sox9 at E12.5.
EGFP was detected by autofluorescenee under a fluorescent microscope.
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scale bar 1  SOum6.3.2  Sox9 misexpression leads to cord formation in the XX genital ridge
EGFP positive embryos from Lines  10F and C were analysed further.  Initial observation 
indicated that XX double positive embryos display gonads resembling ovaries (Figure 6.2A), 
which  are  also  positive  for  EGFP  under  a  fluorescent  microscope.  However, 
immunohistochemistry  revealed  the  presence  of SOX9  and  EGFP  in  these  XX  gonads, 
although  not  all  SOX9-positive  cells  were  positive  for  EGFP  (Figure  6.2B).  Strikingly, 
SOX9 positive cells seemed to be arranged in structures resembling testis cords, implicating 
partial sex reversal (Figure 6.2B).
6.3.3  Sox9 misexpression upreeulates Sfl and Amh in the XX genital ridge
Following  the  observation  of  cord-like  structures  in  XX  gonads  that  are  ectopically 
expressing Sox9,  it was asked if SOX9 downstream targets were upregulated in these XX 
gonads.  SOX9 has been shown to activate the Sfl promoter in vitro (Shen and Ingraham, 
2002). It has also been proved that SOX9 is essential for Amh expression in vivo (Arrango et 
al., 1999). We therefore examined if these factors were expressed in the fi-actin-Cre; ZJSox9 
XX  gonads  following  the  misexpression  of Sox9.  At  El2.5,  AMH  was  detected  in  the 
coelomic  epithelial  cell  layer  of XX  10F  mutant  (Cre+ ;  10FG F P /W T)  gonads,  but  not  in 
wildtype (Cre+; Z/Sox9W T /W T ) gonads (Figure 6.3A-F).  Line C mutant gonads (Cre+ ; c?F P/W T} 
also expressed AMH, but at much lower levels compared to that of 10F  (Figure 6.3G-I). 
Interestingly, the presence of AMH did not always co-localize with SOX9.
On the other hand, significant levels of SF1  could be detected in XX Cre+ ; (f3™ ^ gonads, 
some of which co-localized with EGFP, within the testis cord-like structures.  SF1  was not
127detected, or at very low levels, in wildtype XX gonads (Figure 6.4), indicating the presence 
of SF1 in Cre+ \ cpFP/W T gonads was due to the ectopic presence of SOX9.
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Figure 6.3  For  figure legend see opposite page.
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Figure 6.4  *S^7 is expressed at much higher levels in XX gonads overexpressing Sox9.
B-actin Cre mice were crossed to ZJSox9-C mice.  Embryos were harvested at El2.5 and gonads were 
dissected out, cryosectioned and examined for immunohistochemistry  for SF1.  To  indicate which 
cells might be ectopically expressing Sox9, an antibody against GFP was also used for co-labelling. 
SF1 was found highly expressed in gonads transgenic for the ZJSox9 transgene (D-F), but at only low 
levels in the gonads that are negative for the transgene (A-C).  Note that the sub-cellular localization 
of EGFP is both cytoplasmid and nuclear.
M: mesonephroi; G: gonads.
6.3.4  Sox9 misexpression leads to developmental defects in other tissues
Cre+\ 10F°fp/wt embryos also displayed other morphological phenotypes by E12.5.  Mutants 
displayed  various  levels  of craniofacial  defects,  ranging  from  gaps  around  the  oral  area 
(Figure 6.5A-E) to internal bleeding of the forehead (Figure 6.5A). These embryos were also
129smaller,  more  fragile,  and  more  hunched  (Figure  6.1).  Compared  to  their wildtype  (Cre+; 
10FW T/W T)  littermates,  the  lungs  and  heart  also  displayed  various  levels  of abnormalities 
(Figure 6.6).  This  includes reduction in size of the  lungs,  and  incomplete formation of the 
heart, especially the auricles. In one embryo, the lungs were entirely absent (data not shown). 
The  limbs were shorter compared to those of wildtype littermates, and in some cases were 
still at limb-bud stages, and had failed to start forming digits (Figure 6.1). These observations 
suggested that Sox9 overexpression might have  led to developmental retardation in several 
organs, although the primordial of these organs did form. It is highly likely that embryonic 
lethality  was  caused  by  heart defects,  but further  investigation  is  required to  confirm this 
assumption.
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Figure 6.5  For  figure legend see opposite page.
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1316.4  CAGGSET-mediated misexpression of Sox9 in the developing gonads
With the purpose of bypassing embryonic lethality, the effects of misexpressing Sox9 were 
examined  after  crossing  ZISox9  mice  with  CAGGSET,  and  subsequently  inducing  CRE 
activity with tamoxifen or 4-hydroxytamoxifen (OHT). More  importantly, this would allow 
the  effects  of  Sox9  expression  in  the  XX  gonad  after  sex  determination  to  be  tested. 
Experiments were carried out using Z/Sox9-\0¥.
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Figure 6.7  For figure legend see opposite page.
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Figure 6.8  SOX9 and AMH expression in CAGGSET; Z/Sox9- 10F XX gonads.
CAGGSET mice were crossed with ZJSox9- 10F mice.  Pregnant females were injected with OHT at 
E8.5 and embryos were harvested at E14.5.  Gonads were dissected out, ciyosectioned and examined 
for immunohistochemistry for SOX9 and AMH.  Low levels of SOX9 and AMH could be detected in 
gonads transgenic  for both  iCre  (for CAGGSET)  and  GFP  (for Z/Sox9)  by  PCR  (D-F),  but not 
gonads that were positive for iCre but negative for GFP (A-C).  Inserts at the bottom-left comers 
show a magnified view of an area that misexpresses SOX9.  Note that the strong staining obtained 
from both transgenic and wildtype gonads were non-specific staining, whereas the area highlighted 
were specific for both SOX9 and AMH.
M: mesonephroi; G: gonads.
6.4.1  Induction prior to sex-determination leads to cord formation in the XX gonad
First,  the  effects  of  CAGGSET-induced  Sox9  expression  were  examined  prior  to  sex 
determination.  Pregnant  females  from  CAGGSET X  1 OF crosses  were  administered  with
133OHT  between  E8.5  and  E9.5  by  intraperitoneal  injection,  and  embryos  were  harvested 
between  El3.5  and  El4.5.  Under  a  light  microscope,  no  cord-like  structures  could  be 
detected in XX CAGGSETCre/wr; 10FG FP /W T gonads (Figure 6.7).  However, examination at 
cellular levels revealed SOX9-positive cells in these XX double positive gonads, forming 
structures resembling testis  cords  (Figure  6.8).  AMH  expression was  also  examined,  but 
found  to  be  not  significantly  different  between  CAGGSETCre/wr;  and
CAGGSETCre/wr\ lO F ^ ^ iwildtype) gonads (Figure 6.8).
6.4.2  Induction prior to  sex-determination  leads to more  cord-like  structures  in the XY 
gonad
XY  CAGGSETC re/W T\  10Fgfp/wt  positive  gonads  were  not  significantly  different  from 
wildtype gonads by wholemount observation (Figure 6.7). However, immunohistochemistry 
revealed widespread expression of EGFP, both within and outside testis cords, as marked by 
AMH (Figure 6.9D-F).  Surprisingly, EGFP positive, AMH negative cells also seemed to 
form cord-like structures (Figure 6.9F). Double antibody staining for SOX9 and AMH was 
also performed, in which SOX9 displayed similar expression patterns to EGFP. Like EGFP, 
SOX9  was  also  found  within  and  outside  testis  cords  (Figure  6.9J-L),  with  the  latter 
displaying a less intense staining for SOX9 (Figure 6.9L). It is possible that these cords are 
premature  at  the  stage  of  examination,  and  may  become  proper  testis  cords  later,  or 
alternatively, they may never fully differentiate further because of the low levels of SOX9. 
These cord-like structures also resemble those observed in the CAGGSETC re/W T\  10FG F P /W T 
gonads. Further investigation will be required to confirm the fate of these ectopic cords.
1346.4.3  Induction  after  sex  determination  leads  to  formation  of cord-like  structures  and
reduced expression of the ovarian-specific marker Foxl2 in the XX gonad
To address whether misexpression of Sox9 in the XX gonad after sex determination could 
change cell fate and cause sex reversal, pregnant females from the CAGGSET X 1 OF cross 
were  intraperitoneally  injected  with  OHT  at  El 1.5.  Gonads  of  XX  double  positive 
(CAGGSETCre/wr;  10FG F P /W T)  embryos  were  morphologically  female  at  El6.5.  However, 
examination at the cellular level revealed the presence of SOX9-positive cells, which appear 
in structures resembling testis cords. Also, AMH was detected at low levels in these gonads 
within SOX9-positive cells (Figure 6.10), indicating at least weak activation of AMH.
CAGGSET  induction  was  also  carried  out  in  organ  culture.  Pairs  of  CAGGSETCre/wr; 
lOF*3™™7 XX gonads were separated for culture in the presence of either OHT or the vehicle 
(ethanol) alone. Ectopic Sox9 expression was found only in gonads cultured in the presence 
of OHT but not the vehicle alone (Figure 6.11A-F). Similar to the results obtained from in 
utero  induction  experiments,  SOX9-positive  cells  formed cord-like  structures.  However, 
AMH was not detected in this case.
The  expression  patterns  of female-specific  markers  were  also  examined.  Foxl2  becomes 
expressed specifically in ovarian somatic cells by El2.5, and has been proven to be important 
in  follicular  maintenance  (for  review  see  Uhlenhaut  and  Treier,  2004).  In  XX  gonads 
cultured  in  the  presence  of  OHT,  FOXL2  was  detected  at  reduced  levels,  suggesting 
downregulation of the gene by the ectopic presence of SOX9  (Figure 6.11G-L).  FOXL2
135expression  was  also  examined  in  the  gonads  that  have  received  OHT  in  utero,  but 
preliminary data did not reveal significant differences in expression levels (data not shown).
6.4.4  Sox9 misexpression in granulosa cells leads to Foxl2 downregulation
The granulosa cell culture system was employed to study the effects of Sox9 misexpression 
in the  adult ovary.  CAGGSET-10F females were  induced for superovulation between 3-4 
weeks of age. Dissociated granulosa cells were cultured in the presence of either OHT or the 
vehicle (ethanol) alone. Strong EGFP could be detected in cultured cells as early as 12 hours 
after  OHT  induction  (data  not  shown),  indicating  successful  recombination  events. 
Immunocytochemistry demonstrated the presence of SOX9 only in cells that were treated 
with  OHT  and  had  iCre  nuclearly-localised,  indicating  the  presence  of SOX9  is  due  to 
CAGGSET-mediated recombination (Figure 6.12). SOX9 positive cells are also positive for 
EGFP  (data  not  shown),  indicating  that  EGFP  can  act  as  a  reliable  reporter  for  SOX9 
expression in granulosa cell culture.
Next it was investigated whether the ectopic expression of SOX9 in granulosa cells would 
lead to downregulation of female markers in these cells. To address this question, immuno- 
co-labelling experiments were performed using antibodies against EGFP and two markers, 
FOXL2 and DAX1, the expression of which usually persists in granulosa cells throughout 
folliculogenesis. In the presence of OHT, fewer cells were positive for FOXL2, but all cells 
were still constitutively expressing DAX1 compared to those cultured in the presence of the 
vehicle alone (Figure 6.13). Therefore, the ectopic expression of SOX9 in granulosa cells 
selectively leads to downregulation of FOXL2.
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Figure 6.9  For  figure legend see opposite page.
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Figure 6.10  SOX9 and AMH expression in CAGGSET; Z/Sox9- 10F XX gonads.
CAGGSET mice were crossed with ZJSox9-1  OF mice.  Pregnant females were injected with OHT at 
El 1.5  and  embryos  were  harvested  at  El6.5.  Gonads  were  dissected  out,  cryosectioned  and 
examined for immunohistochemistry for SOX9 and AMH.  The inserts at the bottom-left comer of 
the bottom right panel shows a magnified view of an area that misexpresses SOX9.
M: mesonephroi; G: gonads.
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Figure 6.12  Fctopic Sox9 expression  in granulosa cell culture.
CAGGSETtrc W T ;  10F°fpwt females  were  sacrificed  between  21-28  days  for  granulosa 
cell  culture.  Cells  were  cultured  either  in  the  presence  o f 2pM   OHT  or  ethanol  for 48 
hours.  A ntibodies used for im munolabelling were anti-SOX9 and m ouse anti-Cre.
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Figure 6.13  For figure legend see opposite page.
1416.5 CAGGSET-mzd\2ite& deletion of Sox9 in the developing gonads
Conditional knock-down of Sox9 was carried out during different embryonic and postnatal (P) 
stages.  As  in  the  misexpression  studies,  initial  tests  were  carried  out  prior  to  sex 
determination.
6.5.1  Deletion  of Sox9  prior  to  sex-determination  leads  to  cord  structure  damage  and 
downregulation of Sfl in Sertoli cells
To generate embryos homozygous for the inducible Sox9 null allele, mating pairs were set up 
between  Flox-Sox9  and  CAGGSET-Flox-Sox9  mice.  Pregnant  females  were  injected 
intraperitoneally with OHT at E8.5, and sacrificed at El4.5 for embryo harvest and gonad 
dissection.  Comparisons  were  made  between  iCre  positive  (CAGGSETC re/W T;  Sox9^; 
referred to as “mutant” hereafter) and negative (CAGGSET>vt/wt- , Sox9FIox/FIox; referred to as 
“wildtype”  hereafter)  gonads.  All XY,  iCre positive  gonads were  morphologically testes, 
indicating that no obvious sex reversal events have occurred. However, testis cords seemed 
less tightly packed  in mutant XY  gonads compared to the wildtype by  histology  (Figure 
6.14A-B). Immunohistochemistry for laminin revealed disorganised cord structures in mutant 
compared  to  wildtype  testes  (Figure  6.14E-F),  indicating  that  cord  structures  have  been 
damaged. Also noticed was a different organization of the tunica (Figure 6.14E-F), which 
looked slightly ruptured. Further examination by immunohistochemistry revealed a reduction 
in  SOX9  levels,  but  AMH  did  not  seem  affected  (Figure  6.15A).  Strikingly,  SF1  was 
extinguished  in  Sertoli  cells,  but not  in  interstitial  (Leydig)  cells  (Figure  6.15B),  further
142supporting the earlier suggestion from in vitro studies that Sfl  is regulated by SOX9 (Shen 
and Ingraham, 2002).
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Figure 6.15  For  figure legend see opposite page.
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Figure 6.16  No significant effects were observed in germ cells in the gonads with partial loss 
of Sox9.
CAGGSET-Flox-Sox9 mice were crossed to Flox-Sox9 mice.  Pregnant females were injected with 
OHT at E8.5 and embryos were harvested at E14.5.  Gonads were dissected out and cryosectioned for 
immunohistochemistry for Stella, which marks the male germ cells but not female germ cells at this 
stage.  M: mesonephroi; G: gonads
6.5.2  The effects of Sox9 deletion prior to sex-determination on germ cells
As it is known that germ cell sex is defined by the micro-environment surrounding the germ 
cells (McLaren and Monk,  1981; Palmer and Burgoyne,  1991; Bowles et al, 2006, Kourbova 
et al.,  2006),  it was  examined whether the  germ  cell  lineage  was  affected  along  with the
145changes in cord structure and the reduction in Sertoli cell markers. Stella, also called PGC7, 
starts to be expressed exclusively  in germ cells at E7.25  and lasts until El5.5  in the XY 
gonad  and  around  El3.5  in  the  XX  (Saitou  et  al.,  2002;  Sato  et  al.,  2002). 
Immunohistochemistry  for  Stella  revealed  no  obvious  difference  between  mutant  and 
wildtype  XY  gonads  (Figure  6.16).  However,  histology  of gonad  sections  revealed  gaps 
between  the  Sertoli  cell  layer  and  the  core  region  of the  cords  in  mutant  XY  gonads, 
indicating possible germ cell loss. The nuclei of germ cells also seemed abnormal compared 
to those in the wildtype gonads (Figure 6.14C-D). It was also asked whether germ cells have 
entered meiosis following the disruption of the somatic environment. Meiotic markers used 
for  immunohistochemistry  included  SCP3,  y-H2AX  and  DMC-1,  and  comparisons were 
made between mutant and wildtype gonads of both sexes from embryos within the same litter. 
None of these markers was detected in XY mutant gonads, indicating no significant entry 
into meiosis by germ cells within the XY mutant gonads (data not shown).
6.5.3  Deletion of Sox9 prior to sex-determination leads to ectopic expression of the female- 
specific marker Foxl2
Next it was examined whether female markers were present following downregulation of 
Sox9. The ovary-specific gene Foxl2 has been proposed to antagonize Sox9 expression, as 
SOX9 was detected in the ovaries of Foxl2 null mutants (Ottolenghi et al., 2005). Conversely, 
as  described  in  section  6.4.4  above,  the  ectopic  expression  of  SOX9  led  to  Foxl2 
downregulation.  The  expression  of FOXL2  was therefore examined  in the gonads of our 
Sox9  mutants.  FOXL2-expressing  cells  were  detected  in  the  XY  mutant  gonads  (Figure 
6.17A), some of which were located in the interstitial space of the testis, but many of these
146were found within testis cords and are also positive for AMH. Several also displayed Sertoli 
cell morphology (Figure 6.17B).
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1476.5.4  Deletion of Sox9 after sex determination leads to changes in cord structure
The upregulation of Sox9 in the developing testis by El 1.5 is essential to specify Sertoli cell 
fate.  The  deletion  of Sox9  after this point will test whether the  gene  is  also  required to 
maintain Sertoli cell differentiation. To induce Sox9 deletion, OHT was delivered in utero via 
intraperitoneal injection between El 1.5 and E12.5.  Gonads were harvested either at El8.5 or 
after birth.
Histology at El 8.5 demonstrated abnormalities in the mutant testes: cords were more loosely 
packed compared to those of wildtype testes, with more interstitial space (Figure 6.18A). 
Examination at higher magnification revealed gaps within cords,  consistent with possible 
germ cell loss (Figure 6.18B). However, no meiotic events were seen, either by histology 
(Figure 6.18) or by analysis of meiotic markers (data not shown).
To investigate long-term effects of Sox9 loss, pups that had been induced in utero at El2.5 
were monitored from weaning age for 9 weeks. By three weeks of age, both XX and XY 
mutant  pups  were  significantly  smaller  and  weighed  less  compared  to  their  wildtype 
littermates. However, the growth rate of mutants did not seem affected (Figure 6.19). These 
mutants were fertile: all of them mated with the female mice set up with them within 4 days, 
and all females produced litter sizes comparable to those provided by the control wildtype 
littermates (Figure 6.20A), indicating that the mutant testes were still functional. These males 
were killed to examine testis morphologies. Preliminary results showed that the body weights 
of the mutants were significantly lower than those of wildtype animals. Comparisons of the 
weight of testes relative to body weight showed that the testes of mutants were smaller than
148those  of  wildtypes  by  about  15%  (Figure  6.20B).  Analysis  using  histology  and 
immunohistochemistry will be required to investigate the reason for this at a cellular level.
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Figure 6.18  Histology of XY gonads with partial loss of Sox9.
CAGGSET-Flox-Sox9 mice were crossed to Flox-Sox9 mice.  Pregnant females were injected 
with  OHT  at  El 1.5  and  embryos  were  harvested at E l8.5.  Testes  were  dissected  out for 
either paraffin sectioning.  The red arrow-head highlights a gap found in a testis positive for 
iCre.
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150A Genotype litter size testes weiqht (mq) body weiqht (q) TW/BW (10'3)
iCre- 8 220.3 44 5.007
iCre- 8 225.8 47 4.804
iCre- 7 234 43 5.442
iCre+ 7 151.7 37 4.100
iCre+ 10 172.8 37 4.670
Normalised ratio
1000
0 883
iCfe-  iCre-  iCre-  iCre*  iCre*
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Figure 6.20  Fertility  of  CAGGSEfCremj\  Sox9i/J  mice  and  wildtype  littermates  that  have 
been induced at E l2.5 in utero.
(A)  M ale  m ice  w ere  set  up  with  w ildtype  females  and  plug-checked  daily.  Pregnant  females  were 
separated after plugged and have littered down, with their litter size recorded.  These males were later 
sacrificed to exam ine testicular phenotypes.  M ice were w eighed before schedule-1-killing and testes 
were taken out for w eighing.  Testis-to-body weight ratio (TW /B W ) was recorded.
(B)  G raphical  presentation dem onstrating norm alized TW /BW  ratio using the highest score obtained 
by a w ildtype.
6.5.5  Sox9  deletion  at  neonatal  stages  leads  to  changes  in  testis  cord  structures  and 
reduction in body size
We also looked at effects of CAGGSET-mediated loss of Sox9 function after birth. OHT was 
administered to  CAGGSETCre/W I;  Sox9Flox/Flox males by  intraperitoneal  injection at P3,  and 
testes were examined at PI4. Pups treated with OHT did not display levels of SOX9 different 
from those of littermates that received the vehicle (oil) alone, although testis cords seemed 
less  organized  in  the  former  (Figure  6.21A).  If induction  took place  6  days  later  (at  P9),
151S0X9  levels  and cord  structures  in the testes did not seem  significantly  affected at P22. 
However, the body  size  of the OHT-treated mice was notably reduced by the  same stage 
when  compared  to  littermates  that  have  received  the  vehicle  alone  (Figure  6.2IB).  To 
investigate if this is an artefact of induction instead of a general loss of Sox9 function, similar 
studies were conducted in CAGGSET-R26R EYFP male pups of the same age. No difference 
was observed between littermates that have received either OHT or the vehicle alone, or 
between transgenic and wildtype pups that have both received OHT (data not shown). This 
indicates that the reduction in size of CAGGSET-Flox-Sox9 mice that have received OHT 
was due to the loss of Sox9 and not an artefact of OHT administration. It is highly likely that 
the reduction of body size is due to effects on non-gonadal tissues, as Sox9 plays a general 
role in multiple tissues, and CAGGSET is not a gonad-specific Cre-driver.
6.5.6  Sox9 deletion can be induced bv CAGGSET in postnatal Sertoli cells
To  ask  if  CAGGSET  can  mediate  Sox9  deletion  in  Sertoli  cells,  four-week  old 
CAGGSETCrt/W T;  Sox9Fhx/Fhx  males  were  induced  by  intraperitoneal  injection  of either 
tamoxifen or the vehicle alone. Unlike induction studies carried out at early postnatal stages, 
CAGGSET-induction did not lead to a reduction of body weight or testicular weight. As the 
antibody against Cre did not work well on sections, testes cords were dissociated with cells 
spread onto glass-slides for examination at a cellular level.  Immunohistochemistry for SOX9 
and  iCre  on these testicular  cells  revealed that the two proteins  co-localized only  in the 
absence  of the  inducer  (Figure  6.22),  indicating  a  certain  population  of Sertoli  cells  are 
expressing ERT2iCreERT2. This observation also suggests that the ERT2iCreERT2 fusion 
protein  could  be  activated  in  Sertoli  cells  upon  the  administration  of tamoxifen.  This
152assumption  is  also  supported  by  the  observation  of several  iCre-positive  cells  displaying 
Sertoli cell morphology that were negative for SOX9 (Figure 6.22). Further experiments will 
be required to investigate if iCre-positive cells express female markers, for example, FOXL2.
CAGGSET:
CMV enh Chicken 13-actin promoter
ERTliCntRTJ
Flox-Sox 9:
Chr17:Locus Sox9
Oil 1mg OHT
B
I HI
scale bars; 15Qum
Figure 6.21  For  figure legend see opposite page..
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Figure 6.22  CAGGSET-mediated recombination can take place in the Sertoli cell lineage.
CAGGSET-Flox-Sox9 mice were injected with 4mg of tamoxifen or an equivalent concentration of oil 
for a consecutive 5-day period (total dosage 20mg).  Injected mice were sacrificed 10 days after the 
last  injection.  Testes  were  dissected  out  and  tubules  were  dissociated  and  cryopreserved  for 
immunocytochemistry for iCRE and SOX9.  Note that in the absence of tamoxifen (upper panels, 
labelled Oil),  iCre  is  localized  in the  cytoplasm and co-localization of iCRE and SOX9 could be 
observed.  In the presence of tamoxifen (lower panels), iCRE is localized in both the nucleus and 
cytoplasm.  In  this  case  no  cell  displayed  co-localization  between  iCRE  and  SOX9,  suggesting 
successful recombination events by CAGGSET to delete Sox9.  The white arrow-head points to an 
iCRE positive,  SOX9 negative cell that displays Sertoli  cell morphology,  which might have Sox9 
deleted due to the activity of CAGGSET.
1546.6  Discussion
Embryonic lethality due to overexpression of  Sox9
In the experiments involving Z/Sox9 mice, ubiquitous, ectopic expression of Sox9 leads to 
embryonic lethality by El3.5. At present it is not possible to make conclusions about the 
cause of lethality,  as phenotypic observation of the embryos at El2.5  revealed defects in 
various vital organs. Some of these organs had much reduced sizes and seemed retarded in 
their development.  Further investigation of the effects of ectopic Sox9 expression in different 
organs will require tissue-specific Cre mice to mediate the expression of Z/Sox9.
When Sox9 expression is altered
Sox9 overexpression mediated by fi-actin-Cre led to testis  cord-like structures  in the XX 
gonad,  in  agreement with the  sex reversal phenotypes obtained using  Wtl  to  drive Sox9 
(Vidal et al., 2001) or in Oddsex mice (Qin et al., 2004).
Using  CAGGSET,  Sox9  was  partially  deleted  or  misexpressed  at  different  time  points. 
Induction  of Sox9  misexpression  at  E8.5  led  to  cord  formation  within  the  XX  gonad, 
although  a  complete  sex  reversal  phenotype  was  not  obtained.  This  is  probably  due  to 
insufficient recombination efficiency. It has been shown that a threshold number of Sertoli 
cells must be reached in order for testis cords to form (reviewed by Polanco and Koopman, 
2006). It could be that CA GGSET-mediated recombination did not produce enough SOX9 
expressing cells, therefore only a restricted number of cords could be formed. Alternatively, 
deletion of Sox9 mediated by CAGGSET at E8.5 displayed disorganized cord structures but 
not complete sex reversal, whereas XY Sox9d/A  mice obtained by conditional deletion using a
155Ckl9:Cre are  sex reversed (Barrionuevo et al., 2006).  The  lack of complete sex reversal 
using  CAGGSET can  perhaps  be  explained  by  reasons  similar to  that  of Z/Sox9:  if the 
formation of testis cord requires a certain threshold, the complete loss of cords probably also 
requires  the  number  of Sertoli  cells  to  fall  beneath  a threshold.  Therefore  the possible 
mosaicism of CAGGSET activity may not have reduced SOX9 positive cells to a number that 
can cause cord deformation.
Similarly, induction at El 1.5, a stage when Sox9 is already upregulated in the testis, led to 
structural  changes  in  testis  cord  structures  in  both  misexpression  and  deletion  studies. 
CA GGSET-mediated misexpression  of Sox9 gave rise to the  formation  of testis cord-like 
structures in the XX gonad. In Sox9*/A  XY gonads, cord structures were slightly disorganised, 
leaving more interstitial space in between testis cords. These observations revealed that either 
misexpression  or deletion  of Sox9 in a subset of cells  is not enough to give rise to sex- 
reversal after sex determination has occurred.
The expression of  Sfl in Sertoli cells is regulated by SOX9
An Sfl  regulatory  region has  been  shown  to  be  activated  in  vitro  by  SOX9  (Shen  and 
Ingraham, 2002). The results presented here (section 6.3.3), involving the use of f-actm-Cre 
to  activate Z/Sox9,  displayed ectopic  SF1  in the XX  gonad.  Unlike  SOX9,  SF1  was  not 
detected in the mesonephros, suggesting certain co-factor(s) which are only present in the 
gonad are required for Sfl expression. On the other hand, CA GGSET-mediatcd deletion of 
Sox9 prior to sex determination extinguished SF1  only in Sertoli cells but not Ley  dig cells. 
Combining the in vitro data of Shen & Ingraham (2002) with this in vivo data makes it very 
likely  that Sfl  is  upregulated by  SOX9.  Conversely, unpublished  data  from  the host  lab
156(Ryohei Sekido and Silvana Guioli) shows that Sox9 expression in the testis depends on SF1. 
This suggests the existence of an autoregulatory loop whereby both genes act to upregulate 
each other. However, this must depend on additional co-factors present within supporting 
cells or by co-repressors that block it within Leydig cells.
Factors regulating AMH
Several factors have been shown to bind and activate the 360 base pair minimal promoter of 
Amh, and to regulate its expression in Sertoli cells. These include SOX9, SOX8, WT1, SF1, 
DAX1 and GATA4 (Arrango et al., 1999; Tremblay and Viger, 1999; Schepers et al., 2003; 
Shen et al., 1994; also reviewed by Rey et al., 2003). Whether, and how, all of these factors 
are required for the regulation is still unknown. In the transgenic experiments I report here, 
AMH was detected ectopically in p-actin-Cre-mcdrnXtd expression of Sox9 in the XX gonad, 
particularly in the coelomic epithelial cells, many of which are also positive for SOX9. A 
number of relevant transcription  factors  are  expressed in the  coelomic  epithelium.  These 
include  WT1  and  GATA4,  but  most  importantly  SF1  (de  Santa  Barbara  et  al.,  1998; 
Tremblay and Viger, 1999; Nachital et al., 1998 Ingraham Cell). SF1, at least, was present in 
the XX gonads ectopically expressing SOX9, and this might be related to the upregulation of 
AMH  confined  within the  coelomic  epithelium.  On the  other hand,  CAGGSET-mcdiatcd 
Sox9 misexpression in the XX gonad at E8.5 displayed low levels of AMH around SOX9- 
positive  cells,  but  CAGGSET-mediated  Sox9  misexpression  after  sex  determination,  or 
deletion of Sox9 at any stage tested, did not lead to significant changes in AMH levels, even 
though in the latter case  SF1  is downregulated in  Sertoli cells.  These results suggest that 
SOX9 and SF1  might be required for the initial upregulation, but not the maintenance of 
AMH. After sex determination, WT1  and GATA4 are both expressed in Sertoli cells. WT1
157has recently been shown to be important for AMH maintenance during testis differentiation. 
Conditional deletion of Wtl in XY gonads of El4.5 mouse embryos led to downregulation of 
both SOX9 and AMH, giving rise to uterine structures in addition to normal male internal 
genitalia (Gao et al., 2006). On the other hand, a backup mechanism for AMH regulation has 
been proposed: SOX8 has been found able to bind and activate the Amh minimal promoter, 
partially compensating the function of SOX9 in the upregulation of Amh (Schepers et al., 
2003;  Chaboissier  et  al.,  2004).  It  is  possible  that  Sox8  has  been  upregulated  in  the 
CA GGSET-mediated SOX9*/A   XY  gonads, partially  compensating  for the  loss  of Sox9 in 
these mutant testes.  Therefore the effects on AMH levels after altering  SOX9  expression 
were not significant. Further analyses of marker expression will be required in these mutants.
The efficiency of CA GG57sT-mediated recombination in Sertoli cells raises concerns for both 
the usefulness of the Cre-driver and for the interpretation of some of the results reported here. 
Mosaicism  of transgene  expression  and  accessibility  of the  inducer  can  both  reduce the 
percentage of cells misexpressing or deleting Sox9. It is particularly difficult to guarantee that 
both alleles of Sox9 have been deleted in Sox9F lox/F lox mice upon induction. Unlike humans, 
XY  mice  heterozygous  for  Sox9  deletion  develop  into  normal  males  (Bi  et  al.,  2001): 
disruption of testis differentiation requires both alleles to be inactivated. To ensure both Sox9 
alleles  can  be  successfully  deleted  at  least  in  a  subset  of Sertoli  cells,  I  am  currently 
introducing a germline Cre into the CAGGSEIiC re/,C re; Sox9F lox/F ,ox background. Protamine- 
Cre (PrmCre; O’Gorman et al.,  1997) and ZP3-Cre (Lewandoski et al.,  1997b) are active 
only in the male and female germline, respectively.  An embryo harbouring either of these in 
the  CAGGSETC re/lC re’ , Sox9F lox/F lox background will have one allele  of Sox9 deleted in the
158germline  before  fertilization,  leaving  CAGGSET  to  delete  the  remaining  allele  upon 
tamoxifen induction.
An antagonistic relationship between Foxl2 and Sox9?
The presence of SOX9 has been shown in gonads of XX Foxl2'A mouse embryos, despite the 
absence of testis cord formation (Ottolenghi et al., 2005). In contrast, Foxl2 transcripts were 
detected by real time RT-PCR in Sox9d //S  XY gonads (Barrionuevo et al., 2006). Sox9 and 
Foxl2 have several things in common during sex determination in the mouse: (1) both are 
expressed  in  the  supporting  cell  lineage  in  a sexually dimorphic manner (for review see 
Wilhelm and Koopman, 2006 and Yao, 2004), (2) both are maintained in the supporting cell 
lineage (although in different sexes) throughout life (for review see Wilhelm and Koopman, 
2006 and Yao, 2004), (3) both are essential for gonadal function in terms of maintaining the 
germ cell niche  and (4) both regulate the expression  of supporting  cell-specific hormone 
secretion (AMH for Sox9 and P450 aromatase for Foxl2\ Arrango  et al.,  1999; Uhlenhaut 
and  Treier,  2006).  In  the  studies  reported  in  this  thesis,  CAGGSET-mediated  ectopic 
expression of Sox9 in the XX gonad or in adult granulosa cells led to a reduction in FOXL2 
levels, whereas CA GGSisT-mediated deletion of Sox9 led to ectopic expression of Foxl2 in 
XY  gonads.  These  were  consistent  with  and  confirmed  previous  findings  using  Foxl2 
mutants  or RT-PCR in S o x ^  mice (Ottolenghi et al.,  2005; Barrionuevo  et al., 2006). 
SOX9  and  FOXL2  might  mutually  repress  each  other  so  as  to  reinforce  correct  sexual 
differentiation into either testis or ovary, therefore the deletion of either factor will remove 
the repression effect and lead to ectopic expression of the other. It therefore seems highly 
likely  that  Sox9  and  Foxl2  have  an  antagonistic  relationship  during  mammalian  sex 
determination.  These factors might mutually inhibit the function of each other by activating
159certain paracrine factors, such as FGF9 and WNT4. In the XY gonad, Fgf9 is upregulated 
shortly after the onset of Sox9 upregulation, also coinciding with the downregulation of Wnt4 
(for review  see Kim  and Capel,  2006).  In the XX  gonad, the  absence of SRY (or more 
probably, SOX9), allows the continued expression of WNT4 (which is on in the early genital 
ridges of both sexes), and the downregulation of FGF9, a combination which might then lead 
to the activation of Foxl2 expression (see also Yao, 2004). Although early sex reversal is not 
seen in Foxl2 mutants, Sox9 and Foxl2 may both be required to reinforce cell fate decisions 
taken during sex determination, in part by repressing the opposite pathway.
In  the  granulosa  cell  culture  system,  the  ectopic  presence  of SOX9  did  not  completely 
extinguish Foxl2  expression  in  all  cells.  Presumably,  a cell  will  either express  SOX9  or 
FOXL2. The co-existence (SOX9 as reflected by EGFP) of these proteins within the same 
cell could perhaps be explained by the nature of OHT- induction in cell culture.  As this kind 
of control in gene expression is heterogeneous we cannot assure the time and duration of 
CAGGSET activity. For example, CAGGSET could become activated in a certain cell shortly 
before harvest, allowing insufficient time for FOXL2 to be downregulated. In this case, cells 
that have undergone recombination at the beginning of OHT treatment would have time to 
extinguish FOXL2, whereas those recombined at the end of the treatment would not. Further 
experiments will be required to address how these proteins and their mutual antagonism are 
regulated within this system.
Germ cells
Examination  of gonadal histology revealed differences  in  the  morphology  of testis  cords 
following  OHT-induction,  of CAGGSETCremT\  Sox<T/J  XY  gonads  at  E14.5.  There were
160clear gaps within testis  cords, suggesting possible germ cell loss. The germ cells did not 
express meiotic cell markers, at least at the stage of study. On the other hand, examination at 
El8.5 following induction at El 1.5 revealed more interstitial space in the CAGGSETC re/W T ; 
Sox9d/A  XY gonads. In wildtype testes, the cords were packed with germ cells, but in El8.5 
CAGGSET€re/W T; Sox9*/A  XY gonads, gaps were observed inside several testis cords. Meiotic 
events were also not detected in these mutants. The possibility that germ cells in the XY 
mutant gonads might have entered meiosis can not be excluded, however, as they may be 
eliminated by other male factors, most likely AMH (Josso, 1990). Further investigations will 
include  tunnel  assays,  or  immunohistochemistry  for  activated  Caspase3,  which  reports 
programmed cell death.
Apart from the observed gene expression changes, which included Sfl  and Foxl2, several 
other genetic events must have happened following the alteration of Sox9. These events may 
not be obvious when looking at proteins if these are stable and persist. They will therefore 
require examination of transcripts. Real time reverse-transcription PCR provides an efficient 
and quantitative way to  observe  gene transcription levels  in  different cell types,  and can 
therefore be employed to investigate whether the expression of genes involved in gonadal 
differentiation  is  affected  due to the  alteration  of Sox9.  It will  be  crucial to monitor the 
expression pattern of Sox9 following its alteration, and the genes that are affected by the 
controlled gain- or loss-of Sox9 expression. This will require collecting mutant embryos at 
different stages after induction, to observe gonadal morphology and gene expression at the 
cellular  level.  Sertoli  cells  can  be  labelled  using  Sox9:ECFP  or  its  equivalent,  and  can 
therefore  be  separated  from  other  gonadal  cell  types  using  fluorescent  cell  sorting  for 
comparative examination between different cell lineages.
161It will also be interesting to compare data derived from these experiments with induced Sox9 
alteration with that from Sox9 heterozygous mutants (Sox9wm). Sox9wm tissues can simply 
be obtained at different stages from embryos made by crossing mice carrying Flox-Sox9 with 
those carrying fi-actin-Cre. These can serve as a control in all further experiments concerning 
changes in gene expression patterns, especially to address which genes are sensitive to the 
dosage of SOX9 in the developing mouse gonad.
Some of the additional in vivo studies suggested above are underway, but require extensive 
breeding to achieve the correct combinations of transgenic and mutant alleles, and this will 
take time.
162CHAPTER 7
GENERAL DISCUSSION
This thesis describes the creation of several new tools that rely on conditional strategies to 
study  gene  function  in  mice.  These  include  the  improved-codon  Cre-recombinase  (iCre) 
driven  by  different  regulatory  elements,  which  we  call  “Oe-drivers”,  and  “responder” 
transgenes that allow conditional overexpression of Sry or Sox9.
The Cre/loxP conditional system
The Cre/LoxP system was chosen for these studies. This is the most commonly used system 
to  allow  conditional  gene  alteration  in  mice  and  therefore,  the  new  Oe-drivers  will  be 
compatible  to  many  other  already  established  conditional  alleles.  Another  reason  for 
favouring  Cre/loxP  instead  of,  for  example,  Flp/Frt,  concerns  the  details  of inducible- 
conditional  systems.  Cre-ERT  is  the  most  commonly  available  fusion  recombinase  that 
allows  induction  control,  and  therefore  seems  an  obvious  choice  for  study.  The  recent 
availability of the  improved versions,  iCre  and  iCreERT2,  at the time I began the work, 
meant  that  even  controls  should provide  some  new  information  (Casanova et al.,  2002). 
Several  Oe-drivers  described  in  this  thesis  were  inducible  by  tamoxifen.  Although  the 
alternative  tetracycline-on/off  (Tet-O)  system  may  provide  better  efficiencies  and 
theoretically allows reversible reaction, it requires continuous administration of the inducer 
doxycycline, and also a much longer time to terminate a reaction due to the long half-life of 
doxycycline.  The more complicated genetic build-up required in order to generate the mice
163and  to  achieve  permanent  changes  in  vivo,  was  also  taken  into  consideration.  While 
tamoxifen-inducible Cre requires only two elements to activate the system, namely the Cre- 
ERT-driver and a floxed allele, Tet-inducible Cre requires three elements: a Tet-effector, a 
Tet-responder  coupled  to  Cre,  and  the  flox  allele  (for  review  see  Lewandoski,  2000; 
Bockamp et al.,  2002).  This complexity requires at least four subsequent crosses of mice 
carrying  different  elements  to  obtain  double  homozygotes.  Taking  time  and  the 
administration protocols into concern, the tamoxifen-inducible Cre system was favoured.
The new tamoxifen-inducible Cre-drivers
In this thesis, four elements were used to drive iCre expression.  With the exception of a 
3.2kb Sox9 enhancer element, which was used to drive non-inducible iCre, Daxl, Sfl and a 
ubiquitous CMV enhancer/chicken f-actin promoter were used to drive ERT2iCreERT2.  The 
estrogen receptor-like  domain for tamoxifen-binding  (ERT) has been modified,  such that 
ERT2 is made more sensitive to 4-hydroxytamoxifen (OHT), the active form of tamoxifen, 
and was used in this project.
At  least  one  mouse  founder  from  each  Cre-driver construct  demonstrated  recombination 
activity in vivo, namely Line V for Sox9:iCre, Line M for DaxCSET, Line P for SflET, and 
Line B for CAGGSET.  SflET Line P is lost.  It is not known why all the progeny stopped 
transmitting the transgene. Therefore, additional transgenic mouse lines have to be created 
and characterized to establish the 5/7-inducible Cre-driver. The only founder mouse obtained 
for  AngelBLUE-Sry  is  not  an  expressor,  therefore  more  transgenic  lines  have  to  be 
established with the  aim of conditionally misexpressing Sry in the XX gonad.  Different 
methods were used to create Z/Sox9 mice.  The imported Line  10F was already known to
164express the LacZ transgene at high levels (Cheah, unpublished). Lines C and M created by 
pronuclear injection, also expressed the LacZ transgene at high levels.  Unfortunately, Line 
M was lost due to problems in breeding and possibly to embryonic lethality.
Strong expressors and weak expressors: position effects and genetic background
Different founders carrying the same transgene displayed different expression levels. Also, 
mosaic transgene expression has been noticed in several lines (e.g. Sox9:iCre and Z/Sox9 
Lines  B  and  J).  These  are  commonly  seen  in  transgenic  mice  generated  by  random 
integration,  and  usually  reflect  position  effects  (Kioussis  and  Festenstein,  1997,  also 
discussed  in  Chapter  4).  The  5  different  CAGGSET mouse  lines  generated  are  good 
examples  of this  effect:  the  injected  embryos  carried  the  same  transgene  but  displayed 
different  transcriptional  activities.  This  is  almost  certainly  due  to  different  sites  of 
chromosomal integration (Kioussis and Festenstein, 1997).
To avoid these effects, transgenes can be targeted into identified loci that are not affected by 
DNA remodelling and that are ubiquitously expressed. An example of this is the Rosa26 
locus on the mouse chromosome 6 (Friedrich and Soriano, 1991). Many reporter alleles have 
been targeted into Rosa26 locus, aiming to reflect Cre-mediated activities (Soriano,  1999; 
Srinivas et al., 2001). These mice have been extensively used by different research groups 
and have provided consistent, reliable results. They were also selected for this study to act as 
a  reporter  for  Cre-mediated  activity  (Chapters  3,  4,  and  6).  Particularly,  R26R  EYFP 
(Srinivas et al., 2001) provided 100% reporter protein expression under the mediation of /?- 
actin-Cre mice (Lewandoski et al., 1997a; data not shown), and has served as controls for all 
relevant  experiments  described  in  this  thesis.  To  further  improve  transgene  expression,
165attempts could be made to target a gene of interest driven a strong ubiquitous promoter into 
Rosa26 or similar loci.
Position effects are also likely to be affected by different genetic backgrounds, which are 
different in chromatin structures and DNA remodelling, as well as in sets of genes showing 
polymorphism between different strains (Silver,  1995).  Therefore, activities or expression 
profiles of the same transgene can differ according to the genetic background in which the 
animals were generated or subsequently bred into. Several genes involved in mammalian sex 
determination displayed different phenotypes in different genetic backgrounds. For example, 
Daxl was reported to be important in male development, but only when the conditional allele 
was bred onto C57BL/6 (Meeks et al., 2003; Bouma et al., 2005). Some other mutants were 
bred onto C57BL/6 in order to achieve steadier phenotypes, for example, Fgf9 (Schmahl et 
al,  2004).  In  our  study,  attempts  were  made to  backcross  all  functional mouse  lines  to 
C57BL/6. However, some of these lines displayed (possible) lethality under the influence of 
this genetic background. The most obvious examples were the Z/Sox9 mouse lines. Line 10F 
was generated in a  129Sv/J;  C57BL/6 background,  and was backcrossed to  C57BL/6  for 
maintenance. A significant reduction in litter size has been observed by the third generation 
of backcrpssing. On the other hand, Z/Sox9 Line C was the only line directly generated onto 
C57BL/6, and has so far produced very small litter sizes (n=3-5 per litter). To test if the small 
litter sizes of these lines are related to the C57BL/6 genetic background, Lines 10F and C are 
currently kept on a mixed  129Sv/J and C57BL/6 background.  Flox-Sox9 mice have been 
backcrossed to C57BL/6, and the third generation of homozygotes were recently established. 
Subsequent  crosses  with  CAGGSET mice will be  required to  generate  a conditional null
166allele for Sox9. In future studies, comparisons will be made between Flox-Sox9 mice on both 
the CBA/BL10 mixed and C57BL/6 backgrounds.
The  future ofgonad-specific Cre-drivers
Attempts were made by our lab and others to create Cre-drivers that act only in the gonad 
(e.g. Sfl-Cre, as used in Chaboissier et al., 2004; Amh-Cre, as used in Gao et al., 2006; Amh 
type2 receptor-Cre, as used in Jeyasuria  et al., 2004; Sry/Cre as described in Ito et al., 2006). 
Three common problems have been encountered with these gonad “specific” Cre-drivers. (i) 
The regulatory elements chosen may also give expression in the very early embryo, e.g. Sry, 
Daxl and Sox9 (as reported here), (ii) The expression level or recombination level is not high 
enough  (Chaboissier et al.,  2004;  Ito  et al.,  2006),  and/or (iii)  the  time  of expression is 
delayed compared to endogenous gene expression patterns (Chaboissier et al, 2004; Gao et 
al., 2006; Jeyasuria et al., 2004).  Described in this thesis is a novel Sox9:iCre mouse. One 
line  generated  with  this  construct  (Line  V)  displayed  a  Sertoli  cell  expression  pattern, 
although  its  recombination  efficiency  is  does  not reach  100%  until  El4.5  (Figure  3.10). 
Nevertheless, we have already started crossing this Cre-driver with Flox-Sox9 to try to obtain 
sex reversal phenotype.  Future attempts to make gonad-specific Cre-driver transgenes will 
consider targeting  Cre or its derivatives, including inducible versions,  into gonad-specific 
loci.  Gonad-specific regulatory regions of Sox9 have been identified, and proven to drive 
strong transgene expression in vivo (Sekido and Lovell-Badge, unpublished). Targeting iCre 
or  ERT2iCreERT2  into  the  genomic  locus  of this  region  will  in  theory  allow  robust, 
continuous expression of Cre in a Sertoli cell-specific manner. It would also be important to 
be able to  drive  Cre activity in either genetic sex very early, and Lhx9 ought, at least in
167theory, be able to provide appropriate regulatory elements to do this. To alter gene expression 
in genetic females, the genomic regulatory region of Foxl2 could be considered.
Sox9 and mammalian sex determination - new findings
The biological aim of this project was to ask what happens if Sox9 expression in the gonad is 
altered after sex determination has already taken place. Using f$-actin-Cre mice, Sox9 was 
successfully overexpressed in the XX genital ridge, leading to the formation of cord-like 
structures (Figure 6.2). Unfortunately, mice constitutively overexpressing Sox9 die by E12.5, 
rendering further examination of gonadal development only feasible by either organ culture 
experiments or conditional mutagenesis.
Nevertheless, our studies on misexpression or deletion of Sox9 led to two new findings: (1) 
Sox9 regulates Sfl expression in Sertoli cells, but not Leydig cells in the XY genital ridge, 
and (2) Sox9 and Foxl2 repress each other, so as to repress the opposite sexual development 
pathway (Figure 7.1).
SF1 was detected in XX gonads overexpressing Sox9, and it co-localized with EGFP, being 
used  in  this  case  as  a  reporter  for Sox9  expression  (Figure  6.4).  Moreover,  CAGGSET 
mediated Sox9  deletion  led  to  the  downregulation  of SF1  in  Sertoli  cells  (Figure  6.15). 
Expression of Sfl in Leydig cells was not affected by the partial loss of Sox9 (Figure 6.15). 
In vitro experiments have demonstrated the importance of SOX9 in activating Sfl (Shen and 
Ingraham, 2002). Our data therefore provide the first evidence in vivo to conclude that Sox9 
is not only essential to upregulate Sfl  expression in Sertoli  cells, but is  also required for 
maintaining the expression of Sfl in this gonadal cell lineage.
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Figure 7.1  Schematic diagram of the curcnt genetic pathway involved during sex determination in the mouse.
Newly identified genetic regulations were highlighted in red lines.  Genes in the male pathway arc in blue; 
whereas those in the female pathway are in pink.
Foxl2 is a proposed antagonist of Sox9 during mammalian sex determination (Ottolenghi et 
al.,  2005;  Barrionuevo  et al.,  2006). Foxl2 transcripts have been detected  in XY gonads 
depleted  of Sox9  (Barrionuevo  et  al.,  2006).  Using  immunohistochemistry,  we  located 
FOXL2 positive cells  in Sox9*/A  XY gonads to testis cords,  indicating that these FOXL2 
positive  cells  were,  or  rather  had  been  Sertoli  cells.  Foxl2  was  also  downregulated  in 
embryonic XX gonads misexpressing Sox9, (Figure 6.11) and in adult granulosa cells that 
were misexpressing Sox9 (Figure 6.13), further strengthening the belief that Sox9 and Foxl2 
antagonize each other during gonadal development in mice.
Attempts have been made to delete Sox9 in vivo by CAGGSET. Results showed that testis 
cord structures were moderately disorganized. Surprisingly, Amh, a direct downstream target 
of SOX9 in Sertoli cells (Arrango et al.,  1999), did not seem affected. Several hypotheses 
could explain this:  (i) The maintenance of Amh expression in Sertoli cells is independent of 
the levels  of SOX9  and perhaps  SF1.  In other words,  SOX9  may be required to initiate
169expression but other factors can maintain it (e.g. GATA4, WT1, etc), (ii) The AMH protein is 
very stable in the absence of SOX9 (and SF1).  (iii)  SOX9 protein is itself stable (in the 
absence of new transcripts). Further investigations will be required to draw a conclusion.
Despite  the  limited  efficiency  of  CA GG5£T-mediated  recombination  in  Sertoli  cells, 
CAGGSET is still useful to study the regulation of genetic events in Sertoli cells (or other 
gonadal  lineages).  For example, the downregulation of Sfl  in  Sertoli cells  in CAGGSET- 
mediated Sox9*/A  XY gonads  suggests  further experiments to look at possible changes in 
other  markers.  This  can  be  done  by  immunohistochemistry  on  protein  levels,  in  situ 
hybridization on transcript levels, and more importantly, using real time RT-PCR to quantify 
differences in gene expression levels between mutant and wildtype gonads.  Alternatively, it 
would be possible to make us of cDNA microarrays. The results of these experiments will 
highlight the genes regulated by SOX9 in Sertoli cells.
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1.  Inoculate a single colony of bacteria of interest in 5 ml LB and incubate at 37°C overnight shaking at 250 
rpm
2.  Transfer 1  ml of overnight culture  of 1L of LB  and incubate with shaking at 37°C until OD=0.5-0.6
3.  Centrifuge at 3000 rpm  for 5 mins
4.  Discard supernatant. Resuspend pellet in 40 ml of ice-cold sterile ddwater.
5.  Sit on ice for 30 mins
6.  Centrifuge at 3000 rpm  for 5 mins
7.  Resuspend gently in 20  ml of cold  ddwater with  15% glycerol
8.  Aliquot 50pl, freeze immediately with N2(l)
9.  Store at -80°C
Appendix B: Tail lvsis buffer (for phenol extraction)
Buffer consists of (per lOOmL):
1M Tris Ph7.5  5mL
0.5MEDTA  lOOpL
20% SDS  2.5mL
Water to 50mL
Per sample use 95pL buffer + 5pL proteinase K (20mg/mL)
Appendix C: B-galactosidase (X-gaD staining
1.  Wash embryos/tissues in IX PBS—CMF
2.  Fix in fresh cold fixative.
Fixative: 0.2% Glutaraldehyde (stock 25% at -20°C), 2% Formaldehyde.
- 80pL 25% glutaraldehyde + 540pL 37% Formaldehyde / lOmL L < > .
For cells, fix for 10’ r.t. (NO MORE THAN 20’)
Whole embryos up to 8.5dpc, fix for 5’, add 5’ for each day onwards, 4°C with rocking.
3.  Wash trice, 5’ with Buffer L0.
4.  Add fresh-filtered LacZ staining solution.
Staining base: lmL 500mM K3Fe(CN)6 + lmL 500mM K4Fe(CN)6-3H20  (both 4°C) per 50mL Buffer L. 
X-gal stock 50mg/mL in Dimetayl Formamide at -20°C.
Fresh staining mix: 1/50 dilution of X-gal in staining base, mix well and filter before use.
37°C or 25°C, time varies with strength, from few hours to O/N. (TRY TO MONITOR EVERY 30’)
5.  Wash trice 5’ PBS-A.
6.  Embryos/tissues can either be stored in PBS or refixed with 4% paraformaldehyde.
Buffers involved:
Buffer L (Cells and early embryos):
Phosphate buffer (PB), pH7.2 
MgCl2
EGTA  (stock 0.5M)
NP40  (stock 4%)
Sodium-Deoxycholate (stock 1%)  0.01%
Buffer L0:
Phosphate buffer (PB), pH7.2, lOOmM; MgCl2,2mM; EGTA, 5mM 
Phosphate buffer (PB), pH7.2:
Per 500mL of 0.1 M sodium phosphate stock (water based), add
34.2mL Na2HP04, 1M stock, pH7.2; 15.8mL NaH2P04, 1M stock, pH7.2.  Filter before use.
lOOmM
2mM
5mM
0.02% (0.2% for adults) 
(0.1% for adults)Appendix D;  Genotype abbreviations used to describe mouse genotype in this thesis.
Description of genotype Genotype abbreviation Referring to As in publication
Presence of transgene CAGGSETiC re/iC re Homozygous for iCre unpublished
Presence of transgene CAGGSETiC re/W T aHeterozygous for iCre unpublished
Presence of transgene Z/Sox9-L acZ /W T Heterozygous for LacZ unpublished
Presence of transgene Z/Sox9-gfp/wt Heterozygous for EGFP unpublished
Presence of transgene Cre+ Homozygous for Cre l(3-actin-Cre homozygotes
Floxed allele Sox9F lox/Flox Both alleles of Sox9 floxed 2Sox9nox/flox
Floxed allele Sox9f1 o x/wt One allele of Sox9 floxed 2Sox9flox/+
Floxed or deleted allele Sox9fl/a One allele of Sox9 floxed, the other deleted N/A
Unaltered and delete allele Sox9wt/a One allele of Sox9 unaltered, the other deleted N/A
Deleted allele (assumed) 80x9^ Both alleles of Sox9 (partially) deleted 2Sox9'/'
aalso refers to the presence of iCre in all ERT2iCreERT2 or iCre transgenic lines 
*Lewandoski et al., 1997a 
2Chaboissier et al., 2004
Genes presented in superscript refers to the identification of the presence of a transgene by PCR. WT: locus not altered.LIST OF PRESENTATIONS
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I transformation from a single cell to a functional organ involves events that happen in a highly temporal and cell-specific manner.  To study these events, which take place at the genetic, molecular and cellular levels, we need 
Is that allow us to regulate gene expression and thereby all downstream events in spatial and temporal manner. Last year, we presented the establishment of a ubiquitous, inducible Cre transgene (CAGGSET) that allows us to 
U rol the timing of gene expression in different transgenic systems.  CAGGSET is shown highly specific to tamoxifen or 4-hydroxytamoxifen (OHT), and has been proven functional in several different experimental situations, 
hiding cell and organ culture, in ovo electroporation, and also in vivo.  Due to the mosaic expression pattern of CAGGSET, we can look at downstream events in a cell-autonomous manner, i.e. not affected by the surrounding 
ironment.  Here, we demonstrate with examples how tissue-specific recombination studies in various parts of the body and at various stages would benefit from the use of CAGGSET.
e research focus of the lab is sexual development in mammals.  We use CAGGSET to alter gene expression patterns in the mouse, aiming to look at the downstream effects of loss- or gain-of-function of different genes.  The 
hple for demonstration here is Sox9, which is known to be essential for testis determination and male development in mammals.  The effects of Sox9 alteration after sex determination remain unknown.  Using CAGGSET, we 
eveal molecular changes of the developing gonads that have altered Sox9 expression.  We focus here on Foxl2, an ovarian-specific gene that is thought to antagonize Sox9 function in the developing gonad.  The changes in 
’ expression patterns following Sox9 alteration will be discussed.
(I  III  I Ills  IHVM'II r  I  ii pic 4*\ 
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I positive for CAGGSET and have both Sox9  alleles floxed (Sox9tvn)  were crossed with 
j®” mice.  Pregnant mothers are injected with OHT at different stages dunng gestation, 
tmbrvos were harvested at different stages after OHT-mduction.  Molecular differences 
t gonad arc compared between embryos that are positive or negative for the CAGGSET 
gene.  Demonstrated here is the ectopic presence of the ovarian-specific marker FOXL2, 
h can be detected only in the presence of CAGGSET activity.  Note that in many cases, 
positive for FOXL2 are located very  closely to, or in some cases co-labelling with, 
ill cell maker AMH.  This suggests that these cells might once belong to the Sertoli cell 
ge, but somehow left the testis cords due to the loss of Sox9.
XX gonads that arc positive forboth CAGGSET and a conditional Sox9 misexpression transgenc 
( 7JSox9) were cultured in the presence of either OHT or the carrier, ethanol, in the culture 
medium.  Comparison is made between the two.  In the presence of OHT, which activates  |  1  
CAGGSET.  significant levels of SOX9 could be detected (D-F) in the gonads, as compared  i  I 
to gonads cultured in the presence of ethanol (A-C).  Also noticed is a downrcgulation of 
FOXL2 (J-L), an ovarian-specific marker known to be important for ovarian maintenance,  i
In order to test the effect of Sox9 misexpression in the postnatal ovary, granulosa cells, which 
belong to the same lineage as Sertoli cells in the testis, are placed in culture.  Female mice 
positive for both CAGGSET and the conditional Sox9 misexpression trausgene Z/Sox9  were 
induced for supcrovulation at the age of 3 weeks.  Granulosa cells were taken out for culture in 
the presence of either OHT or the carrier (ethanol).  In the presence of OHT, Sox9 expression 
can be indued. Also noticed is a reducton of levels of FOXL2.
fferent markers downstream of Sox9 have been looked at.  We aim to produce a real time curve of genetic events following Sox9 alteration in the 
veloping gonads.  To do this we will do a real-time PCR for all known gene candidates.
e are using ISH to look at the difference between RNA and protein levels, in order to understand more about gene-gene interaction and events and 
olecular pathways.
ake 7JFoxl2 mice to study the effects of Foxl2 misexpression in the XY gonad. 
ix9, Foxl2 double deletion: what will the gonad look like??
We thank Andreas Schedl and Kathy Cheah for the Sox9 conditional mice; Rold Sprengal and Jinny Kim for the 
|  ERT2iCreERT2 constructs; staffs in the Biological Services Unit who take care of. make and re-dcrive mice, 
j  particularly Sophie Wood. Lorraine Allan and Marie Caulfield.
i  The presenting author would like to thank everyone who has been using CAGGSET for their experiments and have 
'  kept faith in it!
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